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ABSTRACT
1bc frequent use of antibiotics, and the ensuing i.naease in bacterial resist.ance'.
has caused much CODCern in the medical community in recent years. This study examines
antibiotic p~bing from various perspectives. utilising prescribing information from
several SOwt:C:S including market rescareb databases. a provincial prescription drug plan.
bospiwl'el:ords and patient-specific informationo~ through chart review. Overall
quantities and types of antibiotics prescribed have been studied at a national level
comparing both Canada and the USA at a provincial level using prescription claims data
for specific facets of the Newfoundland population. at the community practice level
utilising chan review of a representative sample of patients in the communities of St.
John's and MOUDt Pearl. Newfoundland and at the hospital level using chan review.
Examination of national prescribing databases and the Newfoundland provincial
database has demonstrated similar prescribing trends. Amolticillin was the most
commonly used antibiotic. penicillins accounted for the gmttesl proportion of total
antibiotic prescriptions. a decrease in the amount of penicillins used was noted, and an
~ in macrolide use was Stt8 across all three longitudinal databases. The cross-
sectional study of community practi~ in St. John's demonstrated that amoriciUin was
the most frequently used antibiotic. and the proportions of total antibiotic use comprised
by each antibiotic drug class~ similar to those seen in Canada.
The Ontario Anti-infe<:tive Guidelines for Community-acquired Infections' was
chosen as the tool for measuring prescription appropriateness in community practice.
When the physicians' diagnoses were assumtd to be correct. 59% of prescriptions were
appropriate. Using a criteria-based de<:ision tree to predict etiology, 88% of rnpiratory
tract infe<:tions were likely to be viral, while the physicians thought that only 44% were
viral. The ~atmcnt recommendations outlined by the Canadian Community Acquired
Pnctunonia Consensus Conference Group2 were used to assess appropriateness of
antibiotic treatment in patients admined to hospital with community acquir'N pnetunonia.
Si:o;:ty five percent of initial antibiotics and 59'"/0 of secondary oral antibiotics were
appropriate. However prescribing guideline adherence was much lower for patients with
less severe community·acquir'N pneumonia
To decrease inappropriate and excessive antibiotic use, it is necessary to fim
detennine the: nanae of antibiotic prescribing. The results from this analysis allow for
specific problematic amlS in a.ntibiotic prescribing to be idC'lltified. From this,
interventions to improve ~ribing behaviours can be implemented.
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CHAPTER 1-INTRODUCf10N
1.1 B.~kvou.d or ShHIy
The development of antibiotics has greatly contributed to the eradicatioo of many
infections which were once untreatable before the advent of antimicrobial agents.
However this pharmacological advancement in clinical medicine has DOt occurred
without consequence. In order to survive environmental pressures and attacks on
viabiliry, bacteria have developed several mechani$lIlS to resist eradication. Most notably
bacteria have the capability to become resistant to antibiotics. SeveraJ lines of evidence
have suggested a causal relationship between antibiotic use and the development of
antibiotic resistance in bacteria.J..IO At present, bacterial infections have emerged in
which the causal organism is resistant to most or all available antibiotics. thus making
some infections untreatable. II. 12 [n response to this very serious public bealth issue, it is
necessary to e~ that antibiotics arc only prescribed for scenarios in which medical
indication warrants their usc. As bacterial resistance is a response to antibiotic use, the
problem of resistance may be concrolled by judicious antibiotic prescribing.
In Canada, antibiotics for human conswnption can only be obtained through
prescription by a physician. Therefore these agents can be ~bed in such places as a
hospital or in community practices by both general practitioners and specialists. Each of
these care facilities or locations pose unique problems with regard to antibiotic resistance.
In the hospital, resistance is perpetuated by the abundant use of broad spectrum agents,
prescribed because of the severity of illness of many patients requiring care.
Furthermore. the close proximity of patients in hospital promotes the spread of infection
among patients. thus requiring further antibiotic use, as well as the spread of resistance
genes among bacteria. Approximately 80% of aU antibiotics lft prescribed in
community practice settings. IJ It has previously been proposed that many of these
prescriptions are unnet:essary; one of the most common reasons for an antibiotic
prescription by a family doctor is for respiratory trace infections. such as the common
cold, which are predominantly viral in nature. As a result, many more antibiotics are
being prescribed and consu.med than medically indicated. IMS Health Canada has
determined mae approximately 10-/0 of all prescriptions issued are for antibiotics. This
amounts to 25.4 million antibiotic prescriptions for a population of approximaaely 30
million people. Therefore. on average, about one antibiotic prescription is administered
for each Canadian citizen in a one year period. It is likely that this excessive use has
contributed to the: problem of bacterial resiscance.
1.2 Pu!])OK of S!Pdy
The problems sunounding antibiotic use bave been a tOpical issue in recent~ A5
a result. investiga1Ol"S have undenaken stUdies examining bow antibiotics are prescribed
in the \<Uious bealth can: seeton.. Valid drug use data me essential for determining bow
antibiotics are prescribed. Medical practice panems of antibtotic usc utilisina: patient
specific data impart valuable infonnatioo thai can be used for intervention fIlD"PO'CS
focussed on improving the prescribing habits of the: physicians. Fu:rthmnore, because of
the concern for antibiotic ~istanee, antibiotic utilisation data can aid in predicting fi.tturc
dilemmas regarding bacterial resistance that may arise as a direct result of antibiotic usc.
Geographic variations in lbe prescribing of antibiotics exist. ~fore it is
importanl to study locaJ antibiotic prescribing practices in order to specifically determine
potential JRSCTibing problems lhal: may be present in the: defined population of inteTe5t.
This study has obtained valid data in order 10 study the determinants of antibiotic
prescribing in SL John's, Newfoundland examining both prescribing io community
practices. as well as in-hospital antibiotic: prescribing for patients with community-
acquired pneumonia. Specifically, 11 cbatt review study was conducted in geomU
practitiODCTS' offices to investigale antibiotic prescribing for community infectioos. In
addition to this, antibiotic prescribing databases were obtained from the Newfoundland
and Labrador Prescription Drug Program and IMS Health Canada for comparisoo with
the community antibiotic prescribing trends captured in the chart review study. A cban
review study was also conducted to investigace bow antibiotics are prescribed for patients
admitted to hospital with the diagnosis of cornmunity·acquired poeumoaia.
Although quantification studies provide important insigbts into the types of
antimicrobial agents that are regularly used and the indical:ions for which they arc:
prescribed. it is also important to examine the appropriateoess of these prescriptions. It
has been suggested that measures of approprialc:pcss have been avolded because of
difficulties in assigning 3 tangible and quantifiable definition of appropriateness as it
relates to antibiotics. I. Pan of this problem stems from the soun:es of prescribing
information that are available (i.e. administrative databases compared to patient-specific
infonnation obtained through chart review). The cWRDt study has utilised a chan revlcw
process to obtain maximum information so that one may accunuely assign
appropriateness ratings. Fu:rtheTmore SC"YeraJ appropriauness rating tools have been
employed such as the Anti·infective Guidelines for Comnumity.ac:quired infectioDs l as
well as the Canadian clinical practice guidelines for the tre:aaDeot of community acqwm
pnNmOnia. ~ Once appropriateness has been evaluated. specific pre:saibi.ng problems can
be easily identified. With knowl~ of these specific pre:scribing problems. focuued
interventioos to change pn::scribing behaviour can be developed and implemented with
the aim ofdecreasing unnecessary antibiotic usc.
CHAPTER 0 - LITERATURE REVIEW
2.1 Baeterial RcsisullCt
2.1.1 DcrUlitioll of A.tibiotics ..d Medluis...f AdioI.
Antibiotics are defined as compounds, either occurring naturally or produced
synthetically, that can kill bacteria directly (bactericidal). or prevcot the growth and
proliferation of these microorganisms (bacterioswiC).15 It is thought that antibiotics
originated from microorganisms as natural products made to protect these same
microorganisms in their ecosystem.16 For example soil streptomycete intrinsically
produces the antibiotic streptomycin. To swvive. however. the soil strepIomycete had to
be rcsistanl to its own antibiotic that it produced. 11 1beft:foR the phenomenon of
antibiotic resistance 0CCUJ'ftd naturally, loog before antibiotic thenpy became: a routine
pan of dinic:al medicine:. The bacterial resiswK:e genes presumably continued to evolve
as a result of interspecies competition. Retrospective studies bllve dCDKlllSO'alCd that
cenain miCTOOf"glUlisms W'Cfe rcsistmt to particuJar antibiotics. before these antibiotics
were developed for med.icinai purposes. lhus dcmonstt'ating that antibiotic rcsiSlanCC
occurs naturally. II
Antibiotics act on and evenNaily kill bacteria by inhibition of one or mon: of the
following five bacterial cellular events: ceO wall synthesis, cell membnmc function.
protein synlhesis, nucle1(: add synthesis and metaboli(: pathways.. Antibiotia can be
dassificd according to their mcchani.sms of action. Antibiotia whi(:b inhibit <:ell waU
synthesis arc: the ~Lactams. wbkb indude peniciUins. cepbaJosporins. carbapmc:m..s.. aDd
monobactams. Gencr.illy tbe:sc: antibiotic:s oombet t.;teria by aossing the bacterial (:ell
wall and binding to str\I(:tures alled penicillin binding proteins (PBPs). UDder normal
drcWTlSlarKCS, the activity of PBPs involves c:ala1yzing the (:ross-linking of
peptidoglyaan (:haW in the bacterial (:ell wall. Tbe:se cross-links provide the strueturaI
suppa" of the (:ell wall. When the p.lactam drugs bind to the PBPs. the peptidogly(:M
cross-linking is inhibited, thus oompromising the strength and integrity of the bac:lerial
(:ell wall. whj(:h inevitably leads to osmoti(: rupture and (:ell lysis. 19 These antibiotia IR
thereforebaC1eric:idal.
Antibiotict wtU(:b disrupt protein synthesis inl:hJde the tetraeydiDes.
aminogJywsides. macrolides, chlonunpbeniool. clindamyciD and spectinomycin. The
teU1lCyciincs act by binding to the: 30S subulit of the: becterial nDosome. This binding
inhibits blK:tcriaI protein synlhcsis by preventing the amiDe ac:y1-tRNA from forming a
complex with the mRNA·nbosome. The aminoglyc:osides and spc:ctinomyciD also bind
to the 30S ribosomal subwtit and block protein synthesis or cause the ribosome to
misread the gcneti(: code. Macrolides and c1indamycin bind 10 the SOS ribosomal
subunit., thereby inhibiting the translocation step of protein synthesis. Chlonunpbeniool
also binds to the: 50s subunit. but prcVenI$ proteiD S)"Dthesis by inhibiting the peptidyl
transferase reaction."
The anti-bacterial action of the quinolone groups of antibiotics is facilitated
through the: inhibition of DNA replication. This is accomplisbcd by interfmng ...,;th the
IICtivity of the DNA gyrasc: enzyme called topoisomerase D. 1bis enzyme is responsibk
for unwinding the bacterial DNA in preparation for replication. The quinolones
inactivate the DNA gyrase enzymes. thereby preventing DNA replication.I'
The group of antibiotics which act through inhibition of metabolic pathWllYs is the
sulfonamides. nus is accomplished by either inhibiting folate synthesis or preventing
folate reduction. The active fonn of folate is required by bacteria to aid in absorption of
folic acid. Many of the sulfonamides. which are similar in structure to p-aminoben2oic
acid (PABA) (a substnd.e required to synthesize: fo1alc). compdc with PABA for the
activity ofthc enzyme dihydropleroate synthetase., thus preventing the synthesis of folale.
Trimethoprim is an inhibitor of folate reduction. For folate to be active. it must be
reduced by the enzyme dihydrofolate reductase. Trimetboprim is a potent inhibitor of
this specific enzyme.I'
2.1.2 Mec:h.aisDII of ADtibiotic Resistaace
Bacteria have the ability to overcome the eradicating effects of antibiotics in a
variety of ways. "There are three well described methods in which bacterial resistance to
antibiotics is manifested. These combative resistance mechanisms include production of
antibiotic inactivating enzymes, changes in cell wall penneability and altered structural
targets.2G-ll
The first method of bacterial resistance is through enzymatic degradation of the
antibiotic. For example some bacteria produce ll-Iactamases which function 10 cleave the
~.Iaetam ring. Antibiotics which act through the destructive mechanisms of ll-lactam. are
rendered ineffective in the presence of ll_laetamases.21 However some 13·lactam
antibiotics have been developed which are resistant to the enzymatic activity of ll-
lactamase (ex. methicillin. oxacillin, cloxacillin. dicloxacillin).20
A second mechanism of resistance involves changes in the bac1erial cell wall
permeability. For example, some ~teria have developed cell membrane permeability
resistance through the production of efflux pwnps. Efflux pumps function to actively
extrude antibiotics from the bacterial cell immediately after the antibiotic has entcmJ.
lberefore a high enough concentration of the antibiotics is never reached to ensure that
the antibiotic can act against the bacteria This type of resistance has been effective
against tetnw;:yclines, macrolides and quinolooes.22
A third mechanism of resistance involves altered sttuetural targets tba1 antibiotics
bind to. For examplc the p.lactam antibiotics require bindiD& to POPs for the KtioD of
the antibiotic to OCC\D'. Some organisms have devcloped resistance to l>1actams by
altering the 5t/'UCtlJI'e of thc:sc: POPs. tbc:refore prevcnti.ng the binding of p..lacums. ODe
examplc of this phenomenon is the~ of methicillin resistant SuzphylococCKJ
awt'KS (MRSA). This miaoorganism produces PDP2&. whicb is a suucnaaJly altcml
fonn of PDP. encoded for by the MecA gene. Consequently P-Iaetam5 cannot
successfully bind 10 it and disrupt peptidoglycan cross-linkiDg.ll
2.1.3 Traa.miuio. of Aatibiotic Raisa.a
11Jc resistance of bacteria to an antibiotic can ~i1hCT be intrinsic or acquimi.
rntrinsic resistance is common to and expressed by all members of the genus or species.
This type of resistance involves a naruraJ characteristic that t.c1cria may posses by the
nature of their morphology (ex. gram-negative bacteria resistam to vancomycin) or by
inductive C'X'pfaSion of a Ialent chromosomal. gene. 19 Acquired resistance is • result of
the cransfer of resistance de1mninants or genes from ODe rnicroorpnism to another.
l'b:rero~ this particular rc:sistancc pbenomcnoo is found ooJy in a few members of the
genus or species.
In geoera.l. bacteria can acquire resistance through two mechanisms. The simplest
mechanism. by which bacteria can develop resistance is through gene mutatioo. The more
predominant method is through gene acquisition.2" ~ Through the former process., a
random mutarioo in a bacterial gene may. for example. produce strue:turaI. changes in the
bacterium itself. This change may alter the binding site for the antibiotic: or change the
permeability of the bacterial cell walLn.21 As a result, the antibiobc: can no longer- pass
into the bac:teriwn or bind to a specific target within and is therefore rendeRld ineffective.
The development of resistance in Mycobacterium fllbunJosis is an example of this
phenomenon. Sequential genetic mutations have resulted in strains of M lUMrcuJosu
which are resistant to at least five antibiotics due to mutational alterations in the affinity
of antibiotic binding.26 Bacteria containing these random genetic mutations are selected
for in environments in wttich antibiotic use is substantial.
The second mechanism fOf" developing bacterial resistaoee involves the
acquisition of hctttelogous resistance genes by blIcteria.21 The exogenous genes
presumably originate from bacteria thai are intrinsi<:aJly resiSWlt to antibiotics.2• 1be
exogenous determinants may be ttansferred between bacteria by plasmids. transposons..
or inscrtiOl1-"sequencc: mecharUmu..2J 1bis exchange. of genetic material caD occur via
transformation (dirc:ct exchange of chromosomal DNA). transduction (genetic: exchange
via bacteriophages) or by conjugation ofplasmids {cell to cell conUK:t through a sex pilus
for the purposes of exchanging extrachromosomal DNA).19. 21 Tl'VlSp05OnS are smaJl
groups of mobile genes that typically travel from ODe organism and are incorporated into
another organism via the IJ"avels of becteriopbages." Because of this effective ability to
10
transmit genetic infonnation. including resistaDCe gmes. from ODe bacterial species to
another. a wide variety of bacterial miCl"OOrganisms can quickly inherit resistaDcc traits
which set"i'e to protect the bacteria from the harmful effects of various antibiotics.
2.1.4Iaplic:lltiou or RaisulKt ia Cldiieal Pncdce
Use of antibiotics exerts a selectivep~ on the deveLopment of resistance
traits in bacteria. Because of this. the overuse of antibiotics has significantly contributed
10 the erosion of the efficacy of antibiotic tre8tmenLH It has been proposed that because
of this decreased efficacy of antibacterial treannent, we arc returning to the pre-.antibiotic
era in which some bacterial infections were untreatable.29
Several common pathogens giving rise to infections in the commwtity have
become increasingly resistant to SWJdard therapy.Z'. 19 Pathogens such as StrflplOCOCnlS
pMllnJ(Hfioe. Hrxmophilw injlw'fZM aNi MOf'ta~//Q cQ1arhaJlis, which arc common
respinuory palhogcns. are demonstrating iDcrased res:istaoee to antibiotics.Z' This is
clinically important in that the vast majority of antibiotic use in community practioe is for
respinuory infections.JO• JI Given that antibiotic use exerts sekctive~ for the
SW'Vival of bacteria w;th resistant traits against the antibiotics thal pathogens are exposed
to. it is possible that future bacterial respiratory infections may become d,ifficuh to treat.
PnewnOC()CCi. for example, are the leading cause of community-acquired infections such
as otitis media, sinusitis. meningitis and community-acquired pneumonia. II A recent
II
srudy examined facton assoc1aled "''ith increased mortality from confirmed
pneumoc:occaI. pneumonia (community.acquired) R:quiring bospitali23tioo.12 When
deaths that bad occ:urred within the: first four days of hospitaliurioo wen: ~ved fiom
the analysis. iDcreased monality was associaled with penicillin and cefOlaXlme resistance
in pneumoc:occaI. isolates.12 Methicillin-resistant StaplryiOCtKnlS aavew- (MRSA)., wbi<:h
was previously only • fac10r in nosocomial infections, has been detcctc:d in community
infections as wt:1I.u Therefore resistant organisms causing community-acquircd
infections are becoming an increasing community public health problem. due to
decreased efficacy ofme antibiotics used to previously treat these same infeetil>os.
Antibiotic resistance has typically been a much greal:Cf problem in hospitals.
Resistance rates an: higher among pathogens giving rise to nosocomial infcctioos. as
compared to community.-:quired infections.2S For example Archibald and colleagues
collected bacterial isolates from both inpatients and outpatients al eight hospitals in the
US.}oI The invcstipon tested the isolates for specific combinations of pubogcns and
antibiotic resislancc: and found thai l"CSistaoee was much higher amoug the samples taken
from inpatients. particularly those admitted to the intensive c:are unit.}oI
Bacterial resistanoe has become an incrQsing clinical problem in hospitals. A
poignant example is the very serious problem a.ssociated with escalating resistaDCe in
Enterococci species. Enterococci species are the socoDd leading cause of nosocomial
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infections and the third most commonJy isolated bacteria in positive blood cultures in the
United States.lS Surveillance studies on enteroeoeeal resistance in hospitals have
revealed that resi~ to vancomycin has increased from 0.4% of isolatcs in 1989 to
13.6% in 1992.16 Incidentally some strains of enterococci have developed resistaDCe to
all other antibiotics normally used to treaI these particular bacteria (i.e. ampicillin and
aminoglycosidcs) and an: intrinsically resistant to other antibiotic classes (i.e. penicillins.
cephalosporins and macrolides).l1 Therefore enteroc::occal species, which an:: DOW
resistant to vancomycin (VRE), represent a particwar strain of bacteria present in
hospitals that are potentially untreatable. VRE were predominantly limited to the ICU,
but spread throughout the rest of hospitals has occum::d.17 The mortality rate associated
with bacteremia caused by VRE may be as high as 50%.3'
Bacterial resistance to antibiotics is a serious clinical problc:m with polcntially
very severe adverse conscqucncc::s. The: nature of bacteria and their ability to adapt to
their environment make the problem of resislance a difficult OBC to solve. HO~CT
prudent usc of antibiotics would help 10 cn.sure !hat further development of resistaDCe
would be minimized, thus preserving the armamentarium we presently have against
bacterial pathoycns.17
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2.2 Global Aatibiotk UN
2.2.1 Qa_tUk.1iHI of UN
In 1987. Col and O'Connor published a study which examined worldwide total
antibiotic use. combining inpatient and outpatient prescriptions.}9 Allbaugh lhis study
had several limitations related to !he questionable quality and quantity of !he available
drug utilisation data across various countries and differences in how this data was
collectc:d, nonetheless a striking trend emerged. The investigason discovered that lhen:
~ large diffettnee5 in the panems of antibiotic use across the various studied
countries. These differences not only were evide:nt in the overall quantity of antibiotic
use. but also in the typeS of antibiotics that were dispensed. The authon folIDd tba1
antibiotics comprised berween 3% and 25% of all prescriptions in 1983. with the higher
proportions found in Latin America rather than European cowlO;es.19 Developed
counaics tended to usc less antibiotics than developing couna'ies.J9 With regard to
specific panerns of usc. some examples of trends include incrca5cd usc of te1lacydine
and amox.icilliD in developed COWlrrics and higher usc of ampicillin in developing
countries.J9 At the time the study look place (early 1980's), Spain bad the higbest use of
TMPISMX. while Japan had the highest use of ccphaJosporins.)9 The United States used
the most erythromycin while Australia had the greatest number of prescriptions for
doxycycline and tetraeyclioe.J9
'4
McManus e1 al. used data from lntcn:ontiMntaJ Medical Statistics (lMS) to
demonstrale how retail sales of ot'ilJ antibiotics comparal. across selected developed
countries using Defined Daily Doses (DDDsYIOOO PopuIatiOlllDay.~ The World Health
Organization Collaborating Centre for Drug Statistics Methodology defines a DDD as the
asswned avcnlg~ daily dose of a drug for its IIIain indication in adults..41 Aa:ording to
this data source the ranking of countries. from highest consumption iD 1994 was as
follows: Ff'8tICe, Australia, United StaleS, Canada, Italy, United Kingdom and West
G~nnany.~ The United States sold approximately 24 DDDsl10001Day wh.il~ Canada
sold approximately 21 DDDslIOOOlDay."O The authors abo demonstrated that between
1989 and 1994. ail the studied countries ~xcept Australia and Canada demonstrated a
growth in antibiotic sales.. ranging from 2"10 in the United Slates to almost 5'1, in West
Gcmt.any."O
Other studies have been conducted in various countries examining ovenJ.1
antibiotic utilisatioa trends. including antibiotics prescribed in both inpatient and
outpatient settings., within a specific geographical region. For ~xample. a 1978 study iD
the United Stales reponed a steep rise in antibiotic USC from 1965 to 1973. but then a
7.5% decline occurTed between 1973 and 1977.42 Within the scope of the study's
timeframc. the highest usc of antibiotics occUlTed iD 1973 in which 199.5 million mail
antibiotic prescriptions wen: documented.42
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One Swedish study. reporting consumption between 1975 and 1987. found that
toW antibiotic consumption changed very little over the twelve yeN period of study in
this cowury. During this time. the consumed amoum varied betwc:m 49 and 51 miUioo
ODDs. for a population of approximately 8 millioa pcople.o Treods related to specific
antibiotic groups were noted. For example. aminogJycoside use remained constant. while
cephalosporin use had increased between 1982 aDd 1987.43 nus increased use was
thought to be due to an incn:ased trend towards using cefaclor for the treatmenl of otitis
media in children. lbe aUlhors noc.ed a decreased use of the folate inhibitor group of
drugs such as !he sulfonantides and TMPISMX.43 The mosc commonly uscd: antibioti<: in
Sweden during this time was penicillin. although t*ionaI consumption was lower IhaD
thai. ofother" Scandinavian counme:s.·J
Birkett and collc:aguc:s profiled antibiotic use in AUSO'aIia betwc:m 1987 and
1989." Martel research data was used to compve AUSInlia's use of antibiotics with that
of Sweden and Norway. lbe authors fouod thai JMflemS of use in AusInI1ia ditfen::d
substantially ftom the compari5OQ COW1me:s. For example. 76% of antibiOlics used in
Au:stralia were tnracycline:s. broad specttum: penicillin:s aDd TMPISMX. FOI" Sweden and
Norway, the comparable proportion of tot.aI. antibiori<: use was )5% and 46%
respectively." Conversely penicillin comprised 6% ofantibiotic:s in AustnlIia. while this
same drug acxounted for 45,.... and 34% of use in Sweden and Norway respcctiwly."
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Overall antibiotic usc: had increased by 26-;. in Australia between 1987 and 1989, going
from 36.1 ODDs/lOoo populationlDay to 45.6 OODs/IOOO populationlOay.44
&th England and Scotland experienced an increase: in antibiotic prescribing in
the early 1990's. BetWeen \990 and 1991, antibiotic prescribing increased by 1001. in
England rising from 38.212,000 prescriptions to 42,090,000.•5 Similarly Scotland
increased its antibiotic prescribing from 4,685,000 prescriptions in 1992 10 5,226,000
prescriptions in 1993. represcnting a 12% rise. t5 For both counaies, part of me increase
in prescriptions was attributable to a rise in the usc: of ampicillin. For England in
particular. lberc was a 51>-1. increase in the use of quiDoloncs.t5
All of the aforementioned studies only ancmpted to examine the quantity of
antibiotics that were used for human conswnption. Although human use wouJd
presumably represent the greatest proportion of antibiotic use, antibacterial drugs are also
used in vetcrinar'y medicine and agricuJture and couJd potentially contribute 10 the
problem of bacterial resistance. lbc most comprehensive study of antibiotic use was
undertaken in Norway in which consumption of antibiotics in bwnans as well as domestic
animals and fanned fish was examined between 1992 and 1996.... When all areas of use
were combined., an overall decrease in antibacterial use within the studied timeframe was
discovct'Cd. Notably there was a 67"/0 decrease in antibiotic usc in domestic animals and
farmed fish for both therapeutic and feed additive purposes. Human consumption durin8
17
this timeframe n::mainc:d relatively constant. with • minor 0.6% increase in use.... With
regard to specific anbbiotics prescribed. prescriptions for penic:iUins constituted between
54% and 57% of total prescriptions. Substantial dcdiDcs in the use of quiooloncs aDd
tetracyclines were noted. namely 92-;. and 68% raJuetions respectively." When all
routes of administration were considered, antibacterial use for human medicine was
responsible for 45"10 of total use in 1992 and 71 % in 1996. Overall 76.955 kilograms of
active substance were administered in 1992 comp8lM with 48.792 kilograms in 1996....
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2.3 A.tibiolic UI! i. CO•••,ity Pndig
The vast majority of antibiotic use in humans is prescribed in community practice.
In Canada. 80.4% of all antibiotic ~ptiODS aR: written by general practitioners 01'"
family pbysicians. 1J However. given this substantial nile of aotibacteria1 use, no studies
exist C'X3Itlin.ing their use in the community practioe scttinBo addressing the combined
ilSue5 ofquantification. indications and appropriateness fOl'" aU infections seen by GP's.
2.3.1 Quaatirlc:ario. of UR
tn 1986. Bro and Mabeck published one of the earlier reports of general practice
antibiotic use in five selected counties in Denmark., comparing prescribing patterns in
1919 and 1983.·' In this particular study. participaling physicians (accounting for 66% of
tow physicians in the selected study ~) ~ asked to ~rd all antibiotic
prescriptions. and other relevanl clinical information in ~lation to the prescriptions.
wrinen within a five day time span in the month ofMarcb in the years 1979 and 1913.
In both study years. penicillin was the most commonly prescribed antibiotic. accow:ltina
for 2.1 DDOsfIOOO inhabitanlSlday in 1979 and 2.2S DDDs/lOoo inJl,ab;tanbiday in
1983." The average duration of treaanenl for all antibiotics, excepc tettaeyCline, was
approximately seven days." The authors lIOIed that, over the foW" year period. a change
in the nwnber of antibiotic treaunents had OC(:um:d., increasing from 505 to S83
treatmenlsllOOO inhabiwllslycar due to an increase: in the use of tno.d specO"UlD
peniciUins., erythromycin and sulfonamides!'
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In 1989. Fris et at published a follow-up study to 8m aDd Mabcck's 1986
Ocnmatt study using the same study mcthodology.48 In this updated rqJOrt, which
iochJded 60% of all GP's in the study region, the authors fOUDd that 44% of aU antibiotics
jmSCribed wen: for penicillin. 17% were for topical antibiotics,. 14% were for ampicillin
and 10% were for erythromycin.48 Compared 10 the 1986 study, an increase in the use of
erythromycin was observed.48
An AUSb'31ilUl study published in 1988 a1so examined antibiotic use in gencnl
practice.'" Munro et aI. employed a method whereby various medical stUdents collected
prescribing infonnation for 75 consecutive patients seen by 53 different doctors. resulting
in infonnation obtained for 3980 consuUations. The: authors found that 15.9% of all
fea)rded consultations resulted in an antibiotic prescription. with the majority of these
prescribed to children (30-/1). Amoxicillin was the most commonly prescribed antibiotic
(35.5-;, of IOta! antibiotic prescriptiOl1S), followed by TMPISMX (18.7"/1), erythromycin
(9.7%), doxycycline (8.9%) aDd cephaJexin (6.9%).<&9
Wyatt and colleagues undertook lUI audit of antibiotic prescribing in the geocnal
practices ofNonbem Ireland over a five year period.50 Using adminiSlJ'lUive daIabascs of
the CentRl Servlces Agency. which records the Dumber's of prescriptions and doses of
each prescription by pharmacists and dOdors. the authors were able 10 stlIdy lUItibiotic
prescribing practices of general practitioners between 1983 and 1987. Over the five yean
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of analysis. the authon noted tbal the number of antimicrobials prescribed remained
fairly COllSWlt at approximately two million pn::scriptions per year. 5O Seventy per cent
(70%) of antibiotic use was for broad spectrum penicillins such as amoxiciUin and
ampicillin, 'ThtP1SMX. penicillin V and erythromycin. Althougb the total number of
antibiotic prescriptions remained constant, there wen: notable changes in the patternS of
types of antibiotics prescribed. For example the investigators determined WI within the
study period~ was dc:creased ampicillin use.. but increased amoxicillin usc. Similarly
letracycline prescriplions docreased with a concomitant increase in the numbers of
minocyclinc and doxycycline ~ptiOftS. Tbc:refCft this study demonstrated a trend in
the inc:teased use of newer Of more broad spectNm antibiotics while older or narrower
spectrUm antibiotics became: less popular to prescribe.5O
McCaig and Hughes studied antibiotic prescribing of office-based physicians in
the United Slates utilizing the National Ambulatory Medical CaR Sun'eys (NAMCS)
from 1980. 1985, 1989 and 1992 Sl The number of antibiotic prescriptions i.ncn:ased
from 86 million in 1980 to 110 million in 1992. although !he perceot of antibiotics to
tota.I drugs remained fairly COnstaDl at approximately 13%. Over the 13 yean: of data
collection. the moSl: commonly used antibiotic group was the: broad spoctnD'D penicillins,
with amoxiciJIin the most frequently prescribed drug overa.ll. CepbaIosporins were the
second most frequently prescribed group. Like the Wyatt et aI. study, McCaig and
Hughes noled an increased trend in the prescribing ofexpemive Of broad spcr:trum agents
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like arnoxicillin and the cephalosporins and a decrease in the prescribing of the cheaper
or narrow spectrum drugs such as penicillin. No changes wen: noted in prescription
trends for TMPISMX. macrolides and tetracyclines.51
A second Australian study on antibiotic prescribing was published in 1997.40
This investigation focussed on the communiry use of antibiotics between 1990 and 1995
and captured all government subsidised prescriptions as well as an estimate of
nonsubsidised prescriptions. Over the five year period, the authors noted that the rate of
antibiotic use remained stable al approximately 25 DDDslIOOOIday. In 1995. the lop five
dispensed antibiotics were amoxicillin., amoxicillinldavulanic acid, cefaclOl". doxycycline
and co:phalexin. lbe authors noticed in their study, as in pl"Cviously fCpOrted studies. that
although the numbers of antibiotics prescribed remained COnsIaDt. changes in the type of
drugs prescribed were evident in thaI more broader spectrum and newer agents wen:
being used.oWl
Majeed and Moser studied the age and gender specific prescribing patterns in
general practices of England and Wales. analyzing data from the: General Practice:
Rcscan:h Database.52 This database allowed. the authors to investigate antibiotic
prescribing in 288 general praclices with a patient population totalling 2.1 million. It was
detennined that antimicrobials were prescribed at a rate of 607 Rxs/IOOOlyear for males
and 852 Rxs/lOOO1year in femalcs. Use was found to be higbcsC in children less than 5
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years of age and in the elderly over the age of 75 yean. Broad spectrum penicillins were
the rnost commonly prescribed antibiotic for both males and females.. representing
approximat.ely 40"10 of tocal antibiotic prescriptions. Macrolides were the second most
frequently prescribed group representing 12·13% oftocal prescriptions. Interestingly, the
authors noted a substantial variation in rates of antibiotic prescription among the practices
monitored, ranging from 333 RxsIIQOO/year to 1616 RxsIlOOOlyear.S2
Lindbaek et at's 1999 study correlated the national consumption of antibiotics in
Norway and the prescribing panems of Norwegian general practitiOneTS for the treatment
of respiratory tract infections in particular with community resistao<:e panerns of
respiratory tract pathogens.Sl Similar to Canada, 85% of antibiotics in Norway were
prescribed by GPs. Between 1981 and 1987, the rate of use was approximately 12
DDDs/lOOO/day. This rate increased to 16 DDDslIOOO/day in 1993 and then decreased
to 14 DDDsl1000Jday in 1997. The 3Ct-1e increased rate of usc observed between 1987
and 1993 did not colTelate with any known changes in disease patterns. In all yean
studied. penicillin V was the most commonly used agent representing 27·34% of lotal
prescriptions. The authors found that macrolide consumption increased only slightly,
even after the introduction of both c1arithromycin and azithromycin.n
The only published Canadian study examining antibiotic use examined the
community use of antimicrobials in the province of Manitoba from 1995 to 1997.14 This
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study utilised the provincial Drug Programs lnfonnation Network., a pbannaceutjcaJ
claims database tha! caprures 90% of prescriptions dispeNed in the province. During the
study rime period, the total rate of antibiotic use was calculated to be 894 RxsfIOOOlyear,
with the most commonly used agent being amoxiciUin accounting for 36% of all
antibiotic prescriptions. The oat most fn:quefnJy prescribed antibiotic was TMPISMX
accounting for 13'1. of prescriptions followed by erythromyciD (12%) aDd penicillin V
(6'1.). In a manner similar to previous studies, the authon observed lhat the total rate of
antibiotic usc did not increase during the time period under investigation. However tbcTc
were significant change$: in how antibiotics were prescribed. For example an iJK:rcase in
the rate of use was noted for newer or broader spectrum agents such as the
fluoroquinolones. cephalosporins, c1arithromycin, azithromycin. minocyclioe and
doxycycline. At the same time, dec~ number's of prescriptions were dispensed for
older or narrow·spectrum agents such as penicillin V, tetracycline and erythromycin.
Even though aD intervention was in place to dcc:reue prescriptions for fluoroquinolooes.
some cephaJosporins and arnoxicilliniclavularUc acid. the use of these restricted ageots
increased during the study period.I'
2..1.2 Medical hadic8tiou
Respiratory tract infection is the most common diagnostic category giviDg rise: to
physician consuJtations ($Oun:e: lMS Health Canada), many of which arc treated with
antibiotics. HowevCT the role of mtibiotic therapy in the management of these infections
2.
is coDtroversial. particularly when a bacterial etiolozy for the infection has DOt been
confumed. In general practice settings. diagnostic tests to cstabtisb bacterial etio'ogies
for any type of infection may DOt be readily available and results ofsuch tests often lake
severa.l days to be completed. Therefore GPs often prescribe antibiotics to uear. wba1
would only be presumptive bacterial infectious. A$. result. an understanding of the
range of medical iodications for which GP's routinely prescribe antibiotics is important in
the development of interVentions to assist in alleviating unoecessary antimicrobial use.
Fris and colleagues' 1989 study investigating the use of antibiotics in general
practices in Denmark found that the most COlDJDOll diaposes in which antibiotic
tteatment was administered were tonsillitis and bronchitis/pneumonia. each accoUlninZ
for 16% of all antibiotic pn:scriptiODS. followed by sinusitis (12Y,>' conjuoctivitis (11%),
urinary tract infection (II",) and otitis media (8%)." Therefore treatment ofrespiralOl')'
tract infections was responsible for 48% of all antibiotics rn:seribed. Similarly, the 1999
Norwegian study by Lindt-d:. ct al. found dud: rapirawry Q'Kt infections coo.stitutcd
42% of diagoosc::s leading 10 antibiOli<: therapy, with bronchitis ac:couDting for 1"% of
prescriptions, colds accounting for 8%, tonsillitis accounting for BY.. sinusitis givins rise
to 7% and poew:nonia accounting for 5%.fl
Other comprehensive studies investigating the medical indications for antibiotic
therapy have reponed far greater proportions of antibiotics prescribed for the treatment of
2S
respiratory tract infections. Although specific data on proportions of antibiotic
prescriptions were not reponed, an Australian study listed the top six conditions treated
with antibiotics as acute upper respiratory tract infection (i.e. common cold), acute
tonsillitis, acute otitis media. infections of the Iowa' respiratory tTac:t (including tracheitis,
laryngitis, bronchiolitis and pneumonia), urinary tract infections and sinusitis.49 McCaig
and Hughes 1995 US srudy also detennined that respiratory tract infections ac:coumed for
a substantial bulle. of all antibiotics prescribed.JI 1be authors reponed that the diagnoses
of otitis media. cold, bronchitis, pharyngitis and sinusitis ac:caunted for 76% of atl
antibiotic prescriptions.5I Further 10 this, the five most conunon patient complaints
giving rise to an antibiotic prescription were c:ough, sore throat, fever, nasa1 congestion
and ear·ac:he.sl
2.3.2.1 Lower Kapinlory Tnct IDfKtioas
SeveraJ. studies have examined the indications for antibiotic prescribing by
focussing specifically on respiratory tract infections. With regard to lower respiratory
tract infections. Macfarlane et at. found thai: 75% of adult patients who consulted a OP
with the primary complaint of cough were prescribed an antibiotic.S4 Kuyvenboven and
colleagues completed a study of antibiotic prescribing for lower respiratory tract
infections as well. They found that, for respiraJory tract infections in general. 30-;. of
patients were treated with antibiotics. However when a lower respiraJory t:raet infection
was present, 790/0 of patien1S diagnosed with bronchitis and 73% of patien1S diagnosed
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with poeumonia received antibiotics.!' In lenDS of cough and the diagnosis orbroncbitis
in particular. it has been detennioed thai between 66% and 85% of patients with this
diagnosis received aD antibiotic prescription..lO. ~ Sf Nyquist et al. foWKI thai. 75% or
children with this same: diagnosis also were trealCd with IUltibiotics.SI Signs and
symptoms associated with antibiotic therapy in the treatmenl or bronchitis included
purulenl nasal discharge and sinus tenderness." The high~ of antibiotic: use to treat
this specific condition is of concern in light of~t litmuure which does not support
this practice. SUI
2-1.2.2 Upper Respinlory Tnc1 l.rec1io..
M3Z2aglia et aI. focussed on antibiotic treatment for all upper respiratory tract
infections in primary care practices in Italy.JI The authors discovered that treatment for
URns amounted to 22% of allll1ltibiotics pn::scribc:d. Within this 22% of pn::scriptions.
pharyngitis was responsible for 40%., 26% for- tonsillitis. 15% ror laryngitis and oacheitis.
13% for suppurative otitis media. and rftinjtis and noo suppunrive otitis media were
~nsible ror the mnaining 6% of prescriptions.J1 Gonzales aDd colleagues reported
that. in a US srudy. 51". or patients diagnosed as having acute rhinitis (commoo cokf)
aDd 5~. of patients diagnosed with an upper respimory infcctioo of multiple or
unspecified sites received an antibiotic pr-cscription.Xl Mainous and Hueston discovered
that ~/o of outpatient episodes of care in which any diaanosis of upper respinuory tract
infection was made. including the common cold, resulted in an antibiotic prescription
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being filled.6l. 63 For acute tonsillitis or pharyngitis in particular. stUdies have reported
prescription rates ofup to 90"/, for this diagnosis.""65
1.3.3 Appropr"Ulleaas of AlItibiotic: UN ill COID.....ity Praetic:e
Measuring appropriateness of community practice antibiotic pl'eSCriptions is an
arduous and complex task. Many studies have relied on administrative databases to
capture information and have made indirect conclusions from this information on
antibiotic prescribing appropriateness. For example the total nwnber of antibiotic
prescriptions has increased in the USA from 86 million in 1980 to 128 million in 1998.51
For the most pan. this increase in use was viewed as unnecessary given thai many of the
prescriptions were: wrinen to treat respiratory tlact infections.'1 It has been argued that
physicians have become less skilled in their decisions to prescribe antibiotics thus
warranting physician education interventions. HoweVeT the increase in prescriptions.
when evaluated in a cursory sense from database information. may not directly indicate
increased inappropriateness of prescribing. For example it bas been suggested that the
increase in prescriptions may be due to improvements in access to primary care and more
children anending day can: at an earlier age. thus increasing infection rates.66 Therefore
it is necessary to view not only the trends in total antibiotic prescriptions. but also the
medical indications for which antibiotics arc: used to tteaL
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The National Ambulatory Medical Care Survey (NAMeS) undertaken in the USA
has been used [0 demonstrate the level of inappropriateness of antibiotic prescribing. by
examining the combined issues of numbers of prescriptions and medical indications for
the prescriptions. using patient record fonns and ICD-9 -CM (1nternabooa! Classification
of disease, Ninth Revision., Clinical Modification) diagnosis codes. 30. 51. 51 AJthough
these: studies rqm:sent the most comprehensive investigations addressing the issues of
appropriateness of antibiotic prescribing. inherent cbancteristics of the studies'
methodologies limit the conclusions which may be drawn. More precisely these stUdies
assume that the diagnoses made by the physicians are correct. It has been suggested,
however, that in some cases physicians may be recording a diagnosis whicb wammts a
prescription when perhaps the patient most likely manifests a viral infectioD instead.56. 66-
67 Undoubtedly a prescription for a patient diagnosed as having the common cold is
inappropriate. However. with only information on the primary diagnosis, it is unclear
whether a prescription for pharyngitis is appropriate or DOl Furthermore appropril1lCneSll
of antibiotic prescribing encompasses more tlw1. just medial! indication. Choice of
antimicrobial therapy for a given diagnosis in addition to dose and duration of treatment
are also important in determining bow at'Propriately pbysicians are prescribing
antibiotics. Unfortunately such comprebensive studies are lacking in the literature.
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2.3.4 Facton Innuudal Antibiotic Usc in CommliDity Pndic:e
Antibiotics are used to treat a broad array of illnesses ranging from potentially
fatal bacterial infections to mild and often self·limitcd conditions." Clearly medical
indication will influence the decision to prescribe antibiotics. However other factors
which have been addressed or identified as influencing antibiotK: prescription decisions
include diagnostic unccnainly, diagnostic labelling,69 patient expectation (both real and
assumed), cenain patient characteristics or demographics. prescriber habits or
charncteristics, and visit tennination strategies/time constraints." Therefore other non·
clinical factors may playa role in antibiotic prescription decisions. As bas been
previously described. over-prescribing of antibiotics exists. It is necessary to determine
why physicians WUl~essarily use antibiotics for cases in which antibiotic usc is not
warranted or medically indicated. An WldC'rstanding of the factors which influence
antibiotic usc is required before successful interventions to decrease use can be
implemented.
In general practice. antibiotics are presumably prescribed after the diagnosis of an
infection is made. Often this diagnosis is made with a considerable degree of uncertainty,
panicularly with regard to respiratory ttaet infections. compounded by delays in receiving
the results of diagnostic lests. Diagnostic tests used to arrive at a definitive diagnosis of
bacterial infection often require several days 10 complete; in many cases the patient has
since become well during this time and the test results then typically serve as a
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retrospective analysis of treaunenL70 Mcisaac and Butler hypothesized thai clinical
estimation errors may be an important f8ctor in unnecessary antibiotic use.71 Their
fUldings revealed mat clinical uncertainty may be impacting current antibiotic prescribing
practices; overestimation of the likelihood of bacteriaJ pharyngitis was associated with
unnecessary antibiotic use in thai the greater the oven:stimation, the more likely an
antibiotic would be prescribed.71
Interestingly Bradley has shown that antibiotics are the most frequenlly
mentioned class of drugs that give rise to physician discomfon when making the decision
10 prescribe. Respiratory tract infections were the most common conditions in which the
doctor.; felt uncomfortable with prescribing decisions.n. 73 Given that most respiratory
tract infections are viral in nature74 and therefore antibiotics may not be medically
indicated in these scenarios., it is plausible to suggest that doctor.; may be ptUCribing
antibiotics in response to oon·medical or sociaJ influences. For example Howie has
demonstrated that prescribing for sore throats may be influenced by clinical information
of a non·physicaJ nanue such as professional affiliations. the distance from the patient's
residence to the clinic, and patient stress levels.7S In another study, Howie showed thai
children of mothers who were high users of psychotropic drugs morc frequenlly
consulted a physician for respiratory complaints and received more antibiotics than those
children whose mothers were low or DOn-users of psychotropic medications.76 These
)1
early studies begin to elucidate the potential influences ofnon<linical or social factors on
antibiotic prescribing.
Certain physician or practice characteristics have also been shown to be
associated with antibiotic prescribing. Petursson's evaluative work on his own practice
indicated that an inCTeased patient load resulted in a higher nile of antibiotic prescription
per total patients seen. n He speculated that the increased number of patients in his
practice decreased his direct contact time with patients and therefore afforded him less
opportunity to convince his patients of the uselessness of antibiotics in treating viral
respiratory infections.n On a similar note with ~gard to patient volume in primary care
practices. Hutchinson and Foley fowxi that increased plitient volwne for both salaried and
fee·for·scrvice Canadian GP's was associated with increased rales of antibiotic
prescription, panicularly with fec·foNcrvice physicians.7I lnciden1ally fee-for-service
physicians were found to prescribe antibiotics at a higher rate than salaried physicians
overall, ~garci1ess of patient volume.7I Increased rates of antibiotic prescriptions were
also found with increased patient list sizes in the Nctbcrlands.19 Other physician or
practice characteristics associated with antibiotic prescription include increased years
since medical school graduation,19-11 solo practices.79.• rural practices,lO increased use
of otbcT drogs,12 greater use of cul1Ures and urinary susceptibility tests (but decreased use
of throat swabs).12 non.ped.iatricians.," and practices which an: DOt involved in medical
tnlining.13 Finally Can and Hakansson have suggested that physicians habits or
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tendencies in diagnosing bacterial infections also influences physician antibiotic
prescription decisions.69
Patient or parent expectation for an antibiotic has frequently been hypolbesized as
one of tile contributing factors in antibiotic prescription. In Vinson and Lutz's study, the
doctors sensed that pareots expected an antibiotic for their children in IS.4~. of physician
encounters in which the presenting complaint was cough.14 As well, the authors
determined that if parental expectation was perceived, the doctors were twice as likely 10
diagnose a bacterial infection as compared to a viral cold and an mtibiotic prescription
was more likely to be issued.14 Another study reported physician perceived
patient/parent expectation at a rate of 4r/. ofencounters involving suspected infections."
However the doctors in lhat srudy felt that in 80010 of these ~urcd encounters, the
patients' expectation for an antibiotic prescription bad 00 influence 00 their decision to
prescribe.1S Bauchner C1 aI., in a study involving only pediatricians, detailed that 96% of
the study physicians had parents request antibiotics wben the antibiotic prescription was
felt to be not indieated.16 Fifty.four percent (540;.) of these same physicians felt that
pamltal pressure for antibiotics was the major contributor of inappropriate oral mtibiotic
use."' In 44% of cases in which an antibiotic was prescribed in a stud). of acute lower
r=piJatory tract infection, the doctor admined that non-clinical factors, pmfominately
patient~. influenced prescribing.I? In this same study, 7rlo of patients indicaled
thu they wanted antibiotics and 88% of these patients received a prescription.17
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A.lthough studies suggesting patient expectation does influence antibiotic prescribing
decisions exist. it appean that patients do DOC understand appropriatC'DCSS ADd
effectiveness of antibiotic ther3py, and that physicians are not accurate in determining
patient expectation for an antibiotic prescription.
Studies have focussed on the knowledge of the general public with regard to the
effectiveness of antibiotics for commtmity-acquircd infections and have discovered that
there is a lack of general understanding by the public in this area.11-90 Many of the
subjects surveyed in PalmeT and Bauchoer's study indica1ed that antibiotics could
effectively treat ear infections (93'1.). throat infections (83%), colds (3:z-/.). cough (58%)
and fever (58%)." In anothe'r sW'Vey. 55'Yo of respondents stated that antibiotics were
helpful for viral infections, while only 21 0/. co~y identified that antibiotics were both
helpful for bacterial infections and not helpfuJ for viral infections such as the common
cold or flu.90 For those surveyed who thought that antibiotics were useful for colds and
flu.. a positive association was found with previous antibiotic use in these subjects.90
Hong et a1. also foWKI that patients who desired antibiotics for rnpiratory infections were
mo~ likely to have previously used antibiotics for similar symptoms.91 It has been
suggested that previous antibiotic usc prescribed for likely viral respiralory infections
may enc0Ul'1l8e patients to believe that antibiotic thenlpy is useful in that the adminislered
therapy coincided "ith the natural recovery of lhese predominate self-limited infections.
Therefore patients are inclined to seek antibiotic therapy, and believe that this therapy is
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effective. for each event of minor respiratory illness, thus creating a cycle of repeat and
perhaps unnecessary consultations.r7. 19
In light of the suggestion that physicians' antibiotic prescribing decisions are
influenced to some degree by patient expectation. researchers have set out to determine
how accurate physicians' pcrcq>lions of patient expectation are as compared to aetuaJ
expectation of the patients for an antibiotic prescription. Hanun and colleagues
discovered that the doctors conectly identified patients who desln:d an antibiotic in only
half of the cases.9'2 The study physicians identified paticots as desiring antibiotics in 360/.
of patients who stated that they did not want a prescription.92 1be authors therefore
concluded that a large degree of inaccuracy exists with regard to physicians' perception of
patient expectation.92 Further 10 this. it has boc:n suggested that the reason physicians
succ:wnb to patient expectation for a prescription is simply to satisfy the patient.
Therefore satisfaction of patients who received an antibiotic was compared with patients
who did not receive an antibiotic. The authors found that patient satisfaction was
correlated with the thought that the doctor bad spent enough time with the patient
explaining the illness and the choice of treatmcot. Satisfaction was DOt COlTelatcd with
receipt of an antibiotic prescription.9'2 No diffaences in patient satisfaction comparing
those who did and did not receive an antibiotic prescription wen:: also seen in an earlier
study.91 Therefore the conclusions drawn from this collection of studies indic:ar.e thai
doctors are indeed influenced by patient expectation, possibly in an effort 10 satisfy
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patients. However physicians are very poor in correct.ly discriminating which patients
desire antibiotic treattnent from those who do DOt. In addition, patient satisfaction is not
correlated with receipt of an antibiotic prescription. Rather patients are more satisfied if
the doctor simply spends time explaining their illness and why an antibiotic is not
indicaIc:d.
2.J.s SIIID••ry
Upon review of the literature examining antibiotic prescribing in community
practice. it becomes apparent each study is unique in its approach to study methodology
and presentation of results. Because of this. it is challenging to make direct comparisons
about how and why antibiotics are prescribed in different regions from the available
published studies. Nonetheless some notable trends are apparent. Firstly several authors
have described a progression of prescribing that moves away from the use ofolder and/or
more narrow spectrUm antimicrobials with a concomitant increase in the use of newer
and/or more broader spectrum agents. lltis is a concerning trend which may have
disastrous consequences with regard to the growing problem of bacterial resistance:.
Secondly the penicillin group of antibiotics appear to be the most frequently prescribed
by physicians. regardless of study community or country. Furthennore the medical
indications for which antibiotics are prescribed are of concern. Regardless of
geographical region, many doctors prescribe antibiotics for conditions in which treatment
is DOt warranted due to the likely viral etiology of the infection. that is rupiratory tract
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infections. Therefore more antibiotics are being prescribed than are necessary whicb also
may nave deleterious effects on bacterial susceptibility to antibiotics. Further to this,
several factors unrelated to medical indication have been shown 10 influence prescribing
decisions. Ultimately it appears that doctors are malting poor cboices in deciding when
to prescribe antibiotics, in addition 10 inappropriate decisions regarding wttich antibiotic
sttould be used, and are commonly influenced to prescribe: by non-medical or social
factors.
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2.4 Antibiotic Use For tbe In-Hospital Trameat ofCommuaitv-Arouired
Pneumo.ia
2.4.1 The Epidemiology ofCommuaity·Acquind Panmoaia
Community·acquired pneumonia (CAP) is a common disease with notable
morbidity and mortality. In the United States, approximately foW' million cases are
reponed each year. In temu of monality rates. CAP ranks as the sixth leading cause of
dcath.94 It is also the most common cause of death due to infcction.94 In a study
conducted by Maman ct al., the authors calculated the incidence of CAP requiring
hospitalization 10 equal 2.66 per 1000 per year.'! However. because CAP is not a
reponable disease. true estimates of incidence rates for those in the community and those
requiring hospitalization arc: difficult to calculate.
2.4.21. Hespig. Antimicrobial Trntmenl ofCo.....aity·Acquired Po_moaill
Sevcr.a.l studies have examined the in hospital antibiotic treattnent of CAP.
Although it would be expected that clinical factors related to the patient or local bacterial
susceptibility patterns would dietaJe the choice of antimicrobial thenapy, it is evident that
other non..clinical factors., such. as local prescribing habits or trends, may influence
lreatrneDt decisioDS. Because of this., differences in antibiotic treatment choices across
geographical regioDS and hospitals exisL For example Guglielmo ct al. undertook a study
examining the in-hospital prescribing trmds in 1998/1999 for the treattncnt of selected
J8
infections. one of which was community-acquired pneumonia.96 The authors reported
thai: for 68"-. of patients diagnosed with CAP, single therapy antibiotics were
administered. while 230/. received two antibiotics and 9"/. ~ived three or more drugs.
For patients treated with single therapy, the most common pharmaceutical choice was
third generation cephalosporins (36% of patients), follo~ by aminopeniciJlins (Ir/.).
Third generation cephalosporins were also commonly used in multiple drug~y (44%
of patients). The investigators aiso found that younger patients were more commonly
treated with antibacterial agents that would be active against "atypical" pathogens., while
older patients were typically treated with broad spectrum antibioti~. Infonnation on
etiology of infections and patient outcome was not available in this study.96
In Sweden, only 4% of hospital patients with CAP were treated with two or more
antibiotics.'" Of the remaining 96% of patients that were treated with single therapy,
over half received benzylpenicillin treatment. The: next most common single treatment
choice was a cephalosporin. in which cefuroxime was the most )X)puIar choice. Etiologic
data were available in this study and it was determined that Streptococcus p'leumo"iae
was the most common infecting agent. Four percent (4%) of patients in this study had
died.'"
Studies conducted primarily in the US, but which also included a limited number
of Canadian hospitals., have concluded thai aminogiycoslde use was commonplace in
3.
Nonh America in the late 1980'5 for the in-bospital trearmeDt of CAP.9&. 99 In these
stUdies SrreptococCIU ~llmOItiae or- HaemophjJlJS injIW1fZOI. were the most commoa
infecting 0I"gaI'lisms in patients with positive culture results. The proportion of patients
treated with a singJe antimicrobial agent was approximately 10%. Cefuroxime was the
most common single agent chosen for tteatment (19.5%). followed by «fazolin (17.2%)
and ampicillin (9.9%). Approximately one quarter of CAP patients were treated with a
combination antibiotic therapy and. of these patients, the majority were treated with aD
aminoglycoside. Cefazolin was most frequently used in combination with an
aminogJycoside. Overall. approximately one third of CAP patients were treated with an
aminoglycoside. with most patients receiving treatment with gentamicin.91.99
Route of adminisntion. in addition to cboi« of antimicrobial therapy. is also an
important consideration in the management ofpatienlS with CAP. In a prospective study
conducted by fWnitez and colleagues., the efficacy of an early switch to oral antibiotics
from initial intravenous (IV) antimicrobial therapy was assessed.1OO Patients were
switched to oral therapy once specific clinical criteria were met, including improvemetlt
in cough and shortrleS5 of bn:ath. decreased tempcft1Une. a normalizing white blood cell
count and adeqwue oral intake. The authors concluded thai a significant proportion of
patients could effectively be switched from IV to oral antibiotic therapy and thai patient
outcome was oot affected. loo
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2.4.3 AppropriateDest 0' COlDmunity-Affluired healD•• i11 Trao_eat AIa.D,
Hospilllliud Pa(ieDb
A Canadian study investigated the adherence of in hospital community-acquired
pnewnonia treatment with management guidelines endorsed by the American lboracic
Society. 101 As a whole, this study examined the variation in treatment and processes of
can: that exists among Canadian hospitals for patiCDts admitted with CAP. Although the
specific methods of the assessment of guideline utilisation were not described. it was
found that on average almost 80% of patients admined with CAP were treated according
to selected management guidelines. However a substantial amount of variation in
guideline adherence was discovered; in some hospitals only 48% of patients were treated
in a manner recommended by the American Thoracic Society, whereas in other hospitals,
guideline adherence was as high as 1000/0. Monality rates did differ across the II
leaching hospitals which took part in the study. however an assessment between
management guideline adherence and monality was not performed. IOI
Marras and Chan also a.ssessed the use of American antibiotic prescribing
guidelines for the in-hospital treatment of community-acquired pneumonia. lQ2 Utilising
both prospective and reuospcctive research methodologies, the authors found that
antibiotic prescribing guidelines were widely used; approximately 80% of all patients
were treated according to the American lboracic Society guidelines. Seventy seven
pen:ent (77%) of younger patients with DO comorbid conditions were treated in
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accordance with the guidelines. Among those who were not. therapy involved a
quinolone. Eight)' one percent (81%) of older patients with comorbid conditions wen:
trealed according to guideline recommendations. The authors compamt the length of
stay and in-hospital monaJity for patients who were appropriately treated according to
guidelines with lOOse who were noL No significant differences were noted in either of
the two variables. IOl
An American retrospective study examined the associations between mortality
and initial antimicrobial treatmenL 103 After adjusting for differences in treatment because
of differences in severity of illness, the authors reported that three treatment regimens
resulted in lower 30 day monality rates. Specifically these treatment regimens were
initial treatment with a second generation cephalosporin plus a macrolide, a non·
pseudomonal third generation cephalosporin plus a macrolide, and a fluoroquinolone
alone. It is important to note that this study was carried out in patients over the age of65
years only and therefore may DOt be generalizable to all patients admitted. 103
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CHAPTER III - METHODS
3.1 Oral Aatibiotk Use ia Com.uam Practkes ofSL Joha'L NF
3.1.1 Rec:ruitmnt ..d Partic:ipatio.
General practitioners (GPs) in St. John's. NF and surrounding areas were invited
to participate in an antibiotic utilisation study. Ninety six (96) GPs were identified as
eligible to participate. Physicians were initiaJly contacted by a mailed out letter followed
by a phone call conducted by Dr. J. Hutchinson, the principal coordinator of the project,
inviting their participation in the research study. Of the original 96 GPs identified. 73
agreed to participate and provided wrinen consent, thus constituting 76% of the original
eligible identified sample.
3.1.2 Method of Dab ConectiOll
The panicipating physicians were informed that a research assistant would visit
their offices on one occasion without any prior notice. The office visits occW'Ted between
October I, 1997 aDd January 30. 1998. During this office visit, aJl ckans from the
patients who were seen during the immediate ~eding two days of regular pnlCtice were
reviewed. During the chart review process. those patients with an infection related illness
were identified. Information collected during the chart review process included patient
demograph.ics, presenting complaints, signs and symptoms, diagnoses aDd types and
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quantities of antibiotics prescribed. In addition 10 information extrac1cd from the charts,
me treating physicians were also interviewed i.D order 10 complete data coUcetioo. The
physician i.DterVicws occurred within 2 10 3 days of chart exttaeti.on and were used 10
achieve further darificatioo on informarion obtained &om the charts.. As 'Aldl the
physicians were asked to rate: several factors which may have influenced their decisioa 10
prescribe antibiotics.
3.1.3 Antibiotic Pracriptio. Cosbl
The specific antibiotic prescribed. dose, duration and frequency of administration
for each antibiotic prescription event was abstracted from patients' charts. Based on this
information. the retail cost fOl" each antibiotic prescription was calculated using • druB
COSt list fonnulated by IMS Health Canada for the fiscal year 199711998. which coincides
with when this study took place. In cases in which me dose prescribed did DOl coincide
with unit prices outlined in the drug cost list, the closest lowest dose unit price was used.
This resulted in lower caJculaled prescriptioo costs.
The lMS Health Canada drug cost list provides the dispensed prescripboo prices
from retail pharmacies in Canada and includes mark-ups such as pharmacist professional
fees. This data is obtained through electronic collection from a representative sample of
retail phannacics stratified by province. store size and store type. Projected estimates of
retail druB costs~ then calculated fot each province from this sample. Drug costs fOl"
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each individual province. in addition to national costs, are provided however data from
the provinces of Newfoundland and Prince Edward Island are combined. All costs are
represented in Canadian dollars.
3.1.4 utimatien of Population bla
Population rates of infection and antibiotic usc were calculated from the sample of
patients identified in the chan ~view process. To account for location of~sidcnceof tbc:
patient sample (and therefore utilise population census data obtained from Statistics
Canada) and adjust for the proponion of physicians who panicipatcd in the study, a
correctional calculation adjusttncnl was performed.
[n 1997,608.361 GP visits were made to physicians in SI. John'YMowtt Peart
(data provided by the Medical Care Plan for the province of Newfoundland and
Labrador). Of lhese total visits. 474,542 visits wen: made to the 73 physicians who
panicipatcd in the study. 1lII:rcfore the proportion of 1997 GP visits made to the study
GPs was 78% (474.542/608,361).
The study captured 4218 patient visits in IOtai. of which 949 were for acute
infections. The total visits therefore represented 0.89% (4218/474542) of total 1997 GP
visits made to the study GPs. The proponion of patients with acute infections in the
study specifically from SL John'slMount Pearl was calculated to be 0.847 (8041949).
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In order to determine bow many patients in the community of SL John'slMount
Pearl in a one year period were represented by one patient in the study population. the
following calculation was performed. The proportion of patients with acute infections in
the study who were from SL John'slMount Pearl (0.847) was divided by the proportion of
annual visits to family doctors in SL John'slMount Pearl represented by the sample
(0.0089) multiplied by the proportion of total visits in the year seen by the study OPs
(0.78). 1'herefore 0.847.;. (0.0089)( 0.78) - 122. Therefore one patient visit in the study
represented 122 patient visits by residents of St. John'slMount Pearl for acute infection in
one year. The numba of prescription events or cases of infections for each age category
was multiplied by this calculated multiplier of 122 aod divided by the popuJation in SL
John'slMount Pearl for the corresponding age category, thus yielding a measure of the
number of prescriptions or infections presented to the doctor per person per year.
3.1.5 ['Val.atioD of Appropn.teDea of ADtibiotic' Pracriptiou
The approprilUencss of antibiotic prescriptions was evaluated using the criteria
outlined by the Anti·infective Guidelines for Comrnunity.acquired lnfect.iODS 2-
Edition. l All extracted patients' charts in which an antibiotic was prescribed were
reviewed and the anti·infective guidelines wen: applied in these instances. In a small
minority of cases in which determination of appropriateness was unclear, consensus was
reached by consultation with Dr. J. Hutchinson. aJthough this process was unnc:cc:ssary in
the majority ofeases.
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The appropnaleness of ~escriptions ....'as assessed from four perspectives. These
were m~icaJ IOdlcallon. correctn.,:ss of drug choice. correctn~ in choices of lines of
therapy ll~ Anu-miecme GUllkllnes suggest first. second and sometimes third lines of
therapy), and~ of treatment. JudgmentS of me<llcal indication 1O\·oh..ed detennlnmg
wnether !.he diagnosIs asslgn.:d by the physIcian for each patient warranted an antiblouc
prescnptlon_ Evaluation of correctness of drug chOIce exammed whether lhe prescribed
anubiOllc pro\·Ided ~ITecll\'~ co\crage for the probable microorganIsm giving nS(: to the
dlab,"oscd mltttlOn. E:<alTllnalton of correctness 10 choices oflines of therapy looked at
whether thc prescnbed anUblOtlc was the leasl cosily and had the: most narrow spectrum
of antimicrobial cO\'cragc avaIlable for the diagno~d mlecuon Dose of therapy
compared the physICians' decisIons regarding do~ of trealmenl ",ith the:
n:comrnendauons of IIll: anu-mfectl\e gUIlklmcs. For thiS analYSIS, onl~ antlblotlc
pr~scnpuons admmlslered to adults "cre usc:d. ~,"g recommendations for chIldren are
based on lhe pauenfs .....elgh!. Infonnauon on the patients' welghls "'as not available for
thiS stud~
For delenmnauon of overall appropnateness. Ihe diagnoses made b~ the
phYSICIans wcre assumed to be co~. In addition lIle dia(!TlO5eS of rcsplralory tracl
IntectlOns such as pha~ngills, bronchitis. pneumonia and smusllis as ......ell as OUtlS media
\\ere conSidered 10 bc ofbaClerial enology. ~\"en though It has been shown that >80°·0 of
these mfectlons are most likely 10 be viral In origin. I -. This conservallvc approach 10
etiology affected the detennination of medical indication. Upper respirauM'y tract
infections (i.e. colds) were always considered to be vin.I in nature. [f the doctor bad
indicated thai a patimt was a1krgk or intolervrt or to have failed lhcrapy with a
recommended first line antibiotic. then any second line agmt was ronsidcrm to be
appropriate. even in cases where other first line agents wa'e available. This approach
impacted the dekmUnation of COI'TeCtDeSS of choices in lines of therapy available.
Patients who were thineen yean of age or older weTe considered to be adult for
assessment of appropriateness. as it was fdt thai oral solid medication was a more likely
formula. This mainly affected the a.ssessmcnt of appropriateness for amox.icillin therapy
for pharyngitis.
3.1.6 Criteria-Based Decisio_ TI'ft for AsscslI__t ofVll'1ll1 EtioIocY of Rapinllory
Tnodl.recticHIs
Based on the praentina complaints. signs and sympl0m5 for each patient IS years
of age or olda with a respiJ"alory tract infection. an evahwioo of the likelihood thai the
etiology for the infection was either bacterial or vinI was undcnaken. based on publi.sbed
diagnostic criteria-I. 1011-101 For patients diagnosed as having pharyngitis. the etiology was
accepted as bring potentially bacterial if the patient ~ted with tbroa1 pain and at least
two of the following three symptoms: tonsillar exudate. tendeT or swollen anterior nodes.
and fever. If cough was present. a viral etiology was assigncd.IOll The diagnosis of
bronchitis or pnewnonia was accepted as being potentially bacterial if the patient
presented with symptoms indicative of pneumonia. namely presence of aboonnalities in
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vital signs (bean. rate ~ 100 beaWmin. re:spimory rate 2: 24 breathslmin 01' oral
tempcTatUr'e 2: )8°Celsius) and abnormalities in chest examination (i.e. focal
consolidation).'O'J Therefon: if a paticot pn:sented with cough and
dyspnealwh«zing/raIe$1'cracklc:s. combined with an increased rate of respiration or bean
beats.. or fcver. then the etiology was asswned to be potentially baclerial. Sinusitis was
considered 10 be baclerial if Ihe paticot presented with purulent nasal discharge with
maxillary tooth pain. facial pain or sinus tenderness. 105 Sympcom documentation of poSl-
nasal drip or sputwn was considered as purulttlt nasal discharge. For all cases in wbicb
no symptoms or pn::sn1ting complaints 'WCre documented, a conservativc assumpcion of
bacterial etiology was made. In all cases in which the diagnosis was upper respinalory
IraCt infection (i.c. cold).. the etiology was considered 10 be vinI. IOl
3.1.7 E....lu.rioa of (anHaem. F.eton for Praeribia. Aatibiotia
For each patient given an antibiotic prescription. the physicians were asked to rate
four fllCtOn which may have played a rok in their dec:isioa to prescribe antibiotics.. Their
answers wen: coordinated with the use of a 6ve point liken scale. The (ollowing four
factors ....-eR C'o'ahwcd: medical indicar:iOD (uncena.in • ".ery dear). parientlpan:nt
cltpectation or demand (00 influence • moog influence), time coDSlraint (00 influence •
strong influence). and the SertSC" that the patient would attend another physician iftbey did
nol ~ivc an antibiotic (no influence· strong infl~).
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For the factor of medical indication., the Liken scale was as follows: I=Uncertain.
2=Somewbat Uncertain.. 3"'Somewhat Clear. 4=Clear. and 5=-Very Clear. For the
purposes of analyses. categories I. 2 and 3 were combined to represent the category of
Not Completely Clear. and categories 4 and 5 were combined to represent the category of
Clear to Very Clear. This same categorization of resu.lts was done fOl" the patientl~t
expectation or demand.
3.1.11 P.tient FoUow·Up laform.tioa
All patients identified as having an infection related illness and whose charts were:
used for analysis were contacted via their OP who had participated in the study.
PeTITlission was requested and granted from 97010 of the patients to obtain information on
their use of primary can: services one month following the captun:d OP visit of this
analysis. Follow-up infonnation on use of primary care services was obtained from
Medical Care Plan (Mep). the provincial Medicare agency. This consisted ofnumbms of
office visits to any physician in the 30 days following the captured doctor-patient
encounter. The following billing/fee codes were used to identify all possible physician
visits: 112 - general assessment. 121 - ordinary office visit and 125 - partial assessment
of a patient who is aged 65 or older.
'0
3.'" Pbyskm. C~.""dcristicsud Pn:scribiall Habitl
Subsets of participating physicians were identified based DO their prescribing
habits. Eacb doctor was designaled as a high cost or low COSI antibiotic prescriber based
on each physician's mean antibiotic prescription cost. The meaD aDtibioQc pracription
cost was calculated for each pbysiciao by swnm.in& the toW antilriotic prescription CO$l$
and dividing this tota.I by lhe number of antibiotic presaiptioos wrinen for adult patients
only. Tbose physicians with a mean antibiotic prescription cost in the lowest quartile.
where prescription costs were less than $12.14. were designaled low cost prescribers.
The remainder were designaled hiih cost prescribers. Seven physicians were excluded
from this analysis; four only prescribed antibiotics for children and three did not
prescribe any antibiotics.
Doctors were also categorized by their appropriateness of prescribing. 'The
nwnber of prescriptions for each doctor thai was deemed appropria1e was divided by the
loW number of antibtocic prescriptions written.. Doc1on wm: defined as the lcut
appropriate prescribers if their rate of prescribing approprilUeneSS was below or equal to
the 25* perccntik. where S 47.2". of prescriptions were deemed appropriacc. All
remaining physicians were categorized as the most approprilUe r:nsaibers. 'Three
physicians were excluded from this analysis because they did oot prescribe any
antibiotics.
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J.l.10 Statistical Auly:lil
The characteristics of patients aDd physicians wa'C compaml. using Studeut's I
test for continuous variables and chi-square analysis for categorical variables. For
physician characteristics. Student's I test was used for malysis oftbe foUowing variables:
mean age. mean number of Y"J'S since medical school grwIuation, mean number of
patients seen. mean number of patients with acute infec;tions seen. aDd mean prescribina
r3te for infections. Chi·square analysis was used for the following variables: gender of
prescriber, proponion of graduates from a Canadian medical school. proportion in group
practice. and proportion of appropriate antibiotic prescriptions. For patient
chanlcteristics. Student's I test was used to anaJyze meaD duration ofantibiotic thmlpy by
diagnosis and age. and mean retail antibiotic prescription costs by diagnosis and age.
Chi-square analysis was used for the following: appropriateness of pr-escriptions by age.
influencing factors, proportion of return visits.. gender. proportion with a drug pIao.
presenting complainl.5, and diagnoses. A ~tailed P·vaIuc S O.OS was considered
statistically significanL All statistical analyses were performed using SPSS for Windows
(n::leasc 9.0.1; SPSS lnc:.• Chicago IL, 1998).
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3.2 Community Oral Antibiotic UK in tbe Province of Newfoundlud - NLPDP
The Newfoundland and Labrador Prescription Drug Program (NLPDP) is a
provincial government social program wtuch allows for prescription drug coverage for a
specific facet of the province's population. namely low-income families and seniors
(residents 65 years old or greater) who are receiving government financial social
assistance (Guaranteed lnco~ Supplement). Numbers of prescriptions for oral
antibiotics paid for by the provincial drug program and numbers of claimants covered by
the program were obtained from the provincial health department for the fiscal years
199411995 to 199912000, inclusive. The data was obtained as printouts of the number of
prescriptions for all antibiotics covered by the program. Specific antibiotics in these
printouts were classified by drug identification numbers (DIN). All oral antibiotics were
grouped inlo the following categories and entered into an Excel database: cephalosporins.
macrolides. penicillins. quinolones. sulfonamides. tetracyclines. and other (neomycin.
ch.loramphenicol. clindamycin, fusidic acid. lincomycin and vancomycin). Topical
preparations and injectables were systematically excluded from the analysis by careful
review of pharmaceutical brand and generic names. Oral routes of administration were
confirmed using the Compendium of Phannaceutical Substances (CPS). 109
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3.3 Community 0 ...1Antibiotic: Use iD Can.d...d USA IMS Mukd Datllbues
Data on estimated totals of antibiotics prescribed by office·based physicians in
Canada and the USA in the years 1992 to 1996 were obtained from lntercontincntal
Medical Statistics (IMS) Health Canada and IMS Health USA. • rnaJ'ket research
company that collects data on phannaceutical sales from a representative sample of retail
pharmacies. In me USA. IMS records dispensing information for 34,000 phannacics,
representing greater than 50"/1 of all retail pharmacies in the country. In Canada,
approximately 4.400 retail pharmacies supply tMS with dispensing data. Therefore IMS
Health Canada draws its data from approximately 66% of aU retail phannacies in Canada.
A comparison of nwnbers of oral antibiotic prescriptions (solids and liquids)
written by office-based physicians (i.e. prescriptions wrinen outside hospitals and nursing
homes by general practitioncTS and specialists) was undertaken for selected groups of
antibiotics. The IMS databases provided nwnben of prncriptions for each antibiotic
agent., grouped according to therapeutic class. Antibiotics were re-categorized into the
following broader groups: cephalosporins, macrolides, penicillins. quinolones.
sulfonamidcs, tetrllcyclines and other. For Canadian data, category ofother included the
following antibiotics: chloramphenicol. c1indamycin. dapsone, fusidic acid. lincomycin,
metronidazole. neomycin, nitrofurantoin, rifabutin, rifampin and vancomycin. 1be USA
category of other antibiotics included chloramphenicol. clindamycin., dlrithromycin..,
lincomycin.., methenamine. metronidazole, neomycin.., nitr:>furantoin and vaDCOmycin.
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Rates of antibiotic use were expressed as number of prescriptions per one thousand
persons per year, using population denominators obtained from publicly accessible
government census records. In order to evaluate only oral antibiotic prescriptions. both
the Canadian and US databases we~ modified such that only oral prescriptions were
included. Oral formulations were confirmed using the Compendium of Pharmaceuticals
and Synthetics (Cps).I09
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3.4 Antibioric Use in Acut~ Cart for rile Treac.e.t orcom.aaity-Acqaired
3.4.1 nata Colkc:tio.
All patients aged 18 years of age and older who~ admined to hospital in St.
John·s. NF with the discharge diagnosis of community-acquired pneumonia in the fiscal
years April I. 1995 to March 31. 1996 and April I. 1998 to Marcb 31. 1999~
identified from hospital records. Patients were identified using the CMG 13 code
representing a clinical diagnosis of community-acquired pneumonia. During this time,
three acUle care centres~ in operation in St. John's, NF, namely the Salvation Anny
Grace General Hospital (SAGGH). St. Clare's Mercy Hospilal (SCMH) and the Health
Sciences Centre (lISC). Patients' cham were abstracted and reviewed to collect dala 00
demographics. symptoms. co-morbid conditions, laboratory, radiographic and physical
examination findings. antibiotic treatment in hospital and on discharge, length of stay and
occummce of death within thirty days of admission. A thirty day monality calculation
was used because it was asswned that death after thirty days of admission was unlikely to
be the result of community-acquired pneumOniL 10!. 110
3.4.2 Assessmear of Severity of Diseut
A validated clinical pn:diction rule (Pnewnonia Severity Index - PSO assessing
the risk ofdeath within thirty days for patients with community-acquired pneumonia was
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utilised. 110 lltis prediction rule classifies patients into one of five groups based on a
cumulative score for each patient. Scores are calculated by determining the presence of
specific patient characteristics, co-morbid conditions. physical findings and laboratory
ftndings. Appendix I outlines the point scoring systems as defined by Fine et aI. and
utilised in this analysis. 11o Because patient infonnation on glucose concentration was not
available for da1a abstraction.., patients with diabetes, as noted in the chart. were assigned
points in the same manner as patients with a g1ocose coocentration of 14 mmollliter.
which was the criteria utilised in the development of the clinical prediction rule.
PSI scores classify patients into one of five risk classes. Patients in risk classes l
(no risk. factors for Sl;oring and an estimated 3Q-day mortality of 0-.4) and fI (patients with
scores S 70 and an estimated 30-day mortality of <1.~.4) are at low risk for death within
thirty days due to community-acquired pneumonia. Fine and colleagues recommend that
these patients are suitable for outpatient treatment of their community-acquired
pneumonia. IIO lbose patients with a PSI score ofbetwcen 11 and 90 points may be at
moderate risk for death (estimated mortality of 1.9% and 3.6%) and it is ~fon:
recommended that these patients remain in the emergency department for 24 hours for
obsen1ation.110 Patic:nts assigned to risk. classes rv and V (score >90) are at higher risk
for death within thirty days (estimated mortality of 3.J-I. to 12.1% and >12.1%) and
should ~fore be admitted to hospital. 1lO Assum:ing that PSI scores predicting thirty
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day mortality an: an indicator fOf" severity of disease. the PSI was used to com~
severity of disease. approprialCDeS5 ofantibiotic treatment aDd outcome.
3.•J l.etIlih or Stay
The number of days in hospital (length of stay) Wti calculated by subu¥ting the
admission date from the discharge date. All analyses of length of stay excluded patients
who died in hospital in ordeT to avoid the confounding influence of in.hospital mortality
on lenRth of stay.
3•••• Appropriale.eu or A.tibiotic: Trea"'Cllt
Information on the type. dose. route of administration and duration of antibiotic
treatment was abstracted from patients' cham. Eacb episode of antibiotic treattnent Wti
evaluated for appropriateness by comparison with the ra:ommcndatiODS for the trealment
of community-acquir= pnewnonia in adults outlined by the ~an ConunwLity
Acquired Pncwnonia Consensus Conference Group.l Appc:odix n outlines bow the
guidelines ..~ applied for patients in each risk class.
Antibiotic courses for each patient~ deemed appropriate if all antibiotics
prescribed were in complete accordance with the guidelines. The assessment of
overutilisatioo. was made if more than ODC antibiotic was administered and only OM of
the medications used was re<:ommendcd in the guidelines. Underutilisation occurred
"
when only a macrolide was administered to more severely ill patients.. where the
guidelines n::commend thai. mKr'Olides be used in combination therapy. If DOne of the
administemt antibiotics were included in the guideline recommendations. lhe a.sscssrnent
of wrong dtug was made.
3.4.5 Sc..tistical ADalyH:l
The characteristics and comorbid conditions of patients admitted with CAP were
compared using a SlUdent's I test fOf continuous variables and chi-square analysis for
categorical variables.. A ~tai~ P-value S O.OS was consideTed statistically
significant.
To assess the effects of several predictor variables on appropriateness of antibiotic
treatment. a logistic regression analysis was perfonnod. SevmLI variables were assessed
for statistical significance using bivariate analysis (PSf).tO). Those that were significant
were added to the logistic regression model. Indicator variables for poewnonia risk
classes I through IV (group V was the: referent). as well as indica&or variables for hospital
sites SAGGH and SCMH (HSC ....'8.$ referent), were used in the analyses.
To determine if appropriateness of antibiotic treatme:nt affected lenKtb of stay. a
linear regression analysis was performed. The natw1lI logarithm of the length of stay
values was used. as the distribution of length of stay was skewed to the ri&ht. In the first
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regressioo model. only the pneumonia risk groups were entered as a predictor variable.
In the SttOIId model. patient variables that were DOt considered in the PSI scoring system,
but were considered to be clinically important and thai were statistically significant on
bivariate analysis (pg).IO) were added to the model. 1bese variables included presence
of chronic obstructive pulmonary disease: (COPO), presence of interstitial lung disease:.
and a positive blood culture. Finally lhe variable of appropriateness of antibiotic
ueaunent was added. Indicator variables for pneumonia risk classes II through V were
used in the analyses. The adjusted If values were compared to determine the effects thai
severity of illness. patient characteristics and appropr1ateDC:SS of antibiotic tteatmenl h8d
00 length of stay.
In hospital thirty day mortality across disease severity and appropriall:ness of
initial empiric antibiotic ueatment was assessed using Kaplan-Meier survival curves and
the log-rank statistic. A Cox proponiooal hanlrds model was used to determine the
influence the aforementioned variables bad 00 survival. All statistical analyses were
performed using SPSS fOl' Windows (release 9.0.1; SPSS Inc.• Cbicaao II.. 1998).
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CHAPTER IV - RESULTS
4.1 Onl Antibiotic UH iD Commugity Pnd" ofSL Job" .. NY
4.t.1 Coapal'itoa ofnylici•• Participaaca.1td N_-Partidpaaca
A comparison of the scveoty three (73) participating physicians aod the twenty
three (23) non-participating physicians is presenlOd in Table I. The proportioo of male
physicians in both groups was the same. as was the mean number of years since medical
school graduation and the proportion of physicians in both groups who had graduated
hom a Canadian medical school. The mean ages of the panicipating and non-
participating physicians did differ however. "The meaD age of the study panicipaots was
approximately 45 years while the mean age of study oon-panicipants was almost 50 years
(p-O.04O).
Table I. Baseline characteristics comparing pbysicians who participated in the study
with non-participating physicians (number (percent) WI.1ess indicated).
Pbylkilla ClI.nderisdc Sr.dy ShHIy Noe- P-V.IIH
'artici.,..ca rartidpa.tI
os73 0-23
Mean Age (Years) 45.1 .9.5 .....
Number of Male 40(57.1) 14(63.6) 0.589
Physicians
Mean Number ofVears 18.9 22.5 0.104
Since Gradualioo
Number ofCanadian Med 59 (84.3) 19(86.4) 0.813
School Gradua1cS
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".1.2 Cb.,..C1eristic:s .rtbe StlIdy Pop......
The chan review oft\l.'O days of~gu1arpractice for the 73 participating general
practitioneT'5 captwed 4218 visits. Of these visits 1158. Of 2,.,.. . wen: identified as
infection related iIlnes.sc:s with 949 of these visits idmtified as ~iy acquired, or de no\lO
infections. Table 2 illustralCS the age and gender disttibutioo of those with DeWly
acquired infection. Approximately one third of the gmup were children (age < IS years)
and the gender distribution in this category was equal. However. among the adults. twice
as many women presented to the doctor as compared to men.
Table 2. Age and gender of patients in the study population with newly acquired
infections.
Total
14g(15.6)
159(16.8)
465 (49.0)
In (I8.1)
9-4V_n
5-14 Yaln
15-49 Yaln
~.50 Vain
Pop."tioa "it.. Ih NDWJ I.redioll
No. (-Ie or "'9)
Male Fe.ale
13 (7.1) 75 (7.9)
78(8.2) "(8.5)
156 (16.4) 309 (32.6)
"(5.8) 122 (12.9)
T.... 949{100l 362 (38.ll 587 (61.9)
Table 3 illustrates the diagnoses of the patients with newly acquired infections
separated by age categories. Across all age categories. respinatory tract infections (i.e.
URn. pharyngitis. lRTI. sinusitis) were the most common infection related diagnoses
made. The diagnosis of otitis media was lDOSI frequently made in children under the age
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of five years. Overall the proportion of patients diaanosed with ~ira!ory tract
infections (URTl. pharyngitis. LRll. or sinusitis) was 65% (0-626), 11% for otitis media
(n-IOI), 11% forothcr infections (0=101), 7% for winary tract infection (D""68), and 6%
for skin and soft tissue infection (0=-53).
Table 3. Diagnosis ofpatitnts with newiy acquired infection sepu-aled by age (nwnber
(percent)).
Tour~Yc:anS-14Ynn0.4 Yean
AeeC••epriei
No.(%)
1~'
V..n
URTI 54 (36.5) 49 (30.8) 124 (26.7) 49 (27.7) 276 (29.1)
Pb.ryDgitis 18(12.2) 52(32.1) 82(17.6) 11(6.2) 163(17.2)
Otitis Medill 44 (29.7) 24 (15.1) 28 (6.0) 5(2.8) 101 (10.6)
LRTI 11(11.5) 14(8.8) 41(10.1) 29(16.4) 107(11.3)
Sinusitis 2 (1.4) 8 (5.0) 55 (11.8) 15 (8.5) 80 (8.4)
tm 4 (2.7) 3 (1.9) 34 (7.3) 27 (15.3) 68 (7.2)
ssn 2 (1.4) 1 (0.6) 34 (7.3) 16 (9.0) 53 (5.6)
Otbft' 7(4.7) 8(5.0) 61 (13.1) 25(14.1) 101 (10.6)
TOTAL 148(100) 159(100) 465(100) 177(100} 949(100)
·URn-uppa-R~Tl'1dlnrcetion(i.c.Q)Id).Uln·l.owa"~inIoryTrKtlnr.:ction(ic..
BrondUtisIPncwn), un .. Urinal')' TlKt Wectioa.. ssn .. $lUDISoft TI$SUt Infcctioa..
Of the: 949 patients with oewly acquired infection. 604 received a prescription for
oral antibiotics. This ~JnSC"ts 64% of all patients with M novo infections (6041949)
and 14% oftetal patients who presented to the doctor (604/4218), excluding prescriptions
wrinen for anti-viral. anti-fungal or topical antibacterial agents. The age and gender
distribution of patients who reeeived antimicrobial therapy are presented in Table 4.
Patients within the age nmge of 15 to 49 years received half of all an1.1'biotic prescriptioDS
'Nrinen and consuJtations for pediatric patients 4 years aDd YOWlger resulted in the lowest
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pen:mtagc of antibiotic prescriptions. After the age of 15 years. more fcmaJes than males
received antibiotics. although more females within this age group presented to the doctor
with infection related illnesses. The percentages for age and gender distribution of all
infection paticnts who presented to the doctor (fable 2) closely resemblc the percentages
for agc and gender distribution of those patients who ~eived antibiotics.
Table 4. Age distribution of patients with oewly acquired infections who m::eived
antibiotics (number (DCr'CC1It) unless indicated
Ace Populario. ReceiviJIl Aatibtotia
Ca1e&0ry No. (%)
Perual Wilbill Ace Gro.p
Rec:eivlac Aalibiotia
."
T.... M.1e Fe.ale T_ Mole Fe••1e
0-4Yan &6(14.2) 48(7.9) 38(6.3) 51$.) 65.8 50.7
~1"Yan 100(16.6) 50(8.3) 50(8.3) 62.9 64.\ 61.7
15-49Yan 301 (49.8) 107(17.7) 194(32.1) 64.7 68.6 62.8
2:SOYan 117(19.4) 36(6.0) 81 (13.4) 66.1 65.5 66.'
Total 604 \00) 241 39.9 363 60.1 63.6 66.6 61.8
11Ic: distribution of antibiotics across the diagnostic catcgories is as folloW!: 7% of
~I antibiotics wen: prescribed for URn. 23% for pharyngitis. 15% for lRTI. 16% for
otitis media. 12% for sinusitis, 9% for urinary tract infections. 8% for skin/soft tissue
infections and 10-1, for all other infections. Figure I represents the proportion of
antibiotics given within each diagnostic category. With the exception ofURTI and other
infectiollS. grea&eT than 80% of all patients within ca;b diagnostic calegory received an
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antibiotic prescription. Most notably, 9?-" of all patients diagnosed with otitis media in
particular o.-,oere treated with antimicrobial therapy.
",.
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Figure I. Distribution of diagnoses and proportion ofantibiotics given within c:ach
diagnostic category.
4.1.3 Aaalysil .(Prescribed MtibioOa
In patients Wlder the age of 15 years, prescriptions for penicillins accounted for
66". of all antibiotic prescriptions wntten, wfler-s 43% of prescriptions wa'C for
penicillins among the adult patients (Table 5). Cephalosporins and quinolones were
prescribed more frequently in adults. Overall penicillins and macrolidcs wen: the most
commonly prescribed antibiotics in the study, accounting for 70% of all prescriptions
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captured. Amoxkillin W1LS the single most commonly prescribed agent. giving rise to
35%oftotaiprescripOous.
Table 5. Nwnbers (pc:n:ent) of prescriptions in each antibiotic drug class for pediatri<:
and adult age groups (0-604).
Prescriprio. ClaD Pedialnc ("14 Van) Ad.1t R 15 Van) Total
No.(%) No.(%) No.(%)
Ceplla'osporiu J (,U) 44 (10.5) S3 (8.8)
Cefaclor 3(1.6) 3(0.7) 6(1.0)
Cefuroximc 24 (5.7) 24 (4.0)
Macrolide 40 (11.5) 80 (19.1) 110 (19.9)
Erythromycin 38 (20.4) 52 (12.4) 90 (14.9)
PrniciUill. 111 (65.6) 180 (43.1) 301 (50.0)
Amoxicillin 100(53.8) 109(26.1) 209(34.6)
QuiaoloGes 40 (9.') 40 ('.')
Ciprofloxacin 20 (4.8) 20 (3.3)
S.lfoe.mides 13 (7.0) 40 (9.6) S3 (8.8)
TMPISMX- 13 (7.0) 40(9.6) 53 (8.8)
TrtncydiHi 1 (1.1) 12 (5.3) 14 (4.1)
Minocycli.oe 1 (0.5) 9 (2.2) 10 (1.7)
DIller 11 (1.') 11 (1.0)
Metronidazole 7 (1.7) 7 (1.2)
AU A.libioOa 186 (I.) 411 (III) 604 (Ito)
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Table 6. Numbers of prescriptions (%) in each antibiotic class separated by diaposis.
J)
(27.1)
,
(10.4)
27
(S2.1)
.
(1.3)
1
(1.9)
3
(S.6)
"(31.9)
"(46.3)
"(21.1)
9
(12..7)
"(49.3)
3
(4.2),
(7.0)
.
(5.6)
,,,,
.
(6.6)
l
(3.3)
12
(1).2)
"()7.4)
"()J.4)
2
2
(1.5)
1
(0.7)
.
(2.9)
27
(19.7)
103
(75.2)
1 "(1.6) (1.1)
II 120
(17.5) (19.9)
,. J02
(25.4) (50.0)
. ..
(9-') (6.6)
. "(9.5) (U)
I 1.5 Z4
(2.1) (23.1) (4.0)
4 I IZ
(7.4) (lZ.7) (Z.O)
4Z ])7 (100) 91 91 71 (100) 54 6) 604
(l00) (100) (100) (100) (100) (00) (100)
1
(2.4)
19
(4U)
19
(4U)
1
(24)
2
(4.lj
URn .....ry-e'd- Oddt utTI ~1IIiIII un SST1 Qdler ToCaI
MeII_
.
(6.1)
"(15.3)
.7
(61.4)
3
(3.1)
7
(7.1)
Tet~
T....
·URn· Upper RespinuJry Tract tnreetion, LRn" Lower R.espinlory TrKllnfectioD.. un .. U.....,.
Tract lnrC'Ction and SSTi - SlUnfSoft Tissue Infeclion.
Table 6 displays the numbers arxI types of antibiotics prescribed within each
diagnostic class. With the exception of urinary trxt infections and other infections. the
most commonly prescribed antibiotic group within cail diagnostic category was the
penicillins. Equal number.; of penicillins and macrolide! 'N'Cf'e prescribed for LRTI.
Cephalosporins were most commonly prescribed in cues of sinusitis and skinlsoft tissue
infections. Most urinary tract infections W~ ~ with either TMPISMX or
quinoloDCS.
.7
Overall 74% of antibiotic pn::scriptions 'M:re written for a duration of 10 days or
great.cT (Table 7). lbe mean duration of antibiotic treatment for all age groups and
antibiotic classes equalled 10.5 days (Table 8). 1bc treatment of respiralory tnK:1
infections encompassed.. on avenge. 9 days of tratmenL Urinary tract infections were
treated. on average. for 7 days and for four or more days in 87% of cases in which this
diagnosis ""'as made.
Table 7. DunttiOD of antibiotic tmlDnent by diagnosis groups (number (percent) of
prescriptions).
3o.y. ....90'y. ~ 10 Day.
Respiralory Tract 68 (20.4) 265(79.6)
OlitisMedia 13 (13.7) 82(86.3)
Uriaary Tract 7(13.5) 28(53.9) 17(32.7)
SkialSoft Tissue 17(40.0) 27(60.0)
OI.er 20(37.2) 33 (62.8)
Total 7(1.2) 145 (25.4) 423 (73.4)
Table B. Mean (+ SO) duration ofantibiotic treatment by diaposis and drug class.
Respiralory 0ticiI UTI ssn Odter Total
Tncc Media;
PeDiciUiJu 9.• :t1.. 9.9:t0.' 10.0:t0.0 '.3:t.I.' ' .• :t1.6 9.• :t.1 .•
~bc:rolidea 9.2:t1.7 '.9:t2.1 26.0:tH.' 11.3:t11.7 10.1:t. •.•
Cep"atosporiu 9.1 :t2.1 '.2:t2.0 10.0:t.0.0 9.• :t2.0 7.0:t.0.0 9.1 :t2.0
QuiaolODes 9.5:t1.2 '.7:t.2.3 6.51:2.. '.51:1.7 30.3:t30.5 11.0:t.1•.0
TdracydilMS 10.0:10.0 25.5:t19.• 19.31:16.7
Other 10.2:t1.3 9.3:t1.. 7.31:2.3 .5.6:1;71.2 \3.'1:21.3
Total 9.• J:U 9..5t1.4 7.2:t2.• 10.7±12.2 22.'±36.1 10..5±11.9
-Rcspiruofy T..a - cokl. pn.yng;tis. btonc:hitislpncumonia MdsinllSiriL un .. unn-y Trw;:t Inferno...
SSn·SkinISoftTisstRlnfection.
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Table 9. Mean (± SO) dW'alioo ofantibiotic: beatmau (days) separated by age groups
and diagnosis.
l)...t4Vean
URTI 9.8 t 0.9
n..,..cfti:a 9.1±0.9
Otitis Media 9.8 t 12
LRn 9.5±1.2
Siauitis 10.5 t 1.4
lIT! 7.3 t 2.5
SSTI 8.0 t 1.1
0tItet' 16.1± 11.5
Total 9.8 ± 1.9
t .. Significut at p·vaJue sO.05
O!:. 15 Vean
8.8t 1.1
9.1 1: 1.6
9.1 ± 1.1
8.9± 1.8
10.Ot 1.6
1.21:2.4
10.81:12.7
23.21:37.1
1O.8±' 14.3
p·v-...e
0.083
•.ttlt
8.039t
0.138
0.363
0.906
0.710
0.766
0....
Table 9 demonstrates a comparison between mean duration of antibiotic between
age groups of patients. For the most part. dunltion of therapy was similar across
diagnostic ca~gories. However duration was approximately one day longer for children
beau:d for pharyngitis (PwO.OIO) and obbs media (P-O.039) as compared. 10 adults.
At the time the study was u:ndenaken. 11 of the 30 different types of antibiotic:s
prescribed by the study physicians were W'lder patent in Canada. Table 10 depieu the
proportions of unpatented {or older} agents compan:d to patented (or 1XWt':f) agents
pn:scribed for each diagnosis group. OldcT. unpatented agents were prescribed in 74% of
cases. Older agents were primarily pre:scribed in respiratory tract infections (75%).
skin/soft tissue infections (92%) and other infections (81%). An increase in newer agents
was used for tn:ating otitis media (37%) and urinal)' tract infections (39%).
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Table 10. Number of prescriptions wrinen for olderfunpeCentc:d agents compared to
newerlpatented agcots by diagnosis sroups.
ot...__ OIckrllJ.ptI'n.ed Acn" Newerlhrnted Ainu
No. (-t.) N.. (%)
Respinfof'y Tnd 257 (75.4) 84 (24.6)
Otitis Media 62 (63.3) 36 (36.7)
Uria_ryTnct 33(61.1) 21 (38.9)
SkiafSoft r ....e 43 (89.6) 5 (10.4)
Odocr 51 (11.0) 12 (19.0)
Total 446(73.8) 158 (26.2)
4.1.4 Antibiotic: Pracriptio. COl"
aflhe 604 antibiotic prescriptions events capcumt in the study, 556 were us."li for
the analysis of retail antibiotic prescription costs. Of the 48 prescriplion events which
were excluded from the analysis, 16 prescription events djd not indicale a ~ucncy with
which the antibiotic was to be admUUstm:d, 14 provided DO da1a on the intended duration
of therapy, 9 lacked dose infonnation and 9 fW'thc:r prescriptioos were excluded due to
absence of cost informacion in the IMS drug cost list (6 prescriptions for bacampicillin. 2
for ampicillin aDd I for trimethoprim).
The mean retail cost of antimicrobiaJ thenpy for aU patients reccivin&
prescriptions was $19.73 (± 532.54). Prescription costs ranged from a minimwn of$l.60
10 a maximum of $576.00. Mean costs for each antibiotic drug class are depicted in
Table 1L This analysis did not acCOUDI for diffcrenoes in dwations of1berapy, a11boush
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the mean dwation of therapy for all drug classes was approximately 10 dap as was
p~viously described. Pn:scriptions writteD for penicillins comprised the lowest avenge
retail prescription cost ($12.19) while the most expensive prescriptions were for
quinolones (565.411).
Table II. Mean (± SO) retail prescription drug C05U separated by antibiotic class.
Aatibiotic Dne Clasa Mea. Prescriptio. Cost
C~"'tosporiu S29.10±SI1.31
Macrolides 519.96 ± $2021
PCDicillilll 512.19 ± 510.28
QuinoloDes 165.48 ± 592.55
Sulfo••mldes $16.63 ± $34.30
TetnlcyciiDei $18.43 ± 518.68
OIlier 510.55 ± 58.11
Total $19.13 ± 532.54
Table 12 outlines mean prescription cosu for the treatment of each diagnostic;:
category sepanted by age groups. Overa.ll. pR:SCTiption costs increased with age.
Treaunent for infections such as bacterial var;inosis., epididymitis., acne. dental infections.
gastroenlcrilis ;!,.nd prostatitis. wtUdl are included in the e:ateBO'Y of -other'" infections.,
ga..'e rise to the grealest mean antibiotic prescriptioo cost of$49.24 when all~ groups
Weft: combined. Sinusitis possessed the second highest overaJ.1 average prescription cost
of 521.45. The diagnostic category resulting in the lowest mean prescription cost.
namely 510.18. was pharyngitis. For patients under !he age of 5 years. sinusitis was the
most expensive condition to treat. Combining the diagnostic caaegories of URll.
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pharyngitis, LRTI and sinusitis. the mean retail cost of an antibiotic prescription for the
treatment of respiratory tracl infections equalled $17.10.
Table 12. Mean (± SO) retail prescription costs separated by diagnostic category and
age.
Ojapos.
URn
Phary_w;itis
OtitisMedili
LRn
Siausitis
UTI
SST'
Ocher
G-14Yean
$5.18±$3.89
$6.86 ± $4.60
$6.14 ± $5.56
$6.59 ± $7.\0
$13.39 ±S11.I4
$7.19±$2.47
$5.32 ± $3.77
$17.63 ±$17.64
~ 15 Yean
$20.22 ± $ 12.67
$1422 ± $6.54
$24.63 ± $15.68
$24.70 ± $16.87
$29.27 ± $18.55
$18.38 ± $14.46
$25.04 ± $27.42
$51.30 ±S94.32
T....
$15.07 ± $12.70
$10.78 ±$6.78
$12.44 ± $13.41
$18.60±$16.68
$27.45 ± $18.51
$17.72±$14.28
$23.29 ± $26.92
549.24 ±S91.76
P~V"H
O.OO4t
<G.OOtt
<G.OOlt
<G.OOIt
0.150
0.509
0.641
0.938
RTI Total $7.09 ± $6.16 $22.24 ±$15.69 $17.\0 ± $IS.06 <G.OOIt
Total $6.91 + $6.27 $2S.82 ±S37.81 $19.69 ±S32.S4 4.00lt
·URn ~ Upper RespiratoryT~ InfCC'lion.. LRn '"' Lower Respiratory Tract Infection, un • ulinwy
Tracllnfcaion. SST. - SkinlSoft Tis.sue InfcaioR. Rn - Respinwfy Traa Infcaion.
+-SignifiQlllatp-vaJueSO.OS
The mean retail prescription cost for those patimLS with a drug plan was $22.08.
while the cost for those patients who did nOI have a drug plan. or dntg plan information
was nOI known for the patient, was $16.46 (p....0.026). There were no differences in the
proponions of patients in each diagnosis group with a drug plan as compared to those Dol
covered by a plan (P=Q.307).
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Although the four months of this study occurred dwing the fall and wink!', and
therefore is subject to seasonal bias, estimations of annual population rates of both
antibiotic prescriptions and infections per person per year were calculated. The estimated
annual infection rate by age and diagnosis is presented in Table 13. It is anticipated that
children will become infected with a T'eSplnuoty tract infection aDd present to the doctor
once a year (excluding otitis media) with colds being the most common infection type.
Half of all adults will acquire a respiratory tract infection and present to a GP in a one
year period. Overall the rate of infections presented to a doctor in children is 1.56
infections per person per year while the rate in adults decreases to 0.76 infections per
person per year.
Table 13. Estimated annual population rates of infection in children and adults per person
oer vear bv dia2nOSis.
Ettimaced ADaual Rak
Pediatric (6-." Yean) Aduk ~15Yean) Total
No. 01Pfl/ielltJ ill SIlliiy 307 642 949
Por"dlltioll 23,990 103,465 127,455
URn 0.52 0.20 0.26
Phary1lp 0.36 0.11 0.16
Otitis Media 0.35 0.04 0.10
LRTI 0.16 0.09 0.10
Siausitil 0.05 0.08 0.08
UTI 0.04 0.07 0.07
SSTI 0.02 0.06 0.05
Other 0.08 0.10 0.10
Total 1.56 0.76 0.91
"URn· upPef Rapantory TTkt lnfecDOll. un "'l...owe" RespiJaIory lnfcctioll.. t..rn. u.-m.y TlXI
!nfectioo.. ssn .. SkitIISoft Tissue lnfcaioD. Tbcsecstimltesbli~ IscuotJI!biaastbepresatpcioD
~()CI;UrftdiDdxraJVwima.
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The estimated antibiotic prescription rate by age and diagnosis is rnsented in
Table 14. The prescriptioo rate for URn pharyngitis, LRll. sinusitis (i.e. rc:spiratory
oact) and otitis media in childrcD less than 15 years was 0.90 antibiotic prescriptions pet"
pe:rsoo per- year. This rate declined to 0.31 prescriptions per person per year for those
aged 15 years or greater.
Table 14. Estimated annual population rates of antibiotic prescriptions io childn::o and
adults pet"~n per year bv diagnosis.
\ Pedi.tric (0.14 Yean) Aduh ():15 Van) Total
No. ofPlIlUtUS ill ShUIy 186 418 604
PopMhuio#r 23.990 103.465 127.455
Respin10ry Trad
I
0.56 0.27 0.33
Otitis Mtdia 0.34 0.04 0.09
Urt.aryTrad 0.02 0.06 0.05
SkiaISoft Tiss..~ 0.02 0.05 0.05
OIIoe, 0.02 0.07 0.06
T.... 0.95 0.49 0.58
.Re5fltrllOfylrKt rolcl. WlIISIlU.. phIrytlgms and~Tbcxcsnmacs~.lCUoDUIJ
biasasltw:presc:ripioQ(vm~OCCIll'ftdialbefalllvriral:r.
Table IS depicts the projected rate of antibiotic usc based OD prescriptions
captured during the study period. The penicillin group of antibiotics is cxpc:cted to
account for half of all antibiotics prescribed in the study rqiou in a ODe year period. with
a rate of 289 prescriptions per 1000 pcr.;oDS per year. Amoxiciltin in particular is the
most frequently prescribed within the peniciliiD group. The rate of usc of macrolidc:s is
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e;{pected to equal liS prescriptions per 1000 persons per year. The tetracycline group of
antibiotics is expected to be the least frequently pRSCribed group of antimicrobials.
Table IS. Estimated annual niles of antibiotic prescriptions for acule infections per 1000
per year by drug class.
Cq)halosporilu
Cefuroxime
Cephalex..iD
M.crolida
Azithromycin
Clarithromycin
Erythromycin
Peaic:illiu
Amoxicillin
Amo;{ic:illinlClavulanic Acid
CloxacilliD
Penicillin
QuiaolHcs
Cipronoxacin
Norfloxac:in
S.If••••icIeI
tMPlSMX
Tetrxyc:line
MettonidazoJe
Nitrofurantoin
TOTAL
E.••ted All•••• Rate Per 10M
SI
23
14
"'II
18
85
,..
199
34
23
18
38
19
17
SI
51
23
7
12
7
4
.71
75
4.1.6 Appropriateness of Antibiotic:: Prescriptions
Accepting that the diagnoses made by the physicians are correct, 59% of all
antibiotic prescriptions were appropriate while 41% were inappropriate. Of the
inappropriate prescriptions, 19% were for the wrong drug. 13% were not indicated and in
9% of cases a more appropriate lower line of antibiotic was available for prescription
(F;_ 2).
Figure 2. Appropriateness of antibiotic prescriptions as determined by the Anti·infective
Guidelines For Community-acquired Infections 2M Edition. This analysis is based on the
general practitioners' diagnoses.
Table 16 shows the appropriateness of antibiotic prescriptions by diagnosis and
the reasons for inappropriateness. TIle overall appropriateness rate was 45% for
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respiraiOry tract infections (URTI, pharyngitis, LRTI and sinusitis) and 7')-/0 for otitis
media. 1be appropriateness rate was substantially higher for non.respiratory tract
infections, namely 7')-/0 for urinary tract infection. 81% for skin/soft tissue infection and
76% for all olher infections.
Table i6. Appropriateness of antibiotic prescriptions by diagnosis groups based on the
physicians' diagnoses.
Appropriate Not W....K Lower Liae Total
Indicated Dne
URn 42(100.0) 42(100)
Pbaryagitil 74 (54.0) 3 (2.2) 53 (38.7) 7 (5.1) 137 (100)
Otitis Media 77 (78.6) 7 (7.i) 14 (14.3) 98 (100)
LRTI 36 (39.6) 23 (25.3) 27 (29.7) 5 (5.5) 91 (100)
SiD1IIitis 43 (60.6) 6 (R.5) 10 (14.1) i2 (16.9) 71 (100)
un 43(79.6) i(1.9) 1O(IR.5) 54(100)
SSTI 35 (RI.4) 7 (16.3) 1 (2.3) 43· (iOO)
GIber 31(75.6) 3(7.3) 5(12.2) 2 (4.9) 41.(00)
The 74 prescriptions not indicated for respil1ltory tract infections (URTI,
pharyngitis, LRTI and sinusitis) were for viral infections as indicated by the diagnosis
made by the doctor or by the assessment of probable etiology (bacterial or viral) made by
the doctor and docwnented in the patients' charts. Forty two (570/.) were diagnosed lIS
colds by the doctor (i.e. URTI). 17 (230/0) were cases of LRTIlbronchitis in children, and
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15 (20%) were other rnpiraloty infections deemed of likely viral etiology by the docIor
and were~ as sucb in the patients' charts.
In 26% of pr'eSCriptions wrinen for respiraJory tract infections (0-90), the wrong
antibiotic ....'3$ p~ribed. In these cases. the prescribed antibiotic did not provide
adequate coverage to eradicate the probable micro-organjsm associalcd with the
diagnosis thai the physician bad made. For pharyngitis.. the most commonly prescribed
antibiotic which was deemed 10 be the wrong drug was amoxicillin used to treal adults
(0"'42). For LRTI·s. the predominant wrong drug U5ed was also amoxicillin (n-I7),
although 7 wrong drug prescriptions were for a cephalosporin. Three cipronoxacin
prescriptions wcrt: administered to patients with sinusitis who were given a wrong drug.
1bc wrong drug was prescribed in N .. 2-;.. 16% and 12% of diagnosed cases of
otitis media. urinary tl'aC1 infections. skin and soft tissue infections and oc.hcr infectioas
respectively. For Ihcsc prescriptions. ciprofloxacin was the most commooIy prescribed
wrong drug for all diagnostic C3legories, except for UTI where the one: wrong drug
prescription was for ampicillin.
In 19% of cases diagnosed with urinary trae1 infection and treated with
antibiotics. a lower line of antibiotic therapy was consi~ mort: appropriate by the
guidelines. A lower line of antimicrobial therapy, according to the guidelines, provides a
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more narrow spectrum of coverage and therefore is less likely to contribute to the
growing problem of bacterial resistance. Prescription events for which a lower line was
deemed to be available for the treatment of Ul1 primarily involved the use of
norfloxacin. In only 7% of respiratory tract infections treated with antibiotics, a lower
line of therapy was recommended.
Table 17. Top five agents for inappropriate prescriptions.
Not 1,.4iLtIU~(,.=71)
AmoxiciJlin
Erythromycin
ErythromycinlSulfisoxazole
Clarithromycin
TMPISMX
Wroll, Dr", (,.=11')
Amoxicillin
Ciprotloxacin
Erythromycin
Cefuroxime
Bacampicillin
Lower LUt~A 'l'GiJabk (1I-5})
AmoxicillinlClawlanic Acid
Norfloxacin
Erythromycin
Azithromycin
Clarithromycin
33(42.9)
IS{19.S)
7{9.1)
6(7.8)
6(7.8)
59 (S3.6)
II (IO.O)
8(7.3)
6(5.5)
5 (4.S)
15 (29.4)
7 (13.7)
7 (13.7)
5(9.8)
4(7.8)
For eacb of the three categories of inappropriateness for all diagnostic categories.
the top five inappropriately administered agents were determined and docwnented. in
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Table 17. in 54% of wrong drug cases and 43% of not indicated cases. the
inappropriately prescribed antibiotic was amoxicillin. lbe combination agent of
amoxicillinlclavulanic acid was prescribed in 2~/. of cases in which a lower line of
therapy was more appropriate.
Table 18. Appropriateness of antibiotic prescriptions by age groups based on the
physicians' diagnoses.
P-Valuc 0.349 <0.001 <0.001 0.885
°Nog\liOcliM was .vailableto;wess2 prac:ripcions inlbc 5-14 yaBgJ'Ollp. II ~ptions in !tie 15-49
group, IUld 7 prcscriptions in 1tIe;a50 g:mup.
The proportion of antibiotic prescriptions which were deemed appropriate did nol
differ by age groups of the patients (P= 0.349) (Table 18). However a greater proportion
of pfe'SCriptions administered to children under the age of 5 years were considered to be
not indicated (P<O.OOI) while less prescriptions in this same group were for the wrong
drug, as compared to the remaining age groups (P<O.OO I). Proportions of antibiotic
prescriptions in which a lower line of antibiotic was available were similar across age
groups (P=Q.885).
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Those cases in which an antibiotic pr-escription was given to an adult and that the
prescription was deemed ~approprilde"or ~Iowe:r line available" in the previous anaJysis
were selected. One: hundnd and eighty five (ISS) pracriptiOM met these criteria. These
presc:riptions w~ then used to evaluate the appropriau:ness of the prescribed dose. In
total, ISS prescriptions were \oVrinen for an appropriate dose (84%) while 30 (16%)
prescriptions WCTe inappropria1ely dosed. Of the 30 prescriptions which wen:
inappropriately dosed. 20 were the result of undCT-doSing and were primarily
pl'C5Criptions for amoxicillin used for the treaanenl of respiratory tract infections.
4.1.7 Criterio.·B..ed Decilio. Tree for Viral Ven•• Backrial Etielo&Y 01
Respira.ory Tract 1.ledioaI
Upon examining the presenting complaints. signs and symptoms for each adult
patient diagnosed w;tb a respiratory tract infection. cases of likely viral etiology were
identified and compared v.ith the decisions of the physicians to prescribe an antibiotic::
lTable 19). The physicians' detmninations of miao-organism etiology W'Cre deemed
bacterial if an antibiotic was prescribed and viral if DO prescription was provided.
Patients diagnosed as having otitis media wen: excluded from this analysis. 0vcraI1, the
doctors deemed 44% of the patients to possess a viraJ rnpinuory tnlc1 infection, whereas
the criterion-based d«ision tree: deemed Srh of these same infections to be viraJ in
nalUJ'e. Although some semblance of agreement of etiology was found for the diagnosis
of upper respiratory tract infection (83-;0 vs. 100%), marll:ed diffen:nces in detmninatioo
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ofrtiology were seen for lhe diagnoses of pharyngitis (17% VI. 84%), LRTI (18% vs.
87%) aDd sinusitis (10% VI. 63%).
Table 20 demonstrates lhe nwnbers of possible unoecessary prescriptions wnneo
wilhin each antibiotic drug class for those eases in which the criterion-based decision tree
deemed the infection likely to be viraJ in DlltUI'e. In 274 cases oftbe 553 eases identified
as being potentially v;B1 in narure. an antibiotic prescription was given. Fifty seven
percent (57".4) of the potentially unnecessary prescriptions were written for those drugs
classified as penicillins. Macrolides accounted for 24% of possible unnecessary
prescriptions.
Table 19. 1ne likelihood of viral etiology as determined by a decision tree.
Dialposa Phy,icia••- Decisio. Critcria·a.Hd Dttisio. Total
(not to prescribe an antibiotic)
No. (%) No. (%) No.
URn 144 (B32) 173(100.0) 173
PIil.ryapra 16(172) 78 (B3.9) 93
LRTI 14 (IB.4) 66 (86.8) 76
swum. 7 (10.0) 44 (62.9) 70
TotIll lBI (43.9l 361 (17.6) 412
'URn· upper Rcspinlory Tnal.llfc:etiocl. UTI -lollftl" lUspinraryT~ lnfl'Ctiaft.
.2
Table 20. Numbers of possible unnecessary antibiotic prescriptions for respiratory tract
infections using the criteria based decisions for probable viral etiology (%).
Dr"" ClaD Nu.ber of Pnseriptio••
C~phaloJporias 1S (8.1)
Ma~rolidea 50 (27.0)
P~nic:i1liu 103 (55.7)
Qui.o_a 5 (2.7)
Sulfonamida 8 (4.3)
T~tncydda 4 (2.2)
Total 185(100)
4.1.8 Factors l.nU~Dcia&Antibiotic Prac:riptioas
In over half(54~.) of all cases in which an antibiotic prescription was written, the
doctor felt the medical indication for the prescription was not vcry clear (Table 21). For
thc most part, a physician-perceived very clear medical indication for an antibiotic
prescription OCCWTlCd less for diagnoses associated with respiratory tract infections.
Conversely, in 72% of cases in which a prescription was given for the diagnosis otitis
media. the doctor.; felt the medical indication was very clear.
Table 21. Medical indication as a factor influencing the decision to prescribe an
antibiotic.
UnlCemia Samew"a. So.ewlla. Clar Very T....
U.«rtaiD Clnr C1eor
URTI 1(2.6) 12(30.8) 10(25.6) 14(35.9) 2(5.1) 39(100)
Pharyngitis 1(0.7) 4(2.9) 18(13.2) 58(42.6) 55 (40.4) 136(100)
Otitis Media 3(3.1) 24(24.5) 71 (72.4) 98(100)
LRTI 3(3.3) 21 (23.1) 34(37.4) 33 (36.3) 91 (100)
Sinusitis 1(1.4) 5 (7.0) 12(16.9) 27 (38.0) 26(36.6) 71 (100)
UTI 3(5.7) 7(132) 15(28.3) 28(52.8) 53(100)
ssn 1(2.2) 1(2.2) 6(13.0) 9(19.6) 29 (63.0) 46(100)
Other 3 (4.8) 2(32) 10(16.1) 18(29.0) 29 (46.8) 62(100)
Total 7(12) 30(5.0) 87 (14.6) 19903.4) 273 (45.8) 596(100)
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In Table 22, diagnostic categories and factor results were combined. In this
analysis, less p~riptions administered for respiratory tract infections were based on
clear to very clear indication in the physicians' opinion as compared to aU other
infections. (P<O.OOl).
dUNn
36(13.9)
124 (20.8)
223(86.1)
472 (79.2)
Respintory Tnct
IlIlectio••
Oilier
lalectiou
Total
Table 22. Medical indication as a factor influencing the decision to prescribe an antibiotic
in combined diagnostic categories and factor results (number (percent) of prescriptions),
Clar to Very Not Completely P-V.I.e
Clear Clar
249 (73.9) 88 (26.1)
Those prescriptions in wlIich the doctor felt the medical indication was clear or
very clear, and the guidelines assessed as either appropriate or oot indicated were
selected. A comparison was made between respiratory tract infections and all other
infections (Table 23). Only 3.6% oftbcse particular prescription events were considered
not indicated by the guidelines in non-respiratory tract infections. However, for
respiratory tract infections, 39l'/. of the prescriptions were considered not indicated by the
guidelines. even though the physicians felt the medical indication for an antibiotic was
clear to very clear (P<O.OOl).
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TaMe 2J. Appropriateness of prescriptions in whicb the physicians felt the medical
indication for the prescription was clear to very clear. by combined diagnostic categories
and factor results (number (percent) of prescriptions).
Appropriate Not I.dialled
127 (60.8) 82 (39.2)Respinlory Tnd
I.redio..
OC.er
Iarectioas
Total
159(96.4)
286(76.5)
6(3.6)
88 (23.5)
P·V"1M
<9.001
Table 24. Paticnt/palalt expectation as a factor influencing the decision to prescribe an
antibiotic by diagnostic categories (number (pm:ent) of prescriptions).
39(100)
136(100)
98(100)
91 (100)
71 (100)
53 (100)
46(100)
62(100)
596(100)
ToW
5(5.5)
1 (1.4)
3 (7.7)
2(1.5)
1 (2.2)
3 (4.8)
15(2.5)
14(35.9)
95 (69.9)
77 (18.6)
43 (47.3)
32(45.1)
36(67.9)
27 (5!.7)
37(59.7)
361 (60.6)
No Mosely Se..e Se.-"'t Scrnc
lafhlnce No I.n-ce Stro.c I.n-.et
I.nunce I.n.e.ce
9 (2J.1) II (28.2) 2(5.1)
17(12.5) 14(10.3) 8(5.9)
9(9.2) 6(6.1) 6(6.1)
24 (26.4) 15 (16.5) 4 (4.4)
16 (22.5) 12 (16.9) 10 (14.1)
9 (17.0) 7 (13.2) 1(1.9)
13 (28.2) 1(2.2) 4 (8.1)
8(12.9) 7(11.3) 7(11.3)
105 (17.6) 73 (12.2) 42 (7.0)
URn
PhuYllgitil
OtitisMedL.
lRTI
Sinusitis
UTI
ssn
01...
Total
The pttee1ved expectation of patients that they would receive an antibiotic
prescription had some degree of influence on the physicians' decision making in 39% of
the cases (Table 24). For cases in which an antibiotic prescription was wrinen for the
diagnosis of respiratory tract infection. patient expectation was more of an influence as
compared to non.~inl.toryttaet infections (P""O.OO7) (Table 25).
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Table 25. Patient/parmt expecwioo as a factor inflUCDClng the decision to prescribe an
antibiotic in combined diagnostic categories and factor results (num~ (percent) of
prescriptions).
NalMostly No IaII.Cllce Some ..nlllala:
Respiralory Tract 250 (74.2) 81 (25.11)
I.fediou
Otkr 216 (113.4) 43 (16.6)
l.fectiolU
Total 466(18.2) 130(21.8)
p.VallH'
1.1..
Appropriateness of the prescriptions for which the doctor felt that patient or
parenl expectation for an antibiotic had some influence on the decision 10 prescribe was
assessed (Table 26). A greal proportion ofpaticnl influenced prescriptions for rcspinltory
tract infections was found to be inappropriate as compan:d to patient influenced antibiotic
prescriptions for all othtt infections (P<O.OOI).
Table 26. Appropriateness of prescriptions in which the physicians felt there was some
influence by the paticntlparalt on the decision to prescribe, by combined diagnostic
catelorics and factor results (number <percent) of prescriptions).
Not Approprialte Approprialle
51 (58.6) 36 (41.4)Rcspinlory Tract
IDfcetiolU
Other
I.fcetiou
TObl
7(21.2)
58 (48.3)
86
26(78.8)
62 (51.7)
P-V.I_
<8.0011
rune constraint and the thought thai. the patient might seek an antibiotic
prescription from another doctor if ooc: was oot givell were considered to have had DO
i.nfluence in 90% of prescription decisions. regardless of diagnostic category (Table 27
and Table 28). Ln only 2 ~ptioo events capnued did time consttai.nt completely
dictate the: prescription of an antibiotic.
Table 27. Tune constraint as a factor influencing the deciston to prescribe an antibiotic
bv diaf!J1()Slic categories (nwnber (pcKent) of prescriptions).
T....
39(100)
136(100)
98 (100)
91 (100)
71 (100)
53 (100)
46(100)
62(100)
596(100)2 (0.3)
1(\.4)
1(2.6)
4(0.1)
1(0.7)
1(\.0)
2(2.2)
2 (3.8)
36(92.3)
123 (90.4)
88(89.8)
77 (84.6)
63(88.7)
49(92.5)
43 (93.5)
57(91.9)
536 (89.9)
No Mostly SoaN SMlew.... Stro-e
Innue.a: No lafhteece Stro.. lun-_a:
(.nuna: I.nuna:
2('.1)
10(7.4) 2(1.5)
8(82) 1(\.0)
10(1 \.0) 2(2.2)
7(9.9)
2(3.8)
3(6.')
4(6.5) 1(1.6)
46(7.7) 8(1.3)
URTI
Pbaryap
OtitilMed.Ul
LRTI
Sillu.ilia
UTI
SS1l
0.....
Total
Table 28. Patient atteodaDoe at another physician as a factor influencing the decision to
prescribe an antibiotic by diagnostic categories (number (pm:mt) of prescriptions).
39(100)
136(100)
98(100)
91 (100)
71 (100)
53(100)
46(100)
62(100)
596(100)
1(\.6)
5<0.8)
1(22)
N. Mostly s.- so.cw.... StnIaI Tocal
I.n.ner N. IaIIIIace ser..c laIhIaee
I.n.nee l.fhtna:
9 (6.6) 1(0.7)
9(6.6) 1(0.7)
6(6.1) 3(3.1) 1(1.0)
II (12.1) 3 (3.3) I (\.I)
6(8.') 3 (4.2) 1(\.4)
2(3.8)
4(8.7)
3 (4.8)
44(7.4) 10(1.7)
36(92.3)
126(92.6)
88(89.8)
76(83.5)
61 (85.9)
51 (96.2)
41 (89.1)
'8(93.')
537(90.1)
URTI
na.,..ptis
Otitis Media
LRTI
Sia••itil
UTI
SSTI
Otber
T....
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4.1.9 Patinll o.lUt.el
Table 29. Proportion of patients who made return visits within one month after the
captured visit seeara1ed by receipt of antibiotic at eapnued visit
No AS PreIC'riMd AS Prescribed P-Val.e
No Visits Made ISS (47.8) 249 (42.6) 0.125
Visib Made 169 (52.2) 336 (57.4)
'The proportion of patients who made a rctwn visit to a doctor within 30 days of
the captured visit was the same for those patients who had received an antibiotic
p~5Cription as compared to those who didn't (1"-0.125) (Table 29). Similarly, among
those patients who did make a ~turn visit. there was 1'10 statistical difference in the
proportions of patients making I visit, 2 visits. or 3 or more visits among those who
received an antibiotic during the captured visit compared to those patients who did noc
receive an antibiotic (Figure 3).
88
50%
.,..
".. ,...
• No AB Prescribed
o AD Prescribed
0% +-J--...L.,,..---L.,.---L..L...,...J--....1-
No Visits I Visit 2 visits 3 or More
Visits
Figure 3. Proportion of patients who consulted a pbysician one month after tM capture
visiL separated by receipt of an antibiotic prescription during the capcurcd visit.
".1.10 Low COle Venus Hip COle Pracribialc PIIysici8DJ
Because average prescription costs~ lower for patients who are 14 years or
younger (Table 12). those prescriptions administered to patients IS years or older were
selected for analysis of low cost v~ high cost prescribing physicians. Physicians
assigned to the low cost prescribing group (D"'IJ) bad a mean retail prescriptioo cost of
$12.35 for all adult patients. while the average retail prescription cost for the high cost
prescribing group (n-=-53) equalled $27.39 (p<O.OOOI). A comparison of patient
characteristics oftbe two prescribing groups (Table 30) determined thai the meaD age of
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adult patients seen by the high cost prescribing group (-41 years) was slightly greater
than that of the patients seen by the low cost prescribing group (-38 years). but this
difference was nol statistically significant. Significantly more patients seen by high cost
prescribers were male (p=O.014) and had a drug plaD (po=(I.019). There were no
statistically significant differences in presenting complaints or diagnoses in patients seen
by the two prescribing groups (Tables 30 and 31).
0.131
0.014
0.019
Mean Age (Years)
Proportion of Male Patients
Proportion With Drug Plan
Table 30. Comparison of patient cbanlcteristics seen by low and high cost pr;seribers.
P.tieal Cbnderisria P.tieDtI or Low P.tieBb or Hip P-v.llle
Cosl Pn:sc:riben Cost Prescriben
n=87 n=543
38.1 41.2
:!I.8% 35.2%
43.9% 59.9"10
Prese.tiac CO.plaiDb
Upper Respiratory Illness
Lower Respiratory Illness
Ear Symptoms
Flu Symptoms
Urinary Symptoms
GI Symptoms
0tI=
37 (45.1%)
17(20.7%)
3 (3.7"10)
10(12.2%)
6(1.3'1.)
9(l1.~/.)
175 (35.50/.)
83 (16.r/e)
19(3.9"/0)
44(8.9%)
50(10.1%)
7(1.4%)
115(23.3%)
0.129
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Table 3 I. Comparison of diagnoses made by low and high cost prescribeR.
Pi.poses P.tints of Low P.tiftlts of HiP "-vahle
Cost Pnlcriben CMt Pnscriben
0=87 0"'543
0.405
URn
Pharyngitis
lRn
Sinusitis
Otitis Media
un
ssn
Othc-
29 ()3.3%)
14(16.1%)
12(13.8%)
8(9.2%)
5(5.7%)
6(6.9%)
2(2.3%)
II (12.6-;.)
138(25.•%)
79(14.5%)
63(11.6%)
62(11.4%)
28 (5.2%)
54(9.9%)
47 (8.1%)
nOJ.J%)
In comparing the characteristics of the pnysicians (Table 32), it was found that
physicians in both the low cost prescribing group and the high cost prescribing group
were similar in IcrmS of their age, gendel". years of training. location of training, type of
practice (group versus solo), nwnbcrs ofpatienlS scco both in lOCal and for infections. and
their antibiotic prescribing rate. HoweveI" the low OOSI prescribin& physicians prescribed
antibiotics more appropriately (72% appropriate prescriptions versus 56%; "..,0.007).
Howevel" when the reasons for inappropriate prescriptions were analyzed. DO differences
were SC'eD betw«n the two groups of physicians with respect to specific categories of
inappropriateness (i.e. medical indication. wrong drug, or lower line available).
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Table 32. Comparison of physician and practice ch.uactmstics between low and high
cost prescribers.
Physkia. Charademtics
Mean Age (Years)
Low Cost
Prescribers
n-13
43.3
Hip Cost
Prescribers
n=53
45.9
P-value
0.336
Proponion of Male Physicians
Mean Years Since Med School
Graduation
Proportion ofCanadian Med
School Graduates
Proportion in Group Practice
Mean Tota! Patients Seen in 2
Day,
Mean Nof Acute Infection Patients
Mean Prescribing Rate for
Infections
Proportion of Appropriate
Prescriptions
42.9% 62.3%
18.7 19.3
85.7% 83.00/0
92.9% 92.5°/.
49.2 63.7
11.4 14.6
60.4% 65.4%
72.0%(59/82) 56.2% (276/491)
0.190
0.832
0.809
0.959
0.125
0.243
0.419
0.807
4.1.11 Least Appropriate VenUI Most Approprillte Prescribilll Physicia..
Physicians assigned to the least appropriate prescribing group (n=17) bad a mean
of appropriate prescriptions of 32.2%. compared to a mean prescription
appropriateness rate of 76.0% among the most appropriate prescribing physicians (0-53)
(Table 33). Upon examinatioo of certain patient characteristics. those patients seeD by
!.he least appropriate prescribers tended 10 be older (p..Q.009) and a greater proponion
wen: male (P=<lJ>06). As well. more patients of the least appropriate prescribing group
were covered by a drug plan (P<O.OOI). However the presenting complaints and the
diagnoses made by the two groups of physicians were similar (Table 33 and Table 34).
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Table 33. Comparison of patient characteristics seen by least and most appropriate
prescribers.
Patint Cbanderistic:s
Mean Age (Years)
Propoltion of Male Patients
Propoltion With Drug Plan
PatieDts of Least
Appropriate
Preseriben
D-217
33.0
100(46.1)
98(62.8)
PatietlitsofM_
Appropriate
Prac:riben
n""732
29.0
262(35.8)
260(59.0)
P·"alue
0.009
0.""
<0.001
PresentiD. Complaiats
Upper ROl'iralory Illness
lower Respiratory llIness
Ear Symptoms
Flu Symptoms
Urinary Symptoms
GI Symptoms
0t00
79(40.3)
31(15.8)
9(4.6)
20(102)
15 (7.7)
3(1.5)
39(19.9)
268(39.5)
137(20.2)
39(5.8)
51(7.5)
45 (6.6)
13(1.9)
125(18.4)
0.705
Table 34. Comparison ofdiagnoses made by least and most appropriate prescribers.
0.955URn
Pharyngitis
LRn
Sinusitis
OIitisMedia
un
ssn
Oth'"
Diagnoses Patients of LQ!lt Patients of Most P-valae
Appropriate Appropriate
Pracriben p""riben
n'"'217 n=732
63 (29.0) 213 (29.1)
36(16.6) 127(17.3)
24(11.1) 83(11.3)
20 (9.2) 60 (8.2)
22 (10.1) 79 (10.8)
18(8.3) 50(6.8)
9(4.1) 44(6.0)
25 (I1..S) 7600.4)
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When physician characteristics were examined between the two physician groups,
it was discovered that the least appropriate prescribers were, on average, 01d...'"1' (P=O.OO6)
and had been out of medical school longer (p..:().033) (Table 35). As well, a greater
proportion of least appropriate prescribers were male (P""O.019) compared to their most
appropriate prescribing counterpartS. There were no differences between the two groups
in tenns of proportion who had anended medical school in Canada, were pan of a group
practice at the time the study took place. and average number of total patients seen in two
days of regular practice.
Table 35. Comparison of physician and practice characteristics between least and most
appropriate prescribers.
14(82.4%) 44(84.6%)
15 (88.20/a) 48 (92.3%)
56.4 61.7
12.8 14.1
72.6'1. 60.2%
32.2% 76.0%
Pbysidan Cbaneteristk:s
Mean Age (Years)
Proportion of Male Physicians
Mean Years Since Med School
Graduation
Proportion of Canadian Med
School Graduates
Proportion in Group Practice
Mean Total Patients Seen in 2
Day,
Mean ;# of Acute lnfection Patients
Mean Prescribing Rate for
Infections
Mean Rate of Appropriale
Prescriptions
L....
Appropriate
Preseriben
0=<17
50.0
14(82.4%)
22.8
94
Moo.
Appropriate
Preseriben
0=53
43.6
26(50.0"/0)
17.7
P-vahte
0.llll6
0.019
0.033
0.825
0.605
0.542
0.603
0.033
<0.001
-4.2 Co••••iry On) ADtibiotk UN illl t~, PreviPn or Newfoullldl..d • NLPDP
Data from the Newfoundland and Labrador Prescription Drug Program (NLPDP)
indicate that. since the 1994/1995 fiscal year, the number of antibiotic pl't'5Criptions have
declined by approximately 24%: 169,110 antibiotic prescriptions were dispensed under
the auspices of the program in 1994/1995 compared to 129.337 in 199912000 (Table 36),
Figure 4 demonstrates that the drop in nwnber ofantibiotic prescriptions docs not directly
correlate with decreases in the nwnber of claimants eligible for the program. Although
Table 36. Number of prescriptions (per'ccnt) covered by the provincial drug p1ao
separated by antibiotic category and fiscal YCIJI.
A.libiotie '4/95 ...... 96197 .,108
-
.....
Cat."
C~p'udtnpo,;1U 22.658 24.477 23,991 22.278 20,548 20.279
03.4) (14.2) (15.4) (IS.2) (1'.2) (IS.7)
Mac,olilla 19,816 20,108 18,424 16,880 17,046 18,150
(1\.7) (11.7) (11.8) (11.6) (12.6) (14.0)
P~"iciJIUu 100,095 100,454 88,046 80,730 70,846 63,796
('9.2) ('8.3) ('6.3) (".3) ('2.6) (49.3)
Quiltoltnu:s 17,434 18,752 18,458 18,852 19,513 20.578
(10.3) (10.9) (1\.8) (12.9) (14'» (1'.9)
S,"I,",~ 443 369 230 227 194 1'3
(0.3) (0.2) (0.1) (0.2) (0.1) (0.1)
Tm.cyc1Uws 7,926 7.29' 6,401 6.350 5,807 '.397
(4.7) (4.2) (4.1) (4.3) (4.3) (4.2)
0rJ0« 738 734 727 787 8'3 984
10.4) (0.4 ) (0.') (0'» (0.6) (0.8)
Toc.1 169,110 In.l89 I 56.2n 146,104 134,807 129.337
(100) (100) (100) (100) (100) (100)
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the nwnbtt of low income families did de<:rease between 97/98 and 98/99 (by
approximately 2500), dispensed antibiotic prescriptions began to substantially decrease
between 95196 and %/97. Overall there were 787 fewer seniors covered by the program
in 98199 as compared to 94195. n.erefore. within the time frame of data collection.
overall enrollment of low income seniors in the NLPDP decreased by 2%. enrollment of
low income families decreased by 9% and tola! nwnbeTs of prescriptions decreased by
24%,
180.000
~ 160.000
d 140.000
~ 120.000
~ 100.000
lQ 80.000
_ 60.000i 40.000
z 20.000
r- r0- t-- t-- r-
1 10 1
Ie .. Ie ~
94195 95196 96/97 97198 98199 99100
y""
_Prescriptions
_Seniors
___ Low Incomr Families
Figure 4. Number of claimants (.seniors and low income families) and tow prescriptions
cove!'Cd by NLPDP (claimant data for 99100 was unavailable).
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Figure 5. Graphical representation of me proponions of total antibiotic prescriptions in
NeYlfoundland comprised by each antibiotic category for the yea~ f;l4/95 to 99100
In f;l4.95 the penicillin group ofantibiotics comprised 59.1% of total prescriptions
This proponion decreased to 49.3°;. in 99/00, representing a decrease of almost 10%.
However the contribution to total prescriptions that cephalosporins and macrolides made
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both increased by 2.3¥.. Quinolooes comprised 10-3% of ovcra.ll antibiotic prescriptions
in 94195. This proportion increased to 15.9% in 99100. TbcTefore the greatc:sl
proportional changes occ:~ for penicillins (-9.C}-.4) and quinolonc:s (+5.6%)
The most commonly dispensed antibiotic in the: NLPDP was amoxicillin.,
accounting for 37.~. of total prescriptions in 94195 and falling to 31.8% of prescriptions
in 99100. Among the penicillin group of antibiotics., the greaJest reduction in numbers of
dispensed prescriptions occurred fOf" ampicillin, falling from IOJ¥. of all antibiotics
dispensed in 94J95 to 4.0% in 99100. Among the macrolides. the greatest number of
prescriptions were for erythromycin (11.6% in 94195 and 9.5". in 99100). Cephalex.in
~-as lhc most commonly prcsc:ribed ccphalosporin (6.3% in 94195 and 704% in 99/00).
Among thc quinolonc group. ciproOoxacin accounted for the greatest nwnber of
prescriptions (6.2% of lotal prescriptions in 94195 and 11.2% in 99/00). Then:fore
ciprofloxacin represented the greatest proportional increase in prescriptioas (+5%), while
ampicillin accounted for the greatest proportiona! decrease (~.3%).
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4.3 Commuaitv Oral Aatibioric UH ia CaD.de.Dd USA -IMS M.rket [btab..!!
Evaluation of oral antibiotic prescribing databases derived from Canada revealed
that the numbers of dispensed antibiotics gradually increased between 1992 and 1995.
and then declined to pre.I993 levels in 1996 (Table 37). Betwttn 1995 and 1996. the
number of dispensed antibiotics in Canada deaea.sed by 4% in the absence of a
concomitant dttrease in the Canadian population (Figure 6). Overall Dumber of
antibiotic prescriptions fluctuated between 1992 and 1996 in the USA (Table 37).
In 1992. penicillins accounted for the grealest proportion of prescriptions in both
Canada and the USA (Figure 1 and Figure 8). In 1996. this was still the case. but the
proponion of penicillin prescriptions decreased by approximately 4% in both Canada and
the USA. This was the greatest proportional decrease of all dJug classes between 1992
and 1996. Conversely the greatesl proponional increase in this same time period
occ~ with the macrolides. increasing by 3'Y. in Canada and almost 50/. in !he USA
(Table 37). For !he remaining dJug classes. the proportions among lola! prescriptions
remained relatively constanl.
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Table 37. Estimated number of prescriptions (percent) dispensed in Canada and the USA
Aalibiotk .99. '99' ,- ''195 '996C.I~Ory
c............
C..... 2.674.949 3,242,477 3,241,440 3;162,134 3,301.757
lIl.l) (12.8) (12.1) (12.9) (13.2)
USA 52.922,000 60.489,000 58,141,000 60,940,000 56,463,000
(202) (21.2) (212) (21.4) (20.7)
,"'.crolUa
C~... 3.031.702 3,572,139 3,165,399 4.151,199 4,142,327
(13.4) (14.1) (14.1) (16.0) (\6.6)
USA 30.186.000 34.191,000 34,562,000 40,157,000 44,410,000
(1l.1) (122) (l2.6) (14.3) (16.3)
P,mkUl....
C..... 10.441,417 11,611,201 11,535,020 11.419,606 10,559,343
\46.1) (45.9) (45,2) (43.9) (42.3)
USA 109,491.000 119.925.000 111,.376,000 112.431,000 10l.789,ooo
(41.9) (42.0) {40.7) (39.4) (31.3)
0<........
C..... 1.203.975 1.316.645 1,509,160 1,569,159 1.651,520
(5.3) (5.4) (j.9) (6,O) (6.6)
USA 13,467.000 14,051,000 14,141,000 14,569.000 14.119,000
(S2) (4.9) (j.2) (S.I) (5.4)
S"ljrll'iU1UM5
C~... 2,S94.S16 2.&24.004 2,761.115 2,795,932 2.51s.o74
(lU) (11.1) (10.1) (10.1) (10.4)
23,272,000 24.560.000 24.100,000 24.861.000 23.651,000
(1.9) (8.6) (1.8) (8.7) (1.7)
Tnr«ycJbHs
C..... 1.971.861 1.935,341 1,165,151 1,792.111 1.607.441
(1.7) (1.6) (7.J) (6.9) (6.4)
USA 20.912.000 21.024.000 20,221,000 19,804,000 11,746,000
(8.0) (7.4) (7.4) (6.9) (6.9)
",*W
C..... 116.2S3 169,928 IH,211 940,001 1,011,780
(3.2) (J.O) (J.J) (3.6) (4.4)
10.626,000 10,194.000 11.391.000 11.193,000 12.872,000
(4.1) (3,1) (4.2) (4.2) (4.7)
TObll
C..... 22.655,740 25,331,748 2S,539,936 26,039.942 24.942,248
(100) {IOO} (100) (100) (100)
USA 261,476.000 215.741.000 273,946.000 215,J55,OOO 272.717,000
(100) (100) (100) (100) (100)
100
35.000,000
c; 30,000.000
..
] 15.000.000
..i 10.000.000
:~ 15.000.000
~ 10.000.000
5.000.000
1992 1993 1994 1995 1996
YOM
_Pttscriptions
-+- Population
Figure 6. Population ofCanada and estimated tola! dispensed prescriptions from 1992 to
1996.
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Figure 7. Graphical representation ofLhe proponions oftota! antibiotic prescriptions in
Canada comprised by each antibiotic category for the years 1992-1996.
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Figure 8. Graphical rcp~ntationof the proponions ortota! antlbiQ(ic prcscnptions In
the USA comprised by each antibiotic category for the yean 1992·1~.
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Table 38. Estimated annual nl.les of antibiotic prcscrip60ns per 1000 per year by d.rug
class in 1996 for Canada and the USA.
C~p"lI1osporilu
Cirrac:lor
Ce:ptlakm
Jturo/iIUs
ErytbrolDye:i8
Ouilbromye:iJ1
Pe"iciJliIu
AmosicilliD
Pe:nk:illiD V
Q"i"o/o"a
Cipronoue:iD
Norflouc:iD
ODosac:ia
S"ljo".",iIUs
TMPISMX
Tmac}"cli"D
TdBc:ye:1iDc
DoI)"c:yc:IiDe:
MctroDidazoie
Nilror.......loie
OiIld.myci8
TOTAL
Eso••td A••ual
Ra'e: Pc:r 1001
C••ada
111
44
4<l
'4<l
8'
42
",.
22.5.
56
31
16
3
S7
86
54
24
17
J7
17
II
6
Es.....edAa.ual
Rale Per 1010
USA
2lJ
28
OS
167
68
54
JS4
2635.
56
41
3
II
SO
87
71
22
36
••
"20
6
'll28
In 1996, the most e:ommonly dispensed antibiotic in both Canada and the USA
was amoxicillin. accounting (or 27% and 26% of (otal prescriptions respective:ly. The
estimated annual rate of amoxicillin prescriptions per 1000 persons peT year was 229 in
Canada and 263 in the USA (Table: 38). In the USA, the sec:ond and third IDO$1.
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commonly dispensed oral antibiotics were cephalexin and erythromycin. However, in
Canada. the second most commonly dispensed antibiotic was erythromycin followed by
Penicillin V. Overall 1028 oral antibiotics were dispensed per 1000 persons per year in
the USA, while 842 prescriptions per 1000 persons per year were dispensed in Canada
(Table 38).
Figure 9 and Table 39 demonstrate a comparison of the proponion of oral
antibiotic prescriptions dispensed in the community, by each antibiotic drug class, for
each of the three previously discussed sources of prescribing information (i.e. oraJ
antibiotic use in the community of St. John's and databases from NLPDP (97198) and
rMS (1996». For all fout areas of study, penicillins account for the grealest proponion of
total prescriptions, ranging from 55% (NLPDP) 10 37% (USA). The least amount of
cephalosporins were used by the St. John's GPs (9"/..), while this same drug class
accounts for 2\ 0/. of prescriptions in the USA. For the most part. proponions of each
antibiotic drug class of total prescriptions are relatively similar between St. John's GP
prescribing and the rest of Canada..
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Figure 9. Graphical represc:nution of the proportions oreach antibiotic drug class oftOlaI
prescnptions, comparing or.a.1 antibiotic prescribing in the community of $1. John"s (GP
Study), and as dctcnnined by NLPDP (97f98) and IMS antibiotic prescribing databasd
ll996).
Table 39. Proponions of each antibiotic drug class oftetal PJ"C5Criprions. comparing oral
antibiocic prescribing in the community of Sl John's (GP Study). and as dc:tennined by
NLPDP and lMS antibiotic p'escribing databases.
C~plaalosporiu
Macrolides
Penkillias
Quiaoloaes
SuJfonamides
Tetracyclines
Other
GP Siudy SUOP
8.n-. 15.2%
19.90.4 11.6-1_
50.0-/_ 55.3-4
6.6% 12.~/.
8.8% 0.2%
4.0% 4.3%
2.0% 0.5%
\06
IMSCa••.s.
13.2%
16.6-4
42.3-1_
6.60/.
10.4%
6.4%
4.4%
lMSUSA
20.7%
16.3%
37.3%
5.40/.
8.7%
6.9%
4.'T-1.
4.4 A.tibieric UK .. Acute Cu' for t.e Trnh!!!' of CO!IIDO.ity.AcaDir!d
~
4.4.1 C••neteristics of 'II, S..dy Pop.I8tio.
In the two study time periods. a total of 569 patients weR eligible for this study.
Of these patients. 226 (40-/,) ~rc: admitted dwing the 95/96 fiscal yeu and 343 (60%)
were admitted during the 98/99 fiscal year. Assessment of several. demognaphic and
clinical variables determined that then:: were no differences between the patients admitted
in 95196 and 98199 (Table 40). Therefore all 569 patieots were combined for analysis.
Overall approximately 43% of patients were treated at the Health Sciences Cen~ (HSC),
42'1', w~ treated at St. Clare's Mercy Hospital (SCMH) and the rema.inina 16% were
admined at the Salvation Army Grace GeneraJ Hospital (SAGGH). Overall the mean aae
(± SO) of the patients was 67 ± 18 years. No diffemtce in age was noted across time
periods of study. Approximately 59% of lotal patients were male. The majority of
patients lived in private residences. as opposed to n\D'$ing bomcs. prior to M1missioo to
hospital. Most patients W'CTC admitted to hospital following presentlitioD to the
~y depa.rtml=nt with CAP symplOms. regardless of stUdy period.. Patients
admitted in 95196 spent.. 00 averqe, lday looser in hospital compared to patients
admitted in 98199.
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Table 40. Characteristics of patients admitted with community-acquired poeumooia
(number (pm:ent) of patients unless indicated).
0.177
I'V"',,
0.696
0.773
0.266
0.171
0.628
67.0± 17.8
334 (S8.7)
62(11.1)
SI6(92.3)
242 (42.5)
236(41.5)
91 (16.0)
S09 (100)
8.0 (5.0-11.0)
199111999
67.2 ± 17.8
203 (S9.2)
42(12.2)
313(91.3)
146 (42.6)
146 (42.6)
51 (14.9)
343 (100)
7.0(5.0.11.0)
66.6± 17.8
131 (S8.0)
20(9.2)·
203 (94.0)"
96(42.5)
90(39.8)
40(17.7)
226(100)
8.0(5.{~·11.0)
naraetcristic 199!11996
Ap (Yeus) Mean ± SO
Ge..dn(Male)
NIUSu" HOIf/fIt /taiMlII
ReferrttJfro". Eit
HospittUSit~
HSC
SCMH
SAGGH
Tocal
u"", ofS'-Y Median ± IR
&..rilyo/Ju-.
Risk Class I 28 (12.4) 32 (9.3) 60 (10.5)
RiskClassU 47(20.8) 68(19.8) 115(20.2)
Risk Class m 47 (20.8) 64 (18.7) 111 (19.5)
Risk Class rv 80(35.4) 118 (l4.4) 198 (34.1)
Risk Class V 24 (10.6) 61 (17.8) 85 (14.9)
·dam ,wluvailable (or9 patients in 19991996; ··dau DOC .vailable for 10;-times in 199$11996.
Table 41. Age and gender of patients in the study population admitted to hospital with
communitY-acquired pneumoniL
Felllale
9(1.6)
35(6.2)
97(11.0)
94 (16.S)
Total
19(33)
93 (16.3)
218 (38.3)
239 (42.0)
S25 Va.n
26--SG Va.n
51-1!!1iVnn
~"Vnn
Ace Cal.". ratieD" Ad.-ined wi'" Co."uDity-Acquired PBeulDGDili
No. (% or 569)
.....
10(1.8)
S8(10.2)
121 (21.3)
14S(2S.5)
Tetal 569 (100) 334 (58.7) 235(41.3)
Table 41 illustrates the age distribution and gender of all patients admitted with
CAP. For lhose patients under the age: of 25 years. there were equal nwnben of males
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and females. However. after the age of25 more males than females wen:: treated for CAP
in hospital, although these differences were not statistically significant.
".4.2 Comorbid Coaditio..
The numbers and percent of patients presenting with various comorbid conditions
are presenled in Table 42. The most corrunon comorbid condition that was manifested in
the sample of patients was coronary anel')' disease (370/0 of patients). lltirty one percent
(31%) of patients had chronic obstructive pulmonary disease, 300/0 were smokers and
17% of patients had asthma. lbe mean numbet' of comorbid conditions documented in
all study patients was approximately 2.
Table 42. Comorbid conditions of patients admined with community.ac:quired
pneumonia (number <percent) of patients unless indicated).
Comorbid Coaditioa Total
Alcoholism 37 (6.7)
Asthma 92 (17.0)
Cerebrovascular Disease 50 (9.3)
COPD· 169 (J1.2)
Chronic Renal Failure 50 (9.4)
Congestive Heart Failure 125 (23.2)
Coronary Anery Disease 201 (37.0)
Diabetes Mellitus 114 (21.1)
Interstitial Lung Disease 58 (10.9)
liverDisc:ase 9(1.7)
Neoplastic Disease 107 (20.0)
Neurological Condition 34 (6.3)
Oral Steroids 105 (19.7)
Smoking 164 (30.0)
MeaD II Comorbid Conditioos 2.3
·COPO" Chrome ObsU'uttive P'IIbDoury Discuc. Pen:aMaca _~ &om olllllbcB ofl*icDcs ill
whic;b the infonnaioo .... k:nownf.vail*le.
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The nwober and percent of patients presenting with various complaints associated
with CAP upon admission are ~nted in Table 43. 1be majority of patients manifested
some type of respiratory complaint upon admission. Approximately 1"/0 of patients
admitted with CAP had none of the recorded respiratory complaints.
Table 43. Presenting complaints of patients admitted with community·acquired
pneumonia (number (percent) of patients).
Praelltilll Compl.lIIl
Cough
Dy"",~
Sputum Production
Pleuritic Chest Pain
4.4.4 Physal Eumin.tio••ad L.boralory FiDdiJIp
Tom.
432 (77.6)
370(67.9)
314 (56.9)
161 (30.6)
Results of the physical examination fIDdings in CAP patients are presented in
Table 44. For the vast majority of patients. recorded temperatures were within normal
range, as was pulse rates and systolic blood pressure. However approximately 23% of
admined patients had greater than or equal to 30 breaths per minute.
Table 45 illustrates the laboratory and radiographic fIDdings in the admitted
patients. Sixty five percent (65%) of patients had an x·ray result which indicated that
infiltrate was fouod in only ODe lobe oftheir lungs, while 2r/o of patients had infiltrate
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Table 44. Physical examination findings of patients admitted with community.acquind
pneumonia (number (percent) of patienu unless indicated).
P"ysical Eu•••tiM. Fi8d'" TMai
T~""nwt1llY
MeantSD
<35 or~40 degrees
IlDpiNlfNy It_
MeantSO
~O breathslmin
Mean±SO
2:125 beat.slmin
SystoliJ: Illootl PussMn
Mean ±SO
<9OmmHg
Alu,ftI M~lItlllStll/lU
37.6± LI
\0(1.8)
25.3 ± 6.0
'25 (22.5)
95.0 ± 18.6
35 (6.3)
128.6 ±25.0
\5 (2.7)
126 (22.9)
Table 45. Laboratory and radiogn.pbjc fmdings in patienu admined with community·
acquired pneumonia (number (percent) of patienu unless indicaled).
Labonlo",lIbdiocnpbk Filld.... TMai
Illoot/ Urn Ni/rvrft
Mean ± SO 8.7 ± 7.6
(~11 mmoVL) 106(19.0)
Mean ±SD
<30%
Pol·
Mean ±SO
<60mm Hg
CO..,Il_,"""
(I lobe infiltrate)
CI.atlt~
(>1 lobe infiltrate)
·Panial~ofancrialoX)'JCD
III
0.49 ± 2.76
53 (9.6)
73.6 ±35.7
112(31.1)
358(65.0)
156(28.3)
in both lungs. Therefore no infiltrate was found on x·ray for 7% of patients admined
with CAP.
Results from sputum and blood cultwe reports are presented in Tables 46 and 47.
Approximately 60% of admined patients had a blood culture done and 45"1, had sputum
samples taken. In cases in which a sputwn culture was taken. approximately 35% of
cultures were positive for some type of growth., while only 10"10 of blood cultures
depicted growth. Sireptococcus pneumoniae was most commonly identified for both
sources of samples. Of those sputwn samples that were positive for growth. 27%
harboured Streptococcus pneumo,.ia. Twenty.two percent (22%) of positive sputum
samples grew Haemophitw influenzoe. Among the positive blood cultures.
approximately half were positive for SlreptococCllS pneumonia.
Table 46. Identified pathogens on sputwn cultures in patients admined with commucity-
acquired pnewnonia (nwnber <percent) of patients).
Total
Positive Splltum Cllthire 83 (34.6)
IdeDtified P.'.or-
Streptococcus pneumonia :12 (26.5)
Candidaalbicans 14(16.9)
Haemophilus influenzoe 18 (21.7)
Slaphylococcus aureus ] (3.6)
Gram-negalive bacilli 6 (7.2)
Miscellaneous Pathogens' 20(24.1)
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Table 47. Identified pathogens OD blood culture in patients admined with community-
acquired pneumonia (number (perunt) of patients).
ToW
POlion Blood Culture 31 (9.5)
IdeDtified P.tbOIflI
Streptococcus pneumonia 16 (51.6)
Gram-positive cocci 4 (12.9)
Coagulase-negative staphloccoci 4 (12.9)
Staplrylococcusaurew 3 (9.7)
Miscellaneous Pathogens" 4 (12.9)
-Includes E coli. oon-bKmolytic StrqMocoeci and Kkb5iel1. pneurnoni.Ile
4.4.5 heumonUi Severity lades (PSI) Seora
The mean Pneumonia Severity Index (PST) score for all patients was 88. The
number and percent of patients in each risk class group arc presented in Table 48.
Approximately 31"10 of all patients admitted with CAP were at low risk for death within
30 days due 10 CAP. as determined by their assigrunent to risk classes I and II (Table (8).
Half of admitted patients were at higher risk for death; 35% of patients were assigned to
risk class rv and 15% of patients were assigned to risk class V.
Table 48. Pneumonia Severity Index (PST)" of patients admitted with community-
acquired pneumonia (number (percent) of patients unless indicated).
ToW
MUD PSI Scon±SD 87.9±43.0
Risk Clau I 60 (10.5)
Risk QUI D 115 (20.2)
Risk CIus III III (19.5)
Risk Qau IV 198 (34.8)
RiJk C.... V 85 (14.9)
-PSI cluses 1mel 11 - S«lI'e S 70: PSI c1ls:s III- score betweal70-90: PSI class rv - S«lI'e betweea 91-
130; PSI class V - SC~ >130. ~ts iJ:r. classes rv and V an: u c:oasidmlble risk for ck8d1.
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.4.4.6 Leagth of Stlly
The overall unadjusted median length of stay for all patients was 8 days (Table
49). The median length of hospital stay for patients in risk class I was 5 days while the
median length of stay was 7 days for patients in risk classes n and ID. Patients in risk
classes IV and V 1:x>th had a median length of stay of9 days.
Table 49. Median (and interquartile range) length of stay (days) of patients admincd with
communitY-acquired pnewnonia (unadjusted and stratified by pnewnonia risk class).
Tow
Unadjusted Median 8.0 (5.0-11.0)
Risk Class I Median 5.0 (4.0-7.0)
Risk Class n Median 7.0 (5.0-10.0)
RiskClau III Median 7.0 (5.0-11.0)
RiskClasslV Median 9.0(6.0-13.0)
Risk Class V Median 9.0 (6.5-15.0)
·PSI classes I and U a score:s 70: PSI clus III ~ seem bcfween 7G-90; PSI class IV· SC(ft between Ill-
130; PSI clus V - scon= >130. Patients in classes IV and V an a considenblc risk forde.th.
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4.4.7 Types 01 Antibiotics Used
Upon admission to hospital, the majority of patients initially received intravenous
(rY) antibiotics only (n=384; 67.5%). Of the remaining patients. \9% received a
combination of IV and oral antibiotics. while \3% received oral antibiotics only.
Interestingly 6 patients (10/.) received no antibiotics upon admission or during their
hospital stay.
Of those 384 patients who received IV antibiotics only as their initial empiric
treatment, 297 (77%) received single agent therapy and 87 (23%) received two tv
antibiotics. The antibiotic treaunents used in those patients initially treated with tv
antibiotics only (either as monotherapy or in combination) are displayed in Table 50.
The most common treatment regime for patients receiving IV therapy only was
treaunent with a non-pseudomonaJ third generation cephalosporin only, accounting for
35% oftrca1meD[S. The next most common treatment options for tv therapy only were a
second generation cephalosporin only (290/.) and a non·pseudomonal third generation
cephalosporin plus a macrolide (80/.).
tiS
Table 50. Initial empiric antibiotic tmttmeDts for patients admitted with community·
acquired p~umonia and tmtted with lV antibiotics only (0-384).
Non.Pseudomonal3~Gen. Cephalosporin Only
2- Gcn. Cephalosporin Only
Noo·Pseudomonai )N Gen. Cephalosporin + Macrolide
2- Gen Cephalosporin + Macrolide
Macrolide Only
Non·P:seudomonaJ )N Oen. Cephalosporin + Other
Qujnolone Only I with Other
Penicillins Only
Pseudomonal 3'" Gen Cephalosporin Only
2"" Gen. Cephalosporin + Other
Pseudomonal JI'd Gen Cephalosporin + Other
Pseudomonal )rd Gen Cephalosporin + Macrolide
AJI Other Treatment Combinations
T ...
N(· )
136 (35A)
112 (29.2)
29(7.6)
27(7.0)
21(5.5)
16(4.2)
II (2.9)
8(2.\)
6(1.6)
5(1.3)
2 (0.5)
t (0.3)
10(2.6)
One hundred and seven (107) patients (19".) were initially tmtled with •
combination of rv and oral antibiotic therapy. Table 51 displays the nwnbtt of
~riptionswrirten for each tmttmenl regime for those patients concomitantly treated with
initial oral and rv antibiotics. Almost half of the treatme1lts (49%) were for a sccoocI
generation cephalosporin plus a macrolide. A non-pseudomonal third ge:nnatioo
cephalosporin plus a macrolide accounted for 37% of treatments.
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211d Gen. Cephalosporin + Macrolide
Non·Pseudomooal Jrd Om. Cephalosporin +- Macrolide
2:>d Gen. Cephalosporin ... Other
Non-Pseudomonal Jill Gen. Cephalosporin ... Other
QuinoloDe Only I with Otber
PseudomonaJ Jrd Gen. Cephalosporin + MacTOlide
Pseudomonal. 3rd Gm.. Cephalosporin + Otbc:r
All Other Treatment Combinarions
Table 51. lnitial empiric antibiotic treatme:Dts for patients admitted with community-
acquired pneumonia and treated with both IV and oral antibiotics (0-101).
laitiaiMtibiofieTra"ftIti TotaJ
Nt"")
52 (48.6)
40 (37.4)
4(3.7)
4(3.7)
4(3.7)
I (0.9)
1(0.9)
I (0.9)
Table 52. Initial empiric antibiotic treaDnctus for patients admitted with community·
acguired pneumonia and treated with oral antibiotics only (n=n).
~8CTOlideOnly
QuinoloDe Only I with Other
2- Gen. Cephalosporin Only
2- Gen. Cephalosporin + Macrolide
Non-PseudomonaJ Jrd Gen. Cephalosporin Only
Penicillins Only
2001 Gen. Ccpbalosporin +- Olbler
All Otber Treatment Combinations
\17
T....
N("")
26(36.1)
17 (23.6)
13 (18.1)
8(11.1)
2(2.8)
2(2.8)
1(1.4)
J (4.2)
Table 52 presents the types of antibiotic treatments adminiSlm:d to patients
initially treated with oral antibiotics only upon admission to hospital. Thirty six pm;::mt
(36Y.) of patients received a macrolide only. A further 24% received either a quinolone
only or a quinolonc: in combination with some other antibiotic. Eighteen perccot (18%)
of patients received single therapy with a second geocn.tion ccphalosporin.
Table 53. Antibiotic choice for patients previously n:cciving intnlvcnous thcnapy only
and switched to oral therapy (nwnber (percent) of prescriptions (0-320)).
AaCibiotic C.... Total
Cepb.lolporial 183 (57.1)
Cefuroltimc: In (55.3)
M.cro.... 77 (14.1)
Erythromycin 41 (12.8)
Clarithromycin 35 (10.9)
PftliciUias 17(5..3)
Penicillin V II (3.4)
Q.iaoloHs J8 (9.4)
Cipronoxacin 30 (9.4)
Sulfoa••ides I ('.3)
TMPISMX I (0.3)
Other' 12 (3.8)
Clindamycin 10 (3.1)
• 0UJcr inclU(\e$ clindamyciJI md mett'Onidazole.
Of those patients who initially rucived only IV antibiotic therapy and were
subsequently switched to oral therapy, 254 patienu (89%) were administered ODIC oral
antibiotic.....nile 33 patients (II"'.) were treated with two oral antibiotics. Table S3
liB
demonstrates thai.. in patients switched from IV only aDtibiotics to oral antibiotics,
approximately half of the on! antibiotics chosen~ from the ccpha!osporin drug class
lS1%). Almost all of these prescriptions were for- cefuroxinw:. When a macrolide was
used. similar numbeB of prescriptions for erythromyciu and clarithromyciD 'Neft:
~
The mean number of antibiotics used to treat each patient for their eD~ hospital
stay was 1.8.
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4.4.8 Agreement ofAntibiotic Choice witb Recommended Guidelines
4.4.8.1 Appropriateness of Initial Empiric Antibiotic Tberapy
1%
65%
o Appropriate 65%
DOverutilisation 94'10
o Underutilisation 6%
• Wrong Drug 194'10
• No AB's Used 1%
Figure 10. Overall appropriateness of initial empiric antibiotic therapy (IV and oral) in
patients admitted to hospital with community·acquired pnewnonia.
An assessment of the agreement of initial empiric antibiotic choice (IV and oral)
with recommended Canadian treatment guidelines in patients admitted with CAP
revealed that 65% of initial antibiotic treatment courses were in exact accordance with
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the guidelines (Figure 10). 10 19% of patients the antibiotic trQtmeQt regimen was
incorTeC:t in lhat 1M ,,"TOng druB was prescribed. Overutilisation (combination therapy in
which DOC of the anu'biotics was appropriate) was doc:wnrnted in 9% of patients, while
underutilisation was disc:ov~ in 6% of patients. 10terestingJy DO antibiotics were
prescribed foe' 6 patients (1-;.).
In order to provide a mo~ detailed investigation of antibiotic choice. assessment
of guideline agreement was evaluated by severity of disease. as indicated by PSI risk
classes. This analysis revealed that guideline agreement was very low in patients in the
lower risk classes (Tables 54 and 55). Only 22% of patients assigned to risk class I
~cived an initial empiric antibiotic course which was in complete ~ent with the
prescribing guidelines. Thiny three percent (33%) of risk class I patients received
combination therapy in ....-tUc:b an extra antibiotic was prescribed, thus resulting in
overutilisation of antimicrobial therapy. However. by combining these two assessmenl
categories. 55% of patients in risk class I received at least ooc initial antibiotic (IV or
oral) which was in accordance with recommended guidc:lioes. In the remaining patients
for which their initial course of antibiotic treatment was in disagreement with prescribing
guidelines. 4]-;. of patients received treatment with the wrong drug. while ooc patienl did
nol receive any antibiotic treatment wbile in hospital.
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For cases in which overutilisation was discovered, the vast majority of prescribed
extra antibiotic was for a c:ephalosporin. primarily cefuJoxime, used in combination with
a macrolide. For the patients in which the wrong drug was prescribed, prescriptions were
mostly for cefuroxime as single therapy or a noo-psNdomonal third generation
cephalosporin as mooothaapy.
Table 54. Guideline agreement of initial empiric antibiotic choice av or oral) for
patients assigned to risk class r (0-60).
I. Acne_".
Overutilisatioa
OvenD Acm_etlt
Wroac orue
No Antibiotics UKd
T....
No. ('Y,;95'Y,Cf)
13(21.7; 13.1-33.6)
20 (33.3; 22.1-45.9)
33 (55.0; 42.5-66.9)
26(43.3; 31.6-55.9)
I (1.1: 0.3-8.9)
Table 55. Guideline agreement of initial empiric antibiotic choice av or 0faI) for
patients assigned to risk class n (n-II.5).
Oven. Acru.at
U.de....tilisano.
Wro•• O....
No AB's Used
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T....
No. (%: 95% Cl)
40 (34.8; 26.7-43.9)
6(5.2: 2.4-10.9)
46 (40.0; 31.5-49.1)
1.5 (13.0; 8.1.20.4)
.52 (45.2; 36.4-54.3)
2 (1.7;0.5-6.1)
For patients assigned to PSI risk class n, a similar trend in disagreement with
prescribing guidelines was seen (Table 55). Only 35% ofpaticots in risk class II received
initial antibiotic tTeaunent that was in complete agreement with prescribing guidelines.
Five percent (5%) of patients received extra antibiotic (clindamycin). The wrong drug
was prescribed in 45% of cases (cefbiaxone, a lhird generation cephalosporin), while
underutilisation and lack of antibiotic therapy were foW1d in 13% and 2% of patients
respectively. In those cases in which underutilisation was identified., patients received
therapy with a macrolide only.
Table 56. Guideline agreement of initial empiric antibiotic choice (IV or oral) for
patients assigned to risk classes Ill. rv and V (n'"'394).
la Agree_e.t
Overutilisatioa
OvenD Acmmetlt
Uaderutilis.tio.
WrvagDnIJ
No AB', Ordered
To<aJ
No. (%; 95% Cn
318 (80.7; 76.5-84.3)
25 (6.3; 4.3·9.2)
343 (87.1; 83.3-90.0)
19(4.8; 3.1-7.4)
29 (7.4; 5.2-10.4)
3 (:}.8;0.3-2.2)
As prescribing guidelines are the same for patients in the remaining risk classes,
patients in risk classes III, [V and V were combined for analysis. Guideline agIttment of
initial empiric antibiotic choice for patients in risk classes m, IV and V was substantially
bencr than patients in the lower risk. groups (Table 56). Eighty one percent (81%) of
patients were treated with antibiotics in a manner which was in complete agreement with
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prescribing guidelines recommendations. When overutilisation of antibiotics occurred
(6% of patients), the vast majority of extra antibiotic used was either ciprofloxacin or
c1indamycin. Seven percent ('~Ie) of patients were prescribed the wrong drug
(ciprofloxacin) and, in 5% of patients, only a macrolide was used, whereas the guidelines
state that macrolides should be in combination with either a cephalosporin or TMP/SMX.
4.4.8.2 Appropriateness ofSKondary Oral Antibiotic Choke
o Appropriate 59%
OOverutilisation 3%
.Underutilisation 17"~
5~1o • Wrong Drug 22%
Figure It. Overall appropriateness of secondary oral antibiotic therapy in patients
admitted 10 hospital with community-acquired pneumonia and who initially received IV
therapy only.
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Among those patienlS who initially received IV antibiotic therapy only and were
subsequently sv.itehed 00 oral therapy, the cbosen oral antibiotic was in complete
agreement ....ith prescribing guidelines for 59% of patienlS (Figure 11). Twenty-tWO
percent (22%) ofpatienlS received oral JnSCriptions which were for the wrong drug, 11%
of p;dienlS received suboptimal amounts of antibiotic and 3% re«ived cxtra antibiotic_
For patients assigned 00 risk class I. the ovcrall level of agreement for oral
antibiotics, when switched from IV. was quite low in that only 260/. of prescriptions were
in complctc accordance: with the: rttOmmended guidelines (Table 57). In 65% of
patients, the: wrong drug was prescribed; tbc:sc patients were primarily prescribed
ce:furoxime: in monotherapy.
Table: 57. Guideline agreement of oral antibiotic cboic:c (wbeD switched from intravenous
antibiotics) for patients assigncc! 00 risk class 1(n=-31).
I. AP'UlHat
O\'enatilihrioB
O\'enU AC!ftf!e••
Wru,Dnte
125
T....
No. (%; 95% CO
8 (25.8; 13.743.2)
3 (9.7; 3.3-24.9)
It p5.5;21.2.53.1)
20 (64.5; 46.9-78.8)
Table 58. Guideline agreement oforal antibiotic choice (when switched from intraveoous
antibiotics) for patients assigned 10 rislc class n (n-59).
I. Acfte-.nt
Ovrrufiligtioll
oYrnU Acrrrarat
Tog)
No. (%; 95% cn
34 (57.6; 44.9-69.4)
3(5.1; 1.7·13.9)
37 (62.7; 50.0-73.9)
Uadrntilisalio.
Wroac DRc
It (18.6; 10.7·30.4)
II (18.6: 10.7·30.4)
The total number of oral prescriptions in complctc agreement with guidelines for
those patients in risk class II equalled 58% (Tablc 58). Disagreement with prescribing
guidclines equally occuned for undcrutilisation (using a macrolidc as monotherapy) and
wrong dn1g prescriptions (ciproOoxacin and penicillin).
Tablc 59. Guideline agreement of oral antibiotic choice (whcD switched from intravenous
antibiotics) fOl" patients assigned 10 rislc classes III. rv and V (n"" 199).
37 (18.6; 13.8.24.6)
31 (15.6; 1l.2·21.3)
131 (65.8; 59.o-n.l)
UDderutiliuno.
WroltlDnc
GuiddiH Ap-etarat ToIDI
No. ('Y.; 95% Cn
128 (64.3; 57.5.70.6)
3(1.5;0.5.....3)
Among the patients wilb more scv~ disease (risk classes nI. rv and V).
guideline agreement for secondary oral antibiotic prescriptions was approxima1c:ly 6W.
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(Table 59). For the most part, the reason for the discrepancy bdwccn wbar was
prescribed and what the guidelines recommend was equaJly due to usiaa • macrolide
singularly and using a drug DOt iochJded in the guidelines. When the wrong drug was
used. the antibiotic chosen was primarily ciprofloxadn followed by penic:iIIin..
4.4.9 Futon Associated ...ith I.correct Aatibiotic: Prescribiaa
Results from the previous analysis w~ confirmed in a logistic: ~gression
anaiysis determining factors associated with initial empiric pre:sc:ripUOD events (IV or
oral) thai were deemed to be in disagn::emmt with prescription guideline
recommendations. The resu.lts from the regression model are presented in Table 60.
Patients assessed to be in risk group I were almost five times more likely. and patients in
risk group II were ten times more likely. 10 receive initial empiric antibiotic: treatment
that was in disagreement with the guidelines. as compved to patients in risk group V.
Site of admission also inflUieDCed guideline disagreement in that patients admitted to
SAGGH were four times ~ likely to receive initial empiric: treattnent DOt in
accordance with recommenckd guidelines as compared to patients admined to HSC. No
other patient or clinical factors were identi6ed as influencing appropriateness of initial
antibiotic: treatment.
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Table 60. Logistic regressaoo model of guidelines disagreement of initial empiric
antibiotic prescription events (IV or oral) (n=569).
Chandltristics N (-"') V.adjusted OR§ AdjlUted ORt
(95-1. ell (95% en
/tistGN/IIp
1
U
II!
IV
V
Hospital Sit~
27 (45.0)
69 (60.0)
17(153)
23(11.6)
11(12.9)
5.50 (2.44-12.40)-
10.09 (4.84-21.05)-
122 (0.54-2.76)
0.18(0.41-1.91)
1.00 (Referent)
4.99 (2.16--1 LS3)-
9.87 (4.65-20.92)-
1.20 (0.52·2.76)
0.80(0.37.1.75)
1.00 (Refemlt)
SAGGH 4S (49.5) ).76(2.24~.29)-
SCMH 52(22.0) 1.09(0.70-1.68)
HSC 50 (20.7) 1.00 (Referent)
4.15 (2.30-7.48)-
1.30(0.80-2.13)
1.00 (Referent)
§OR. Odds ratio obtained &Qftl bivviale Io&isti<:~ion analysis.
tOR· Odds l'lItio obtained from multivlfiabk logistic regressioa 1I'IOde1, adjusted for all odIer vllrilbkes
liscedin thco;olwnn.
°p<O.OOOI
~.4.10 Erred of Anlibioric AppropriafeDess OD Leaet" of Stay
A linear regression analysis assessing the effects of several clinical ''Viables, in
addition to appropriateness of initial antibiotic treatment. demonstnlles thai severity of
disease. as indicated by PSI risk classes. accounted for 9.2% of the variatioo in length of
stay for patients admined with CAP (fable 61). Other important clinical variables such
as the~ ofCOPD. iotemitiallung disease and a positive blood cuJture account fOl'"
a furthct- 2.9% of the variatioo. However, when appropriateness of initial antibiotic
treatment was added to the regression model, it bad no effect 00 the measWl: of variation
in length of stay. Therefore inappropriate initial antibiotic treatment did DOt prolong
hospilal stay.
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Table 61. Lineae regression mode1 of length of stay for patients admincd with
communitv-K9uired pneumonia.
PrtrlllrlDll;' lIis. CLur
II 0.196 OJlO3
III 0.271 <0.0001
rv 0.423 <0.0001
V 0.330 <0.0001 0.092
COPD 0.110 0.020
Interstitial Lung Disease 0.088 0.053
Positive Blood Cultw'e 0.106 O.oJ5 0.121
Appropriate Initial
Antibiotic Treannent 0.055 0.262 0.121
".4.11 Erred of Aolibiotic: AppropriakDas o. Patinl Oulco_e
In lotal. 10.J-Io of patients admitted with community4acquired pnewnonia died
during their hospital stay (n=o61). None ofme patients assigned to risk group I died while
in hospital. For patients in risk. groups II. Ill. [V and V. 2.6'1.., 6.3%. 13.6'1. and 28.2'1. of
patients within each risk group. ~ve1y. died in hospital (fable 62). The effects of
initial antibiotic pr-escription appropriateness on survival was assessed usin& Kaplan·
Meier SW"Vival analysis and. Cox proponiooaJ hazards n:~ioD analysis.
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Table 62. Comparison of patients who died in hospital separated by risk groups (number
(percent».
Risk Group
1
U
1U
IV
IV
Total
T....
3 (4.9)
7(11.5)
27(44.3)
24(39.3)
61 (100.0)
Kaplao·Meier survival analysis confirmed the findings that disease: severity, as
determined by assignment to risk group classes, was the only factor which influenced
survival, as measured by thirty day in·bospital monaJity (P<o.OOI) (Figure 12).
Inlerestingly adherence of initial empiric antibiotic prescribing to recommended
guidelines was not associated with survival.
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Survival Functions
,.'!-,-------:::;--------::!
rune to Oiscbargt (Days)
Figure 12. Kaplan-Meier survival curve for each risk group.
A Cox proportional hazards regressioD analysis determined that patients iD risk
group U were 7.7 times less likely to die as compared to patients in risJc class V (0.04 -
0.44 CJ; P-=O.OOl). Similarly, the hazard ratio for patients in risk group IJI was 0.19
(0.07 - 0.50; P<O.OI), and was 0.46 (0.27 - 0.81; p..().OO7) for patients in risk group IV,
as compared to risk group V patients. Like the Kaplan-Meier survival analysis,
appropriateness of initial antibiotic treatment did not have a statistically significant
influence on this analysis. Therefore inappropriate initial antibiotic prescription did not
influence survival of patients admitted to hospital with CAP.
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CHAPTER V - CONCLUSIONS
5.1 Antibiotic:: Pmuibin, iD CommuDity Pndice
The epidemiology of community oral antibiotic use was elucidated through the
evaluation of antibiotic prescribing administrative databases and a community-based
chait review study of a representative sample of patients with infections in the
community. This srudy was unique in its detailed population-based perspective.
examining the combined issues of quantity. indications. factor.! influencing antimicrobial
prescribing and appropriateness.
Overall trends in antibiotic prescribing were similar. but not exactly the same.
between the three sources of prescribing information. namely the community chart
review study. the Newfoundland prescription drug program (NLPDP) antibiotic
prescribing database and prescribing information from Canada and the USA provided by
[MS. Antibiotic prescribing trends in the USA differed from the Canadian SOW'CeS of
prescribing information (i.e. increased use of cephaJosporins and less use of penicillins).
but this is not surprising as geographical variations in treatment, without diffen:nces in
clinical facton or measures of appropriateness. across various clinical scenarios is a
common phenomenon. III The analysis of prescribing through the NLPDP database and
the OP study differed somewhat, but this can be explained by differences in paUCIlt
populations from which the prescribing information was derived. The limitation
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associated ....,jth using NLPDP data is that the NLPDP patient population consisted of low
income and older patients. whereas the OP study was based oc a representative sample
from all of St. John's. including all ages and economic classes of patients. Therefore
these two samples may not be entirely comparable. More importantly. though. is thatlhe
trends in antibiotic prescribing comparing the GP study and Canada as a whole were
quite similar. Therefore the results from this study on appropriateness of prescribing and
factors influencing the decision to prescribe an antibiotic may be generalizable to other
urban communities in Canada. However several limitations should be noted. A
limitation of using the lMS prescribing data is that it includes prescriptions written DOl
only by GP's. but office-based specialists as well. Therefore comparing the prescribing
trends identified in the OP study ....,jth prescribing trends identified in IMS databases
would not be a comparison of exactly the same type of physicians making the antibiotic
prescription decisions. A funhe'r limitation of comparing both the NLPDP and IMS
databases ~ith results from the GP study would be differences in the time frames of da1a
collection. Specifically the NLPDP and lMS databases are longitudinal whereas the OP
study is cross--sectional.
The fall in antibiotic use seen in the Newfoundland drug program from 1995 and
onwards may have been due to the influence of the ongoing nature of our utilization
review study of antibiotic prescribing in the community. Planning and physician
recnUtment for this study staJted in 199511996 and data was collected in 1997/1998.
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Each physician ....no panicipatc:d in this study was aware that his or her antibiotic
pEUCribing practices would be evaluated at an unspcdfied time. 1krcfore it is possible
thaI some of the fall in antibiotic usc. as demonsmued in the NLPDP prescribing
database. was the result of physician monitoring.
Nonetheless the level of inappropriate antibiotic use, revealed by our utilizatioo
review among the: majority of GPs in 51. John's. is of concern. Overall only 59-.4 of all
prescriptions analyzed in the study were considered to be appropriate. as defined by
agreement with community antibiotic prescribing guidelines in patients defined according
\0 the doctors' diagnoses. Prescriptions administered for respiralory traCt infections
tended to be less appropriate than those administered for non-respiratory illnesse:s.
Inappropriate antibiotic prescriptions for respiratofy tract infections tended to be
inappropriate because of a lack of medK:aJ indicatioo for the prescription. Convenely
inappropriate prescriptions for noo-respiratory infections were predominantly because of
poor antibiotic choice (i.e. a WTtlflg drug was used or a lower lineImon: nanow specuum
of antibiotic was available). Amoog those prescriptions ....iUch ....-ere considered
inappropriate overall. regardless of diagnostic category, ~ ""not indicated"
prescriptions were administered to children.. whereas tbe -wrong drug" or "lower line
available'" prescriptions were administered to adults.
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It is likely that inappropriate prescriptions, because of the lack of a medical
indication., in patients with respiratory ttaet infections was underestimated. Rather than
accepting the doctors' diagnoses as being correct. we used a criteria-based decision tree
to identify the probable etiology of respiratory tract infections. Presenting complaints,
signs and symptoms of each adult patient were considered. In this anaJysis, greater than
80-/0 of the respiratory infections were thought 00 be viral in nature, and thus did 001
require an antibiotic prescription, as de1ennined by the decision tree. The physicians.
based on their decision to not prescribe an antibiotic, thought that 44% of respiratory
infections wue viral.
Clearly this type of analysis has its limitations. Complete documentation of
clinical findings in the patients' cham is necessary. It was asswned thai if a particular
finding was nol noted in the chan then that fmding was not present in the patient
(elevated temperature/presence of fever, for example). Therefore this analysis falls
victim 10 the same limitalions of all chart review studies in that the extent of the
infonnation collected is based on how much the physicians have reponed in the chart. To
cin:umvent this problem, physician interviews were conducted in which physicians had
the opportunity 10 provide any additional clinical information that may nol have been
previously recorded in the chart. These interviews took place within three days of seeing
the patients and the charts were available for the physicians' perusal during the interview.
tlS
In the vast majority of cases, no further c1irUcai information was provided by the
physician. beyond what was already abstracted from !he patients' charts.
In addition to inapproprialeness when compared to guidelines and diagnostic
mislabeling, inappropriate duration of antibiotic therapy was examined. Eighty six
percent (86%) ofUTl cases were trealed for between 4 and 14 days. despite the fact that
current recommendations suggest that uncomplicated acute urinary tJacl infections in
females can be eradicaled with proper antibiotic therapy in lhrce days. Ill. III The patients
who fonned the study sample were presenting to the doctor with acute infections.
Therefore those patients who wen:: making a repeat visit for a previous infection were
excluded from the analysis. Therefore all patients diagnosed with UTIs in the study
sample would most likely be suitable candidales for a shon.. three day course of antibiotic
therapy.
Reasons why antibiotics were prescribed in clinical situations not requiring
antibiotics were investigated, including the clarity of the medical indication and patient
expectation. (n 80% of prescription events, the pbysicians perceived the medical
indication for the prescription to be clear or very clear. Nonetheless, when respiratory
tract infections wen:: considered separately. the clarity of the medical indication was less.,
when compared to non.~pinttory infections in which confidence in the clarity of
medical indicatiOll was 86%. The difference in the perception of medical indication
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between these two diagnostic groups may be a reflection of the problems associated with
the assessment of respiratory infections. Even though research has shown thaI greater
than 80-/0 of respiratory infections arc viral in Danuc.7• it is obvious that many physicians
practice a Mbetter to be safe than sorry" approach. In this study. it is likely thai the
physicians assumed bacterial rather than viral etiology and prescribed an antibiotic in
order to not miss treating a bacterial infection, an observation suggested by our criterion
based dedsion tree. Clearly if lbe assessment of an infection is based on the assumption
that it is probably viral (and not undeniably viral as would be confirmed through
microbiological analysis). then the possibility still remains that the infection mighr be
bacterial.
Patient or parent expectation also influenced the antibiotic prescription decision,
panicularly in those with respiratory tract infections. The demand for antibiotics by
patienu may be a m;u1t of the pervasive. yet wrong, belief held by the general public
that antibiotics arc an effective treatment for the common cold.
It is possible that many unnecessary or questionable antibiotic prescriptions are
administered because of the perception lhat few serious side effects occur if
inappropriately administered. combined with the perception that these drugs arc
inexpensive relative to other phannaceuticals. Tbc:sc perceptions ignore the major public
health problem of bacterial resistance to antibiotics and the fact that the national costs for
Il7
antibiotics are substantial. In Canada, anti-infective! have ranked as the third most
commonly prescribed pharmaceutical class in both 1998 and 1999 (source: IMS Health
Canada). and consequently are associated with the problem of increasing drug
expenditures in Canada. In the prescnt study, the average antibiotic prescription cost was
approximately $20. The total retail costs for all 604 prescriptions capnaed in the study
equalled $10.888.30. This amount is derived from only two days of regular practice
among 76% of the GPs in St. John's. Those antibiotic classes for which members are
primarily still under palent have greater mean retail prescription costs (i.e. quinolones).
Therefore quinolone prescription costs, for example, contributed to 23% of total costs
among those prescriptions captured in the study. However the penicillin group of
antibiotics which are. for the most part. considered to be relatively inexpensive drugs.
contributed to 30% of total costs. Undoubtedly the high level of cost contribution
represenled by the penicillin class of pharmaceuticals is due to the substantial volume
with which these prescriptions are administered to patients in the community.
It is of inlerest that prescription costs were. on average. almost $6.00 greater for
those patients who were coveTed by some form of drug plan as compared to those
patients who paid for their prescriptions without any form of reimbursement. However
there were no differences in the diagnoses of these two patient groups. II is plausible to
suggest that more expensive antibiotics were prescribed simply because the patient was
able to seek reimbursement Ihrougb some type of drug plan. In addition to this, when
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high cost prescribing physicians were identified and compared to their lower cost
prescribing COWlterparts. it was discovered that a greater proportion of patients seen by
the high cost prescribing physicians had a drug plan. No clinical differences existed
between the patients of the high and low cost prescribing physicians in terms of
presenting complaints, signs, symptoms and diagnoses. Further to this, it was found thai
the high cost prescribing physicians had a greater proportion of inappropriate
prescriptions. Although one would intuitively expect the predominant category of
inappropriate prescriptions to be ~Iower line available" (as the lower line drugs listed in
the guidelines tend to be less expensive), the inappropriateness equally encompassed all
categories thus indicating that problematic antibiotic prescribing associated with high
cost prescribers is multi-faceted.
Other physician characteristics or prescribing habits have been identified as
giving rise to potentially problematic prescribing. When physicians were categorized
according to their rate of appropriate prescriptions, it was discovered that the least
appropriate prescribing physicians tended to be older and male. 1besc two characteristics
are probably related in that the proportion of females anendi!1g medical school twenty to
thirty years ago was far less than it is now. It is possible that the greater number afyears
since medical school graduation contributes to inappropriate antibiotic prescribing.
Specific areas of problematic antibiotic prescribing have been identified in this
study. The CUlTCflt estimated annual rates of antibiotic prescriptions d:monsttate that
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almost half of the study population receive antimicrobial therapy in a year. The overall
quantity of antibiotic prescriptions could potentially be far less if physicians critically
evaluated the likelihood of bacterial etiology for infections, panicularly in relation to
respiratory tract infections. Other areas of inappropriateness of prescriptions must also
be improved. Our study has demonstrated that physicians erT in prescribing longer than
necessary durations of treatment for UTI. lack of medical indication, and mistakes in
recommended drug choices. Therefore. with this infonnation regarding lhe epidemiology
of antibiotic prescriptions in community practice. inlerventions to encourage judicious
use of antimicrobial therapy can accurately address curmll antibiotic prescribing
problems.
S.2 Trntment orCommunity-ASQuind PDcumolllili
This study examined lhe antibiotic treatment of patients admitted 10 hospilal with
CAP. Previous studies addressing this same issue have uncovered a substantial amount
of heterogeneity in the antimicrobi:1l treatment trmds across various geographical
regions. The present study examined not only bow antibiotics were used for this
particular diagnosis. but also the appropriateness of antibiotic choice as compand to
Canadian prescribing recommendations.
Two key issues arise from the present study. These issues ate the requirement for
a more critical evaluation of the need to admit low risk: patients diagnosed with CAP and
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the associated level of antibiotic prescribing that is not in accordance with recommended
Canadian prescribing guidelines.
Overall 31 % of patients admitted to hospital with CAP wen: assigned to risk
classes I and II. Fine and colleagues suggest that these low risk patients do not require
hospitalization, as their risk for mortality within 30 days of admission due to CAP is less
than 2%. Fine et a1. recommend that these particular patients can be appropriately and
effectively treated as outpatientsYo In another Canadian study examining the treattnent
of CAP in Canadian hospitals, only 19.4"10 of admitted patients wen: assigned to risk
classes I and 1I. I01 Therefon: a large discrepancy exists between the severity of illness
among patients admined to hospital in St. John's as compared to the rest of Canada. A
mon: critical evaluation of the need to admit these low risk patients in Sl. John's hospitals
is necessary. Given the enonnous difference in costs between treating patients in hospital
and treating patients as outpatients, low risk CAP patients represent an important segment
of the health care system in which acute care cost savings could potentially be achieved,
assuming thai adequate outpatient suppon services are available.
By assessing the approprialeDeSS of antibiotic pn:scriptions used 10 treat admitted
CAP patients, the present study has uncovered that the majority of the initial prescriptions
which were not in agreement with the guidelines were administered to patients who were
at very low risk for dc:aIh within thirty days due to CAP. Of patients assigned to ris.k
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groups I and II. approximalely one balf received an initial empiric antibiotic which was
not in agreement with the Canadian prescribing guidelines. Furthennore another 15% of
the same low risk patients received extnl. antibiotics not suggested in the guidelines. in
addition to correct recommended tJ'eab'nenL Therefore only 30-... of patients assigned to
risk classes I and II were appropriately prescribed initial empiric antibiotics as outlined
by the recommended guidelines. However infonnation 00 concomitant diagnoses in
addition to CAP was not collected. Therefore it is possible that patients receiving extra
antibiotics may have had a second diagnosis for which the extra antibiotic was
administered and therefore would be potentially appropriate.
The problematic prescribing associated with low risk patients primarily resulted
from the administration of cephalosporins in risk group I patients and 3'" generation
cephalosporins or clindamycio in risk group II patients. However. if these patients were
assigned 10 higher risk groups. most of these prescriptions would have been considen:d
correct. Therefore it appears that physicians an:: asswning that all patients who are
admiRed to hospital must suffer relatively severe illnesses and be treated accordingly,
with severe being defined based on the deeision to admit rather than clinical criteria.
Cenainly soWKi clinical judgment on a per-patient basis always overrides any clinical
practice guidelines. However a more critical evaluation oftbe necessity to admit low risk
patients \Vilb CAP to hospital would result in substantial health care savings with regard
to reducing costs associated wilb acute care bed utilisation and in.hospital drug costs.
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Initial antibiotic prescribing for patients with more severe il1ncss \WS
commendable in that 87'/0 of initial antibiotic treatment choices were in accordance with
the recommend guiddines. Only 6% of patients received extra antibiotics in addition to
recommended therapy. with the extra drogs primarily consisting ofeither ciprofloxacin or
clindamycin. Although c1indamycin is not listed in the guidelines as an appropriate agent
for any patient, ciprofloxacin is recommended for patients admitted to the intensive care
unit (leU). l1Lree percent (3%) of patients in the present study were mechanically
ventilated and therefore were cared for in the ICU, however none of these patient
received treatment with ciprofloxacin. Therefore the cases in whicb this particular drug
was used may have resulted from physician ove~ationof the severity of disease.
Less adherence to recommended prescribing guidelines was found when
treatment was switcbed from TV to oral therapy, in that only 59'% of the secondary oral
prescriptions were in accordance with the guidelines. Again. overall guideline agreement
was less for patients in risk class I (36%) as compmM to patients in risk classes III, TV
and V (66%). Like lhe inappropriate initial antibiotic prescriptions for low risk patients,
the inappropriateness of secondary oral prescriptions resulted !Tom the use of agents that
an: recommended for more severely ill patients (i.e. cephalosporins). The
inappropriateness of oral prescriptions administered to sicker patients was equally the
result of using a macrolide as monotherapy and the use of a wrong drug, with
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ciproOoxacin. again being the most common incorrectly prescribed agent followed by
penicillin.
Even though problematic antibiotic prescribing was identified in this present
stUdy. it did not appear to affect length of hospital stay or patient outcome in lerms of
monality. 1l1ree explanations caD account for this finding. Firstly the Canadian
antibiotic prescribing guidelines for the treatment of CAP have not been validated. That
is to say the recommendations are based on expen opinion. but it has never been proven
that adherence to these guidelines results in better patient outcome or reduced length of
hospital stay. The results of this study certainly suppan the notion !hat further evaluation
of tile prescribing guidelines is required.
Secondly the use of in-hospital mortality as a measure of patient outcome. albeit it
very objective and not prone to error, may not have been the best measure for patient
outcome. Subtle differences in time to subjective improvements in respiratory symptoms
and time required to return to nonna! daily activities (i.e. employment) were not
measured in this stUdy. Perhaps if these outcome measures wen: assessed in a
prospective manner. differences in patient outcome accounted for by differences in
adherence to antibiotic prescribing guidelines may have been revealed.
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Finally the type of inappropriateness of empiric therapy most likely accounted for
the lack. of influence of antibiotic prescribing appropriateness on length of stay and in·
hospital mortality. The majority of antibiotic treatments which wen:: considered to be in
disagreement with the prescribing guidelines were cases in which low risk. patients were
treated as being more severely ill than what the PSI score would indicate. The therapy
these patients received, albeit inappropriate according to guideline criteria, still provided
good coverage for their infection. Because of this, most patients treated with
inappropriate therapy probably experienced the same COl1l'5oe of illness as patients treated
with appropriate empiric therapy and thus no differences in length of stay or in·hospitaJ
monality were evident between these two groups of patients.
Patients admined to hospital in 51. John's for CAP spend more time in hospital as
compared to lengths of stay reported in other studies. A recent Canadian study
examining lengths of stay for twenty hospitals across Canada reported a median length of
stay for cornmunity.acquired pneumonia patients of 7.0 daYS.IOl In our study, the
median length of stay was 8.0 days. When examining median lengths of stay by risk.
groups, St. John's patients consistently spent exactly one day longer in hospital than other
Canadian hospitals. Comparing patient outcomes, as measured by monality, only 10-,.. of
patients admitted in 51. JOM's died in hospital, whereas 14% of patients admined to other
Canadian hospitals died within thirty days of admission. IOI Although this may indirectly
suggest that the longer lengths: of hospital stay may result in better patient outcome,
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previllUS studies have refuted this claim. 114. lIS This difference in outcome is more likely
due to lower proportions of sicker patients admined to hospital in St. John's; patients in
risk groups IV and V l.'ICCOUnted for only SO% of total patients whereas in other Canadian
hospitals, lhc:se same high risk patients accounted for 65% of total patients. I01 Perhaps if
physicians in St. John's admitted less numbers of low risk patienu, overall rates of
monality CAP at St. John's hospitals ....'OU1d be mort: in line with nationa.l figures.
(n conclusion the present study has detennined that a greater proponion of low
risk CAP patients is admitted. to hospital in St. John's, as compared to other Canadian
hospitals, and a high proportion of these low risk patients receives aggressive antibiotic
therapy. A validated prediction rule assessing thirty day mortality due to CAP supports
the notion that these low risk patients may not necessarily need to be admined 10 hospital.
Because of this, a more critical evaluation of the necessity to admjt lhc:se patients is
recommended.. Problematic prescribing with regard to lack of adherence to Canadian
antibiotic prescribing guidelines was also noted, particularly for low rislc patients_ The
problematic prescribing did not appear to affect length of hospital stay or patient
outcome, although these outcome measures may not have been sensitive enough to detect
differences among those patients who were appropriately truted with antibiotics and
those who were not. As ~1I the prc>Cribing guidelines used in this analysis have DOC
been validated. Nonetheless it is imponant to encounge hospital physicians to closely
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~xaminc their antibiotic prescription choices such tbal agents whicb should be reserved
for more sicker paticotS are DOt used in less severely ill petients.
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CHAPTER V1 - DISCUSSION
This study on antibiotic prescribing in both community practices and in acute care
senings has detailed a disconcerting level of inappropriateness in prescribing, as defined
by discordance with recommended prescribing guidelines. as well as an overall
unn~ssary high level of antibiotic use. Although these studies have provided valuable
insight into the wide-reaching extent of unnecessary and inappropriate antibiotic use
within two specific sectors of health care delivery, rnearchabie interVentions to instigate
improvements in antibiotic prescribing within the studied environments were outside the
scope of this research project. The information revealed in this body of research
undoubtedly is valuable to developing successful interVentions to change prescribing
behaviour or may be used as an impetus for developing antibiotic prescribing policies. It
is necessary to fU'St identify specific problems such that interventions and policies
designed to cbange behaviours, in this case antibiotic prescribing, can be focussed and
therefore potentially give rise to desired improvements in physician practice patterns.
Nonetheless a simple question is yet to be answered. What can be done about
problematic antibiotic prescribing? 1lte problems associated with antibiotic prescribing
are multifaceted. involving both health care professionals and the general public.
Therefore a multi-faceted approach to a solution is WlUT8Il1ed. In light of this. several
recommendations are proposed, including the development of evidence-based and
validated antibiotic prescribing guidelines, implementation of a strategy for the
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successful dissemination and adoption of these guidelines utilising a computer-based
decision support system. initiation of an antibiotic prescription monitoring progrun,
utilisation of a detailing or mentoring program by respected opinion leaders. continual
surveillance of loc.al bacterial resistance patterns and implementation of a public
education campaign in which prudent antibiotic use is promoted.
Of paramount importance is the development ofevidence-based and scientifically
validated antibiotic prescribing guidelines. The potentiaJ usefulness of clinical practice
guidelines in processes of care and patient management has been demonstrated in
previous studies. 116 However just because guidelines have been shown to be useful. does
not necessarily mean that guidelines are used. Hayward and colleagues surveyed
Canadian physicians about their attitudes toward clinical pnact.ice guidelines. The
majority of physicians had positive attitudes toward clinical practice guidelines.
indicating !hat they are a convenient source of advice and good educational tools.
However only 40";' of surveyed physicians had changed their practice in the year before
the survey as a result of referring to guidelines. ll1 In recent years physicians have been
inundated with a myriad. of clinical practices guidelines. some of which are even of
questionable scientific meriL 111• Il9 As Jonathan Lomas points out, ~Iron.ically. the
recognition standards routinely required of research studies are rarely foWKt in the
consensus reports that make the synthesis of such studies popularly available.~I20
Therefore it is plausible to suggest that lack of adoption of some clinical practice
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guidelines may be because the guidelines are not scientifically validated and therefore are
not seen as useful and applicable to daily practice.
In this study the Anti-infective Guidelines for Community-acquired Infections l
and the community-acquired pneumonia treatment ru:ommendal:ions outlined by the
Canadian Community Acquired Pneumonia Consensus Conference Group2 were used as
tools 10 assess appropriateness of antibiotic prescriptions. Although both of these sources
of prescribing guidelines were fonnulated by expen opinion from numerous sources,
neither of these tools have been scientifically validated. A recent assessment of various
Canadian clinical practice guidelines determined that the Anti-infective Guidelines for
Community-acquired infections in particular were sub-optimal with regard to scientific
rigour of development. and scored slightly above average for contexl and content
(reliability, applicability, flexibility and c1arity).l1' This may have accounted for the
suboptimal level of adherence to prescribing guidelines discovered in the present study.
Because neither set of guidelines have been subject to rigorous scientific cvalual:ion for
efficacy, it has not been unequivocally proven that prescribing in the recommended
manner is useful and therefore warranted, even though both lools were fonnulated from
expen opinion. Therefore it is imperative that guidelines which withstand scientifically
rigorous evaluation are developed so thaI physicians can have uanost confidence that
aligning their antibiotic prescribing practices with the guidelines is the best approacb for
their patients and is beneficial from dl perspectives.
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Once evidence·based and validated antibiotic: praaibing guidelines have been
developed. a second recommendation is to ensure that an effective SU'alCgy is in pt.:c: to
facilitale the adoption of the antibiotic prescribing guidelines in daily practice by
physicians. 121 . 122 Such stralegies arc oeccssary to make c:ertai.o thai the disscminaled
guidelitJC5 will impacl prescribing behaviour. Simply providing a printed version of
guidelines has bttn previously shown 10 have a very 'Neale influcoce 00 prescribing
behaviour or physician practice pancms.. l12·m Therefore simply diS1ributing the
prescribing guidelines does not CTlSUJ'e that physicians will incorporate them into their
daily practice. Although this second recommendation is perhaps a costly venrure. easy
access to antibiotic prescribing guidelines could be ensured through the implcmemation
ofa computCt'·ba.sed prescribing decision suppa" system. 1bis type of intervention could
feasibly be operated in both community practices and hospitals. With this type of system.
antibiotic prescribing protocols or guidelines would be CCDtral to the program..
Information specific 10 the paticot would be entered into the program. resulting in patient.
specific recommendations for traltmcrlL12&. 129 lbc pwposc of implemcotalion of this
type of computer-based dttision support system: would be to improve quality of care with
regard to antibiotic treatment by potentially reducing excessive or inappropriate antibiotic
prescriptions.
A pn:ccdent for the usefulness of a computer-based decision support system for
antibiotic prescribing has been rcportcd.1JO, 1]1 Evans and colleagues implemented a
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point-of-care computer-assisted management program for the treattnent of infections in
an acute care centre. With this system.. patient-specific infonnation such as diagnosis.
white cell count. temperature. surgical data, chest radiographs and reports from
pathology, serology and microbiology are incorporated together to determine the
appropriate antibiotic treaonent. As well. other factors such as allergies. drug..<frug
interactions. toxicity and cost are also considered in the computer program. A
recommendation for choice of antibiotic treaanent in addition to route of administration.
dose, frequency and duration are provided. Physicians can override the suggestions, but
must explain the rationale for their own antibiotic choice. III Evaluation of this computer·
based decision support system has revealed that improvements in antibiotic prescribing
have occurred since its implementation. For example less adverse drug reactions,
susceptibility mismatches, and overdosing occurred after the system was in place. As
well overall fewer doses of antibiotics were administered. reductions in antibiotic drug
costs occurred, and patients treated with antibiotics spent fewer days in hospital. III
Therefore improvements in antimicrobial use have been docwnented following the
implementation ofa computet.based decision support system.
A third recommendation with regard to improving antibiotic prescribing practices
is to incorporate an antibiotic prescription monitoring program for both cooununity
practices and in hospital. This type of intervention, typically refened to as physician
profiling, woul.d involve the comparison of the physicians' individual antibiotic
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prescribing behaviour to some sort of prescribing gold standard, evolved from either
antibiotic prescribing guidelines or a "benchmark" that bas been previously established.
In this manner. differences between aetuaI antibiotic prescribing panems of individual
physicians and recommended practices would be noted. Periodic reponing of the
monitoring results to the individual physicians would be provided and preswnably this
feedback would serve as the impetus for change in those pnysicians prescribing
antibiotics in a less than satisfactory manner.
Previous studies have shown that individual monitoring or feedback is a
moderately effective intervention giving rise to change in physician practice panems. 132
This type of intervention has been previously anempted with regard (0 antibiotic
prescribing in bom hospitals and community practice, also giving rise to encouraging
results. In a study conducted by de Silva and colleagues, an ongoing program of peer
review of antibiotic prescriptions in an acute care facility was found to significantly
reduce inappropriate prescribing of third generation cephaJosporins and aminoglycosides
(the two targets of the intervention), in that the percentage of mean monthly costs of
inappropriate prescriptions fell from 41% to 70/0 after a prncription monitoring; system.
was implemented. lJ3 Two feedback studies focussing on antibiotic prescribing have been
conducted in community practices. Pins and Vincent's study involved a one time general
feedback on antibiotic prescribing for sore throats following a two month audit period. 1JoI
The prescribing data for individual doctors was presenled in addition to a proposed policy
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on antibiotic prescribing for sore throats. Although overall variation in antibiotic
prescribing rates had not changed after !.be audit, the choices in antibiotics used to treat
sore throats had improved; substantially more patients were treated with either penicillin
or erythromycin thus increasing the appropriateness ofthc prescriptions. llt
A Canadian study also demonstrated positive effects from a feedback program
involving antibiotic prescribing. lJ5 The goal of this particular program was to reduce
antibiotic prescription costs by providing individualized feedback to primary care:
physicians. Choices in antibiotic therapy were compared with recommendations for
treatment outlined in the Ontario Anti-infective Guidelines for Community-acquiJed
Infections. I Given that cost of therapy was an importaDt consideration in the
development of the guidelines (i.e. with efficacy and safety being equal. the less
expensive antibiotic would be listed as a first line agent for treatment before more
expensive choices), it was hypothesized that individual feedback on antibiotic prescribing
would encowage the physicians to prescribe more first line agents. thus reducing
prescription costs. IH After the implementation of the feedback program. the authors
found that there were no changes in the median antibiotic prescription costs among those
physicians who had received prescribing feedback. However thc control physicians. for
which no feedback was provided, increased their average prescriptions costs by over
S3.00. lJ5 A post·study survcy indicated tha1 82-;. of participants would readily
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panicipate in similar future programs. us Therefore the feedback intervention was not
only successful, but favourably received by the participants as well.
All of the above cited refcm1ce5 utilising a feedback or audit on antibiotic
prescribing included some type of educational componenL 1bc educational component
was delivered either at a seminar or by an infonnational mail-out. Although
infonnational mail-<luts or seminars in isolation have not been shown to resuJt in changes
in prescribing behaviour, their inclusion in physician profiling programs appears to be
useful. With regard to antibiotic prescription monitoring. the educational component of
future audit programs could perhaps incorporate both seminars and printed mail-<luts
outlining the recommended guidelines for antibiotic prescribing. The monitoring
program could potentiaJly serve as a means to determine whether the guidelines wen::
effectively disseminated in addition to serving as an intervention on its own.
A fourth recommendation to improve antibiotic prescribing is the commencement
of a detailing or mentoring program for physicians by respcelcd opinion leaders. This
type of program is typically modelled after the detailing programs in use by private
industry, in which sales representatives visit physicians in a onc-<ln-<lDC meeting to
infonn the physicians about various aspects of phannaccuticals. The academic detailing
program should be nonpunitive, concise and endorsed by the local medical association.
The ftrst successful academic detailing programs focussed on antibiotic prescribing wen::
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published almost twenty years agO.Il6., 1)7 Schaffner aDd colleagues demoMtnled thal a
sbon.. single visit by a physician colleague can reduce prescribing of contraindicated
antibiotics and oral cephalosporins.1l1 In follow.up studies. Ray aDd colleagues
demonstrated that the effectual changes in antibiotic pn:scribing from the detailing
program were long term with the positive changes in antibiotic prescribing lasting up to
rwo years afteT the physician visits. u, interestingly the variation in prescribing behaviour
in response to the educational visit could not be explained by medical demographics of
the participating physicians (i.e. type of practice, year since graduation, board
certification., receptivity to the educational visit).I39 As the authors point out, this finding
suggests that no panicular group of physicians arc refractory to an educational visit. l39
Since these earlier studies, other investigators have abo published the results of
successful academic ddailing interventions involving antibiotic prcscribing.13r42 A
corrunon aspect of these studies involves the usc of a focussed antibiotic prescribing
message delivered by an opinioo leader. In one oftbesc published reports, a pilot study
....-as initiated to determine the CXIlCt nature of problematic antibiotic prescribing in order
10 formulate the focussed academic detailing me:ssqe. l40 lbcrefore the results of the
current study on antibiotic prescribing in St. John's, NF could be used to develop
focussed academic detailing I'I1CSSagC$ as well. Specifically, messages oullining the need
for a more critical evaluation of bacterial versus viral ctiolOi)' in respiratory tract
infcctiOll$ (and therefore the need for antibiotic lreatment), improved drug choice for the
I'.
treatment of non-respiratory infections. and decreased length of treatment for urinary
tract infections would serve as useful messages to be imparted to geDeTa1 practitiooen in
the community. For acute care pbysicians treating patients admitted to hospital with
community-acquired pneumonia, the current stUdy bas revealed the need for a more
critical evaluation of severity of disease (and therefore the Deed to admit patients to
hospital) and improvement in drug choices for both initial empiric treatment and when
patients are switched to oral medications.
10 order to ensure that antibiotics are as effective as possible. it is important that
local resistance panerns are regularly monitored. Therefore a fifth recommendation is to
establish a program in which pathogens giving rise to local nosocomial and community-
acquired infections are routinely collected., isolated and monitored to measure their
resistance pattems. With this approach, resistance would be measured from a clinical
perspective based on the number of infected patients as opposed to a laboratory one based
on the Dumber of isolates. l43 This type of program would ~uire the local coordinated
effort of physicians. patients. microbiologists and infectious diseases specialists. and
could be overseen by the local public health departmenl. A bacterial pathogen resistance
surveillance program would serve to keep local antibiotic prescribing guidelines up to
date. as resistance is a continual evolutionary process. Furthennore regular surveillance
of local bacterial resistance patterns could potentially allow researchers to detennine if
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implemented antibiotic prescribing policies or interVentions are effective and successful
by cross referencing data on resistance panems with antibiotic prescribing data. 1.(3
The final m:ommendation to improve antibiotic prescribing, specifically affecting
general practitioners, is to launch a public education campaign in which prudent
antibiotic prescribing is promoted. Physicians are ultimately the individuals who decide
whether or not an antibiotic should be given and, if so. which ODe. However public
pressure has been implicated in confounding the antibiotic prescribing decision. In the
present study, patient presswe or expectation for an antibiotic prescription (as perceived
by the physician) was an influencing factor in many of the cases in which an antibiotic
was prescribed, particularly for respiratory tract infection diagnoses. Therefore to
singularly implement interventions or policies that focus on cbanging physicians'
attitudes and behaviolUS toward antibiotic prescribing negates the role that the patients
play in prescription decision-making. If this wen: the case and pbysicians were the only
ones 10 change. in the absence of public education., patients would continue 10 expect or
demand antibiotics and possibly become very dissatisfied with physicians for not
providing a prescription. Patients would perhaps become confused about why
prescriptions were given in the past. but not during CW'T'eIlt visits.
An example of a CW'T'eIlt Canadian public education campaign promoting the
message of decreased antibiotic use in the community is the "00 Bugs Need Drugs?'"'
15.
campaign launched in the Edmonton area in the province of Alberta
(http://www.dobugsneeddrugs.org).This particular campaign is comprehensive in the
dissemination of its message. wgeting healthcare professionals. the general public.
leachers. parents and children. Three key messages have been emphasized: I) the
importance of handwashing to stop the spread of infections, 2) the difference between
bacterial and viral infections and the uselessness of antibiotics in the treatment of
infections caused by viroses. and 3) the prudent use ofantibiotics being an important step
in preventing bacterial resistance. The goaJ of the campaign is to increase public
awareness about the seriousness of bacterial resistance and how inappropriate use of
antibiotics contributes to this public health problem.
Because this study has identified antibiotic prescribing problems that an: multi-
faceted. a multi-faceted approach 10 a solution for these problems is required. Changing
antibiotic prescribing to reduce excess of prescriptions and to make necessary
prescriptions in line with CW'T'Ctlt recommendations most likely will not entirely fix or
reverse me current problems with bacterial resisww:e. However changing CWTent
practices to more appropriate future prescribing trends will undoubtedly contribute to the
prevention of funber resistance from developing. Given the prevalence of bacterial
infections and the distinct possibility, in some cases, for the infection to result in death, it
is imperative that we preserve the power that antimicrobial agents have over bacterial
pathogens. Antibiotic utilisation studies an: the first step toward this goal. By
159
identifying bow antibiotics are prescribed in various health care senings. problematic
prescribing caD be aptly identified. Subsequently, interventions or policies directed
towards changing prescribing behaviour in rc5pODSt to the identified problems can be
implemented. As a result the development ofadverse consequences originally stemming
from problematic antibiotic prescribing can be stymied, leading to future mention of the
power lhat antibiotics have over bacterial pathogens.
160
CHAP'TER VD • REFERENCES
Ontario Anti-infective Review Panel. Anti-infective Guidelines for Communif)'·
acquired Infections. Toronto: Publications Ontario, 1997.
2. MaodeU LA. Antimicrobial treaDDeDt of community acquired poewnonia in
adults: a c:onference report. Can J Infect Dis 1993; 4:25-21.
3. O'Brien TF. Pia MP, Mayer KH, et aI. lntere:ontinental spread ora DeW antibiotic
resistance gene on an epidemic: plasmid. Science 1985; 230:87·8.
4. Blumberg HM. RimJand D. Carroll OJ. Tcny P. Wachsmuth IK. Rapid
development of ciprofloxac:in resistance in methicillin· susceptible and -resistant
Staphylococcus aurew. J Infect Dis 1991; 163:1279-85.
5. Seppala H. Klaukka T. Lehtonen R. Nenonen E, Hoovinen P. Outpatient use of
erythromycin: link 10 increased erythromycin resistance in group A StreplOCOC:ci.
Clin lnfect Dis 1995; 21: I 378-85.
6. Baquero F. Trends in antibiotic: resistance of respiratory pathogens: an analysis
and commentary on a collaborative surveillarx:e study. J Antimicrob Chemothet
1996; 38 Suppl A:I17·32.
7. Levin BR. Lipsite:b M. Perrot V. d. aI. The popuJation genetics of antibiotic
~istance.Clio Infect Dis 1997; 24 Suppi 1:S9·16.
8. Miller GR Saba1e1li FJ. Hue RS. et aI. The most frequent aminog.lycoside
resistance mechanisms-changes with time and geographic: area:: a reflection of
amioogIycoside usaae panems? AminogIymside Resistance Study Groups. CLin
Infect Dis 1997; 24 Suppl 1:546-62.
9. Seppala H. Klaukb T. Voopio-VarlciJa J, et aI. The effect of changes in the
con.'runlplion of macrolide antibiotics 00 erythromycin resistance in group A
stt1:pIococci in Finland. Finnish Study Group for Antimicrobial Resistance. N
Eng} J Mcd 1997; 337:441-6.
10. Austin OJ. Kristinsson KG. Anderson RM. The relationship bctwccn the volume
of antimicrobial consumption in human communities and the frequency of
resi.stane:e. Proc Nat! Acad Sci USA 1999; 96:1152-6.
11. Neu HC. The crisis in antibiotic resi.stane:e. Science 1992; 257: 1064-73.
'61
12. Campbell GO. Jr., Silbennan R. Omg-resistant Streptoc:occus pneumoniae. Clin
Infect Dis 1998; 26: 1188-95.
13. Controlling antimicrobial resistance: an integrated action plan for Canadians.
Montreal: Health Canada and The Canadian Infectious Disease Society, 1997.
14. Carrie AG, Zhanel 00. Antibacterial use in community practice: assessing
quantity. indications and appropriateness. and relationship to the development of
antibacterial resistance. Drugs 1999; 57:871-81.
15. Mycek M. Gertner S, Perper M. In: Pharmacology. Harvey R ed. New York: J.B.
Lippincott Company, 1992.
16. Davies J. Another look at antibiotic resistance. 1991 Fred Griffith Review
Lec~. J Gen Microbiol 1992; 138:1553-9.
17. Comroe m, Jr. Pay dirt: the story of streptomycin. Part I. From Waksman 10
Waksmao. Am Rev Respir Dis 1978; 117:773-81.
18. Gardner P, Smith DH. Beer H. Moellering RC, Jr. Recovery of resistance (R)
factors from a drug-free community. Lancet 1969; 2:774-6.
19. Neu H. Goott T. Antimicrobial Chemotherapy. In: Medical Microbiology.
Galveston: The University of Texas Medical Branch at Galveston, 1996.
20. Shaw KJ. Rather PN, Hare RS. Miller GH. Molecular genetics of aminoglycoside
resistance genes and familial relationships of the aminoglycoside-modifying
enzymes. Microbiol Rev 1993; 57:138~3.
21. Livermore D. beta-Lactamases in laboratory and clinical resistance. Clin.
Microbiol. Rev. 1995; 8:557-584.
22. Chopra I, Hawkey PM, Hinton M. Tetracyclines., molecular and clinical aspects. J
AntimicrobCbemotheT 1992; 29:245-77.
23. Micbel M. GutmanP L. Methicillin-resistant Stapbyloc:occus aureus and
vancomycin-resistant enterococci: thenlpeutic realities and possibilities. Lancet
1997; 349:1901-6.
24. Davies J. Origins and evolution of antibiotic resi.staDCe. Microbiologia 1996;
12:9-16.
162
25. File TM. Jr. Overview of resistance in the 1990s. Chest 1999; 115:35·85.
26. Honore N. Cole 5T. Streptomycin resistance in mycobacteria. Antimicrob Agents
Chemother 1994; 38:238-42.
27. Davies J. Vicious cireles: looking back on resistance plasmids. Genetics 1995;
139:1465-8.
28. Mazodic:r p. Davies J. Gene: transfer between distantly related bacteria. Annu Rev
Genet 1991; 25:147-71.
29. Cohen ML. Epidemiology of drug resistance: implications ror a plst-
antimicrobial era... Science 1992; 257:1050-5.
30. Gonzales R. Steiner IF, Sande MA. Antibiotic prescribing ror adults with colds.
upper respiratory tract infections. and bronchitis by ambulatory care physicians.
lAMA 1997; 278:901-4.
) 1. Mazzaglia G, Greco S, Lando C. Cucinona G. Caputi AP. Adult acute upper
respiratory tract infections in Sicily: pancm or antibiotic drug prescription in
primary care. J Antimicrob Chemother 1998; 41 :259-66.
32. Feiltin DR. Schuchat A. Kolczak M. et aI. Monality from invasive pneumococcal
pneumonia in the era or antibiotic resistance. 1995-1997. Am J Public Health
2000: 90:223·9.
33. Moreno F. Crisp C. Jorgensen JH, Panersoo ]E. Methicillin-resiSWIt
Staphylococcus awellS as a community organism. Clio lnfect Dis 1995; 21: 1308·
12.
34. ArclUbaid L. PlUmps L. Monoet D. McGowan JE, Jr.• Teoover F, Gayncs R...
Antimicrobial resistance in isolates from inpatients and outpatients in the United
Stales: increasing importance or the intensive care unit Clin Inrect Dis 1997;
24:211·5.
35. Schaberg DR. Culver DH. Gayncs RP. Major tn:nds in the microbiaJ etiology or
nosocomial infection. Am J Med 1991; 91:72S·755.
36. Nosocomial enteroeoeei resistant to vancomycin-United States, 1989- 1993.
MMWR Morb Mona! Wldy Rep 1993; 42:597-9.
163
37. Gold HS. Moellering RC. Jr. Antimicrobial~gresistance. N Eng.! J Mcd 1996;
335:1445-53.
38. Shay OK., Malooey SA. Montecalvo M. et aI. Epidemiology and moctality risk of
vancomycin-resistant enteroeoeeal bloodstream infections. J Infect Dis 1995;
1n:993-1 000.
39. Col NF. O'COllDOr W. Estimating worldw;de C\UT'CDt antibiotic usage: report of
task force 1. Rcv Infect Dis 1987; 9:$232-S242.
40. McManus P. Hammood MI.. Whicker SO. Primrose JG. Mant A. Fairall SR.
Antibiotic usc in the Australian comnu.mity. 1990-1995. Mcd J Aust 1997;
167:124-7.
41. WHO. Guidclines for ATC Classification and DOD AssignmcnL Oslo. Norway:
World Health Organization, 1996.
42. Finkel MJ. Magnitude of antibiotic use. Ann lnt Med 1978; 89:791-792.
43. Norrby SR. Johansson H. Antibiotic consumption in Sweden 1975 to 1987:
changes in prescription panmtS. Scand J Infect Dis Suppl 1989; 60:9-15.
44. Birkett OJ. Mitchell AS. Godeck A. Grigson T. Cully R. Lee C. Profiles of
antibacterial drug usc in Australia and trends from 1987 10 1989. A report bom
the OnJg Utilization Subcommittee of the Phannaccutical Bcocfits Advisory
Commince. Mcd J Aust 1991: 155:410-5.
45. Davey PO. Sax RP. Newey J. et aL Growth in the use of antibiotics in the
community in England and Scotland in 19~93. 8MJ 1996; 312:613.
46. Grave K. Lingaas E. Bangen M. Ronning M. Surveillance of the overall
consumption of antibacterial drugs in humans, domestic animals and fanned fish
in Norway in 1992 and 1996. J A.ntimic Cbcm 1999; 43:243-252.
47. Bro F. Mab«k CE. Use of antibiotics in general practice in Oenmari. Presaibcd
daily dose. duratiOD of treatment and nwnbcr of treatmmts in general practice.
Scand J Prim HeaJth Care 1986; 4: 101-4.
48. Friis H. 8ro F. Mabcck CEo Vejlsgaard R. Use of antibiotics in general practice in
Denmark in 1987. Scand J Infect Dis 1989; 21 :551-{i.
164
49. Munro C. Boston R. Bogiatzis G. Gibbons J, O'Sullivan J. Panems of antibiotic
prescribing in Queensland general practice. Aust Fam Physician 1988; 11:1014-1.
50. Wyatt m, Passmore CM, Morrow NC. Reilly PM. Antibiotic prescribing: the
need for a policy in genmal practice. BMJ 1990; 300:441-4.
51. McCaig LF, Hughes 1M. Trends in antimicrobiaJ drug prescribing among offi,*
based physicians in the United States. JAMA 1995; 213:214-9.
52. Majeed A. Moser K. Age-and sex-specific antibiotic prescribing panc:ms in
general practice in England and Wales in 1996. Br J Gen Prac 1999; 49:735-136.
53. Lindbaek M. Berild D. Straand J. Hjortdahl P. lnfluence of prescription patterns
in general practice on anti- microbial resistance in Norway. Br J Gen Pract 1999;
49:436-40.
54. Macfarlane J. Lewis SA. Macfarlane R. Holmes W. Contemporary use of
antibiotics in 1089 adults presenting with acute lower respiratory tract illness in
genera! practice in the U.K.: implications for de...eloping management guidelines.
Respir Med 1997; 91 :421·34.
55. Kuyvenho...en MM. Verheij n. de Melker IV\. ...an der Velden J. Antimicrobial
agents in lower respiratory uaet infections in Dutch general practice. Br J Gm
Pract 2000; SO: I33-4.
56. Gonzales R. BarTen PH. Jr.• Crane: LA, Steiner JF. Factors associated with
antibiotic use for acute broochitis. J Gen Intern Med 1998; 13:541-8.
51. Met.lay JP. Stafford RS. Singer DE. National trends in the use of antibiotics by
primary care physicians for adult patients with cough. Arcb lntem Med 1998;
158:1813·8.
58. Nyquist AC. Gonzales R. Steiner IF. Sande MA. Antibiotic prescribing for
children with colds. upper respiralory b'aCt infections. and bronchitis. JAMA
1998: 219:815-1.
59. Orr PH. Schern K.. Macdonald A, Moffatt ME.. Randomized placebo-controlled
trials of antibiotics for acute bronchitis: a critical re'liew of the literature. J Fam
Pract 1993; 36:501-12.
60. Gonzales R. Sande M. What will it take to stop physicians from pl'escribing
antibiotics in acute bronchitis? lan<:e11995; 345:665-6.
165
61. Bent S. Saint S. Vininghoff E, Grady D. Antibiotics in .cute broochitis: a meta·
anaJysis. Am J Med 1999; 101:62·1.
62. Mainous AG. Huestoo WJ. Clut 1R Antibiotics and upper respiratory infection:
do some folks think there is a cure for the common cold. J Fam Pract 1996;
42:351-61.
63. Mainous AG!'. HuestOlJ WJ. The cost of antibiotics in treating upper respiratory
tract infections in a medicaid popuJation. Arch Faro Mcd 1998; 7:45-9.
64. Howie JG. Richardson lM. Gill G. Dumo D. Respiratory illness and antibiotic use
in general practice. J RColl GeD Pnw;:t 1971; 21:657-63.
65. Touw-Ot1en FW. Johansen KS. Diagnosis. antibiotic treatment and outcome of
acute tonsillitis: repo"- of a WHO Regional Office for Europe study in 17
European countries. Fam Pract 1992; 9:255-62.
66. Bauc:hner H. Philipp B. Reducing inapproprilJe oral antibiotic use: a pm;criptioa
for change. Pediatrics 1998; 102:142-5.
61. Pitts J. Vil1Cft1t SH. Diagnostic labels, treatment and outcome in acute sore throaL
Practitioner 1988; 232:343-6.
68. Avom J. Solomon DH. Cul1uIaI and economic factors that (mis)shape antibiotic
use: the: nonphatmac:ologic basis ofthmapeutics. At'\D Intmt Med 2000; 133:128-
)S.
69. Cars H. Hakanssoo A. To ptt:seribe-or DOt to pre:scribe-antibiocics. DiSbict
physicians' habits vary greatly. and are difficult to change. Scand J Prim Health
Care 1995; 13:3·1.
10. Belongia EA. Scbwanz B. Strategies for promoting judicious use of antibiotics by
doctors and patients. BMJ 1998; 311:668-11.
11. Mcisaac WJ. Butler CC. Docs c1itUca1 error contribute to unnecessary antibiotic
use? Meet Oe<:is Making 2000; 20:33-8.
12. BnIdley CPo Uncomfonable prescribing decisions: a critical incident study. 8MI
1992; 304:294-6.
166
73. Bradley CPo Factors which influence the decision whether or not to prescribe: the
dilemma facing general practitioners. Br 1 Gen Pract 1992; 42:454-8.
74. Makela MJ. Puhakb T, Ruuskanen 0, et: a1. Viruses and bacteria iii the etiology
of the common cold. 1 Clin Microbial 1998; 36:539-42.
75. Howie IG. Clinical judgement and antibiotic use in general practice. Br Med J
1976; 2:1061-4.
76. Howie IG. Bigg AR. Family trends in psycbottopic and antibiotic prescribing in
general practice. Br Moo 11980; 280:836--8.
77. Petunlson P. What detennines a family doctor's prescribing habits for antibiotics?
A comparative study on a doctor's own behaviour in lwo different senings. Scaod
1 Prim Health Care 1996; 14: 196--202.
18. Hutchinson JM. Foley RN. Method of physician remuneration and rates of
antibiotic prescription. CMAJ 1999; 160:1013-7.
19. Kuyvenhoven M. de Melker R. van der Velden K. Prescription of antibiotics and
prescribers' characteristics. A study into prescription of antibiotics in upper
respiralory U"llCt infections in general practice. Fam Pn.ct 1993; 10:366-70.
80. Kawamoto R. Igarashi M. Antibiotics for URIs in Japan. J Fam Pract 1997;
45:461.
81. Mainous AGr. Hueston WJ, Love MM. Antibiotics for colds in children: who are
the high prescribers? Arch Ped.iatr Adolesc Moo 1998; 152:349-52.
82. Steffensen FH. Schonheyder HC. Sorensen HT. High prescribers of antibiotics
among general practitioners-relation to prescribing habits of other drugs and use
ofrnicrobiological diagnostics. Scand 1 lnfe<:t Dis 1997; 29:409·13.
83. Steinke DT. Bain OJ. MacDonald TM. Davey PG. Practice factors that influc:oce
antibiotic prescribing in general practice in tayside. 1 Antimicrob Chemother
2000; 46:509-12.
84. Vinson DC. Lutz U. The effect of parental expectations on treatment of children
with a cough: a repon from ASPN. J Faro Pract 1993; 31:23-1.
85. Miller E. MacKeigan LO. Rosser W, Marshman J. Effects of perceived patient
demand on prescribing anti-infective drugs. CMAJ 1999; 161: 139-42.
167
86. Bauchner H, Pelton SI, Klein 10. Parents, pbysicians, and antibiotic use.
Pediatrics 1999~ 103:395-401.
87. Macfarlane 1, Holmes W. Macfarlane R, Britten N. Influence of patients'
expectations on antibiotic management of acute lower respiratory tract illness in
general practice: questionnaire study. BMJ 1997; 315:t21 1-4.
88. Palmer DA, Bauchner H. Parents' and physicians' views on antibiotics. Pediatrics
1997; 99:E6.
89. Mainous AG. 3rd, 1.oorob RJ, Oler MJ, Haynes OM. Patient knowledge of upper
respiratory infections: implications for antibiotic expectations and \llI.lIe<:CSSlU
utilization. 1 Fam Pract 1997; 45:75-83.
90. Wilson AA. Crane LA. Banett PH, Gonzales R. Public beliefs and use of
antibiotics for acute respiratory illness. 1 Gm lntem Med 1999; 14:658-62.
91. Hong lS, Philbrick IT. Schorling 18. Treatment of upper respiratory infections:
do patients really want antibiotics? Am 1 Med 1999; 107:511-5.
92. Hamm RM, Hicks RJ. Bemben DA. Antibiotics and respiratory infections: are
patients more satisfied when expectations are met? 1 Fam Pract 1996; 43:56-62.
93. Cowan PF. Patient satisfaction with an office visit for the common cold. 1 Fam
Pract 1987; 24:412-3.
94. Bartlen lG, Mundy LM. Community-acquired pneumonia. N Eng! 1 Med 1995;
333:1618-24.
95. Marston 81. Plouffe JF. File 1M, lr.• et aI. Incidence of community-acquired
pncwnonia requiring hospitalization. Results of a population-based active
surveillance Study in Ohio. The Comnumity-Based Pnewnonia Incidence Study
Group. Arch Intern Med 1997; 157:1709-18.
96. Guglielmo L. Leone R. Moretti U. Conforti A, Spolaor A. Velo G. Antibiotic
prescribing panems in Italian hospital inpatients with pnewnonia, chronic
obstructive pulmonary disease. and urinary tract infections. Ann Phannacother
1993; 27:18-22.
97. Onqvist A. Prognosis in commWlity-acquired pneWDOnia requiring treatment in
hospital. Imponance of predisposing and complicating factors, and of diagnostic
procedures. Scand J Infect Dis Suppl 1990; 65:1-62.
168
98. Grasela TH, Jr.• Schenlag JJ, Boekenoogen SJ, Crist KD, Lowes WL, Lum BL. A
clinical pbarmacy-oriented drug surveillance netWork: results of a nationwide
antibiotic utilization review of bacterial pnewnonia-1987. DlCP 1989; 23:162·
70.
99. Grasela TIl. Jr., Welage LS, WalawaDder CA. et aI. A nationwide survey of
antibiotic prescribing panems and clinical outcomes in patients with bacterial
pneumonia DlCP 1990; 24:1220-5.
100. Ramirez lA. Vargas S, Ritter GW. et aI. Early switch from intravenous to oral
antibiotics and early hospital discharge: a prospective observational study of 200
consecutive patients with community-acquired pneumonia. Arch Intern Mod
1999; 159:2449-54.
101. Feagan BG, Martie TJ, Lau CY, Wheeler SL. Wong CJ, VandeJvoort MK..
Treaunent and outcomes of community-acquired pneumonia at Canadian
hospitals. CMAJ 2000; 162:1415-20.
102. Manas TK.. Chan CK. Use of guidelines in tmnin& community-acquired
pneumonia Chest 1998; 113:1689-94.
103. Gleason PP. Meehan TP. Fine 1M, Galusha DH, Fine MJ. Associations between
initial antimicrobial therapy and medical outcomes for hospitalized elderly
patients with pneumonia. Arch Intern Med 1999; 159:2562·72.
104. Bartlett J. Management of Respiratory Tract Infections. New York: Lippincon
Williams&. Wilkins, 1999.
105. Hickner JM, Bartlett 10. Besser RE, Gonzales R., Hoffman JR.. Sande MA.
Principles of appropriate antibiotic use for acute rhinosinusitis in adults:
backgroWKI. Ann Intern Mod 2001; 134:498-505.
106. Cooper RJ, Hoffman 1R, BanJen JG, et aI. Princip~ of appropriate antibiotic use
for acute pharyngitis in adults: background. Ann Intern Mod 2001; 134:509-17.
107. Gonzales R. Bartlett JG, Besser RE, et aI. Principles of appropriate antibiotic use
for treaunent of uncomplicated acute bronchitis: background. Ann l:1tem Mod
2001; 134:521·9.
169
108. Gonzales R. Bartlett JG, Besser RE, Hickncr 1M, Hoffman JR, Sande MA.
Principles of appropriate antibiotic usc for treatJncnt of nonspecific upper
respiIatory tract infections in adults: background. Ann lntem Med 2001; 134:490-
4.
109. Compendium of Pharmaceuticals and Specialties. In: Krogh C, ed. Toronto: CK
Productions. 1996.
110. Fine MJ. Auble TE. Yea1y OM. e'l aI. A prediction rule to identify low·risk
patients with community-acquired pneumonia. N Eng! J Med 1997; 336:243-50.
III. Chassin MR. Kosecoff l. Park RE, e'l at Does inappropriate use explain
geographic variations in the use of health care services? A study of three
procedures. lAMA 1981; 258:2533-7.
112. Normy SR. Shol1-tenn treatment of uncomplicated lowet" urinary tract infections
in women. Rev infect Dis 1990; 12:458-67.
113. Hooton TM, Stamm WE. Diagnosis and treatmc:nt of uncomplicated urinary tract
infection. Infect Dis Clin North Am 1997; 11:551-81.
114. Fine Ml. Singet" DE. Phelps At. Hanusa BH, Kapoor WN. Differences in length
of hospital stay in patients with community· acquired pneumonia: a prospective
four-bospilal study. Med Care 1993; 31:371-80.
115. McConnick D. Fine MJ, Coley eM. et a1. Variation in length of hospital stay in
patients with community- acquired pnewnonia: are shorter stays associated with
worse medical outcomes? Am 1 M,...j 1999; 107:5-12.
116. Grimshaw 1M. Russell IT. Effect of clinical guidelines on medical practice: a
systematic review of rigorous evaluations. Lancet 1993; 342: 131 7·22.
117. Hayward RS, Guyatt GH, Moore KA, McKibbon KA, Caner AO. Canadian
physicians' attitudes about and preferences regarding clinical practice guidelines.
CMAJ 1997; 156:1715-23.
118. Shaneyfelt TM. Mayo-Smith MF. Rothwangl 1. Are guidelines following
guidelines? The methodological quality of clinical practice guidelines in the peer-
reviewed medical literature. lAMA 1999; 281:1900-5.
119. Graham ID. Beardall S, Carter AO, et aI. What is the quality of drug therapy
clinical practice guidelines in Canada? CMAJ 2001; 165:157-63.
170
120. lAlmas J. Words without action? The production, dis.'>C'Inination, and impact of
consensus recommendations. Annu Rev Public Health 1991; 12:41-65.
121. Wise eG. Billi IE. A model for practice guideline adaptation and implementation:
empowennent of the physician. Jt Comm J Quallrnprov 1995; 21 :465-76.
122. Davis DA. Taylor Vaisey A. Translating guidelines into practice. A systematic
review of theoretic cOn<:epts. practical experience and research evidence in the
adoption ofclinical practice guidelines. CMAJ 1997; 157:408·16.
123. Berbatis CG. Maher MJ, Plumridge RJ. Stoelwioder m, Zubrick SR. Impact of a
drug bulletin on prescribing oral analgesics in a teal:bing hospital. Am J Hosp
Pharm 1982; 39:98-100.
124. Evans CEo Haynes RB. Birken NJ. et al. Does a mailed continuing education
program improve physician perfonnance? Results of a randomized trial in
antihypertensive care. JAMA 1986; 255:50)-4.
125. Soumerai SB. Mclaughlin TJ, Avom J. Improving drug prescribing in primary
can::: a critical analysis of the experimental literature. Milbank Q 1989; 67:268-
317.
126. Denig P, Haaijer-Ruskamp FM. Zijsling DH. Impact of a drug bulletin on the
knowledge, perception of drug utility, and prescribing behavior of physicians.
DICP 1990; 24:R1-93.
127. Lee TH. Pearson SO. Johnson PA. et aI. Failure ofinfonnation as an interVention
to modify clinical management. A time·series trial in patients with acute chest
pain. Ann Intern Med 1995; 122:434-1.
128. Randolph AG. Haynes RD. Wyan JC, Cook OJ, Guyan GH. Users' Guides to the
Medical Literature: xvm. How to use an ankle evaluating the clinical impact of
a computer-based clinical decision support system. JAMA 1999: 282:67-74.
129. Weekley J5. Smith 81, Pradhan M. The intersection of health infonnaUcs and
evidence-based medicine: computer-based systems to assist clinicians. Med J
Aust 2000; ) 73:376-8.
130. Pestotnik SL. Classen DC, Evans RS. Burke JP. Implementing antibiotic practice
guidelines through computer-assisted decision suppon: clinical and financial
outcomes. Ann Intern Med 1996; 124:884-90.
171
131. Evans RS. Pestotnik Sl. Classen DC. et al. A computeT-assisted management
program for antibiotics and other antiinfective agents. N Engl J Med 1998;
338:232-8.
132. Oxman AD. Thomson MA, Davis DA. Haynes RB. No magic bullets: a
systematic review of 102 trials of interventions to improve professional practice.
CMAJ 1995; 153:1423-31.
133. de Silva MI. Mize GN. Rissing JP. Peer review of antibiotic use: positive impact
on physician prescribing patterns. QRB Qual Rev Bull 1985; 11:302-5.
134. Pins 1. Vincent S. What influences doctors' prescribing? Sore throats revisited. 1
R Coli Gen Pract 1989; 39:65-6.
135. Hux IE. Melady MP. DeBoer D. Confidentiai prescriber feedback and education
to improve antibiotic use in primary care: a controlled triai. CMAJ 1999;
161:388·92.
136. McConnell TS, Cushing AH, Bankhum AD, Healy lL, McUvenna PA. Skipper
Bl. Physician behavior modification using claims data: tetracycline for upper
respiratory infection. West 1 Med 1982; 137:448·50.
137. Schaffner w. Ray WA. Federspiel CF. Miller WOo Improving antibiotic
prescribing in office practice. A controlled trial of three educational methods.
lAMA \983: 250:1728-32.
138. Ray WA. Schaffner W, Federspiel CF. Persistence of improvement in antibiotic
prescribing in office practice. lAMA 1985; 253:ITI4.6.
139. Ray WA. Fink R, Schaffner W. Federspiel CF. Improving antibiotic prescribing
in outpatient practice. Nonassociation of outcome with prescriber characteristics
and measures of receptivity. Med Care 1985; 23:1307·13.
140. De Santis G. Harvey KJ. Howard D. Mashford ML, Moulds RF. lmproving the
quality of antibiotic pt'CSCription patterns in general practice. TIle role of
educational intervention. Med J Aust 1994; 160:502·5.
141. Braybrook S. Walker R. Influencing prescribing in primary care: a comparison of
two different prescribing feedback methods. J Clin Pbarm Ther 1996; 21:247-,54.
142. lien KF. Johnson S. Greenhill G. et at. ModiiK:atiOl1 of gmeral practitioner
~bing ofantibiotics by usc ofa therapeutics adviser (academic delailer). Br J
elin PhamtacoI2000; 49:168~73.
143. Livermore OM. Macgowan AP. Wale Me. Surveillanc:e of antimicrobial
~istance. Centralised surveys to validale routine data offer a practical approach.
8MJ 1998; 317:614-5.
173
CHAPTER VIII - APPENDICES
AppeDdd I • Point Scoring System ror PDeumoDia Severity Inde!: <PSO Score·
Slep I or Pneumonia Severity Indu S<:OriDg Syslcm:
I) Is the patient more than 50 years of age?
2) Does the patient have a histOf)' of any of the following coexisting c( ._Ajtions?
Neoplastic disease
Congestive heart failure
Cerebrovascular disease
Renal disease
Liver disease
3) Does the patient have any of the following abnonnaJities on physical examination?
Altered mental status
PuJse2:125/minute
Respiratory rate 2:30/minutl:
Systolic blood pressure <90 nun Hg
Temperature <35"C or 2:40°C
If ~no~ is the appropriate answer for all of the above questions. then the: risk score equals
zero and the patient is assigned to Risk Class I.
If "yesft is answered 10 anyone or more of the above questions. then move to Step II of
the scoring system.
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Cbaracteristic
/h1ftOl,.."lIic FIIdDr
Age-Men
-Women
Nur.;ing Home Resident
Coo:istillg IU"ena
Neoplastic Disease
liver Disease
Congestive He:an Failure
C~brova.sculacDisease
Renal Disease
P1fysictU ExtlMilt.no,. r",tlUtp
Altered Mental Status
Respitatofy Rate ~OImiD
Systoltc Blood~ <90 mm Hg
Temperature <J5"C or ~400c
Pulse ~125/min
LlIboTfltory lI"d RlIdiog,.."lIic Fi"dillp
Blood Urea Nitrogen ~ll mmoVL +20
Glucose ~14 mmoVLt +10
Hematocrit <3()l'/, +10
Panial Pressure: of Anerial OxYgen <60 Hg + I0
• Adapted From Fine MJ. Aubk TE. Yealy OM. HWIUM BH. Wt~rtkl LA. SinfCG" DE. CoWy eM. Marie
TltlDd KJipoor. WN. A pndictioD Nk 10 idmOfy Iow-rislt pItialls wilb eorDlQwUry--.quirai poNIDOlliL
NE1M 1997; 3)6: 243-250.
tEkauKpukrlIirlrOl'!N£iononJlUCOfC"QlIXDInDoa_DotlvailablcrOl"dI&ll~P"lieaIswilb
diaMca.,1III1'1CMd indlc dwt. weft assipcd pom ill dlc __ l1li pDau wRb. &IUl:OtC:
~orl.IIUftOVIM.
Risk Class I'"
Risk Class 11 ...
Risk Class Ill-
Risk Class rv-
Risk Class V-
o Poinu
S10 Poinu
71-90 Poinu
91-130 Points
~13t Points
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APDs-dn n - Aoti.knbilll Tral_nl C ..iddiDa for CO.III...iIy·A~.iftd
PaeulDo.iII*
Noo·Sn~rr Pa,inu + PatieDI Prniously WeU ••d/or <65 Yean Old (RiskClali 0:
Macrolide
TetraCycline
Noa·Sntrr PalltDIJ + Co.orbid IIlDeH aad/or > 65 Yean Old (Risk Clus 11):
~- Generation Cephalosporin ::t: Macrolide
TrimethoprimlSulphamcthoxazole ± Macrolide
Penicillin plus beta·lacwnasc inhibitor::t: Macrolide
Sn'trt PltieDU· Hospital Ward (Risk Class In or IV or V):
2- or 3'" Generation Cephalosporin ± Macrolide ± Rifampin
. in penicillin-aJlttgic patients:
TrimcthoprimfSulphamethoxazole + Macrolide
Sn'trt Palieols· IDf~o,;veCarr Uoit (Risk Clalllll or IV or V):
Macrolide ± Rifampin + 3'd Generation Cephalosporin with
antipseudomonas activity
OR:
lmipmcnlCilaslaUn
OR:
Ciprofloxacin
• Adapted from Mandell et al. Anlimicrobial tmltmenl of community acquired
pnewnonia in adults: A conference repon. Can J Infect Dis 1993: 4: 25-28.
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